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Abstract 
 
1,2,3-Triazoles have proven to be highly successful in ligand design due to their facile synthesis owing 
to the advent of the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The Cu(I) species 
necessary for the CuAAC reaction can be generated in situ with simple purification of the resulting 1,4-
disubstituted products and has proven to be an outstanding method to prepare triazole-containing 
ligands. 
The present work focuses on the synthesis, characterization and photophysical investigation of triazole-
containing transition metal complexes and their possible use in applications, such as LECs and 
biological cell imaging. To explore this wide topic different types of 1,2,3-triazole containing ligands 
including 2-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine as a bidentate ligand, 2,6-bis(1-phenyl-1H-1,2,3-
triazol-4-yl)pyridine as a tridentate ligand  and 1,4-bis((4-(pyridin-2-yl)-1H-1,2,3-triazol-1-
yl)methyl)benzene as a bridging ligand.  were prepared and used with Re(I), Os(II), Ru(II)  and Ir(III) 
transition metals.  
Chapter 2 deals with rhenium complexes [Re(CO)3(Bn-pytz)(X)]+/0 (X = Cl or substituted pyridine). 
The photophysical investigation indicates that the emission can be further shifted towards the blue by 
replacing the Cl- ligand with pyridine. Two of these complexes were utilised in preliminary tests as the 
phosphor in light-emitting electrochemical cell LEC devices.  
In Chapter 3 a series of osmium(II) complexes [Os(bpy)3−n(Bn-pytz)n](PF6)2 (where bpy = bipyridine, 
n = 1, 2, 3) were prepared and characterised. The progressive replacement of bpy by Bn-pytz leads to 
blue-shifted UV-visible electronic absorption and emission spectra. Successful separation of the fac and 
mer isomers of [Os(Bn-pytz)3](PF6)2 complexes was achieved, which exhibits phosphorescence  (λem = 
615 nm, in degassed acetonitrile). [Os(Bn-pytz)3][PF6]2 was shown to exhibit significant quenching of 
luminescence intensity in the presence of oxygen (Ksv = 83 atm-1). The water soluble chloride form of 
the complexes were prepared and were subjected to preliminary cellular uptake and luminescence 
imaging microscopy studies. The results from these studies reveal that the [Os(Bn-pytz)3]2+ is 
successfully taken up by two cancer cell lines. Bright emission from [Os(Bn-pytz)3]2+ can be seen by 
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confocal microscopy with localisation at the lysosomes, however, no photodynamic therapy (PDT) 
activity is observed.  
Described in Chapter 4 is the synthesis, characterisation and photophysical investigation of an 
osmium(II) 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine (btzpy) complex. From photophysical 
investigations [Os(btzpy)2](PF6)2 exhibits phosphorescence (λem = 595 nm, τ = 937 ns, φem = 9.3% in 
degassed acetonitrile). The complex undergoes significant oxygen-dependent quenching of emission 
with a 43-fold reduction in luminescence intensity between degassed and aerated acetonitrile solutions 
(Ksv = 110 atm-1), demonstrating its capability as a singlet oxygen sensitiser. The water soluble chloride 
form of the complex was prepared on the basis of the photophysical properties and was subject to 
preliminary cellular uptake and luminescence microscopy imaging studies. The complex easily entered 
the HeLa and U2OS cancer cell lines with mitochondrial localisation observed with intense emission 
permitting imaging at reduced concentrations up to 1 µM. Long-term dose toxicity results show low 
toxicity in HeLa cells with LD50 >100 µM.  
Described in Chapter 5 is the synthesis and characterisation of a range of dinuclear supramolecular 
complexes, containing a bridging ligand incorporating the 1,2,3-triazole moiety. The homonuclear 
complexes ([Ir(ppy)2-L-Ir(ppy)2](PF6)2, [Ru(bpy)2-L-Ru(bpy)2](PF6)4, [Os(bpy)2-L-Os(bpy)2](PF6)4 and 
[Os(Bn-pytz)2-L-Os(Bn-pytz)2](PF6)4 and heteronuclear complex ([Ru(bpy)2-L-Ir(ppy)2](PF6)3 (where 
L = 1,4-{bis-4-(pyrid-2-yl)-1,2,3-triazol-1-yl methyl}benzene) were  prepared. Photophysical studies 
show that the dinuclear species display greater luminescence intensities than their mononuclear model 
complexes. The emission spectra of the heteronuclear complex [Ru(bpy)2-L-Ir(ppy)2](PF6)3, exhibits 
features similar to those observed in the emission spectra of the mononuclear complexes [Ir(ppy)2-
L](PF6) and [Ru(bpy)2-L](PF6)2. This indicates dual emission occurs from both the Ir- and Ru-centred 
chromophores (φem = 0.33% in acetonitrile). Interestingly the emission from the Ru-centred 
chromophore seems greatly enhanced relative to the emission of the Ru mononuclear analogue. This 
indicates partial energy transfer from Ir to Ru. The dual emission results in near white light emission 
and could be used for the devolpment of single component white light emitting phosphors.     
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1.1 Introduction  
 
Transition metal complexes occupy a prominent position in photophysics and photochemistry 
because of their remarkable properties and stability.1 The field of photophysics and 
photochemistry of coordination complexes of transition metals has received increasing interest 
in the last few decades for the understanding of the excited state properties and photochemical 
reactions.2 In the earlier studies, transition metal complex photochemistry was mainly confined 
to and dominated by photosubstitution reactions typical of ligand field (LF) excited state 
reactivates of chromium(III) complexes3 and metal carbonyls.4 In 1971 photoredox reactivities 
characteristic of the metal-to-ligand charge transfer (MLCT) excited states of ruthenium(II) 
bipyridine complexes became apparent.5 This has also eventually led to the emergence of a 
new branch of supramolecular photochemistry.6 d6 transition metal complexes which 
demonstrate luminescence have been utilized as probes in photosensitizers developed for 
conversion of solar energy7 and electron transfer reactions.8 Although most of these 
applications use Ru(II) complexes, researchers have been exploring the excited state 
characteristics of Re(I),9 Ir(III),10 Mo(O),11 W(O), Os(II)12 and Pt(II)13 complexes. Control of 
the photophysical and photochemical properties of the complex can be achieved by 
manipulating ligands and metal. The ligand design was perhaps the most important step in the 
development of metal complexes which display unique properties and novel reactivity. The full 
potential of color tuning of complexes can be controlled by ligand design. Therefore reactions 
that enable the facile routes to the modular construction of new ligands and these architectures 
are particularly useful in the development of such materials. The structure of the complex is 
important for development of the solar energy conversion device that relates to the different 
applications such as luminescent sensors, dyesensitised solar cells DSSCs, light-emitting 
electrochemical cells LECs and OLEDs.14 Over the last 40 years, transition metal- complexes 
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have been realized for their therapeutic properties in several fields of medicine. Since 
phosphorescence is longer-lived than the autofluorescence from biological organic compounds, 
emissive complexes are amenable to use in time-gated imaging microscopy.15 A combination 
of rich photophysical and electrochemical properties of the metal complexes has led to their 
use in numerous applications, covering a wide range such as photocatalysis, luminescent 
sensors, DSSCs, LECs and OLEDs 
1.2 Photophysics of d6 transition metal complexes 
 
Octahedral d6 transition metal complexes have received attention in the past few decades due 
to their rich photophysical, photochemical and redox properties. These characteristics make 
them amenable to application in artificial photosynthesis,16 solar fuels catalysis,17  
electroluminescent devices,18 dyesensitised solar cells (DSSCs),19 molecular sensors,20 
luminescence live-cell imaging,21 photoinitiated anticancer agents and singlet oxygen 
sensitisation for photodynamic therapy.22  It is essential to describe the energy levels involved 
in electronic transitions for better understanding of the photophysics of this type of complex. 
Molecules have many occupied and empty molecular orbitals, for this, there are many possible 
transitions to elevate an electron from an occupied low-energy orbital to the empty higher-
energy orbital.  For d6 transition metal complexes, the π* ligand orbitals are typically lower in 
energy than dσ* orbitals. The highest occupied molecular orbital (HOMO) is localised on the 
metal center and the lowest unoccupied molecular orbital (LUMO) localised on the ligand. The 
lowest-energy electronic transition corresponds to a transition of an electron from the HOMO 
to the LUMO. The HOMO-LUMO energy gap (∆E) usually determines the color of light we 
see transmitted through a solution. Transitions of an electron from lower-energy occupied 
orbitals or into higher-energy empty orbitals will essentially need higher-energy photons. The 
[Ru(bpy)3]
2+ complex, displys all the general properties of the d6 complexes, making it the most 
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studied complex in transition metal complexes since the 70s. It is used here as an example to 
describe the energy levels which are involved in the electronic transitions that occur as a result 
of absorption or emission of light. In this type of d6 complex the HOMO is dominated by metal 
d-orbital and the LUMO has predominantly ligand-based π* character. Above the LUMO lie 
dπLπ* orbitals which are mostly ligand-based π* character. At higher energies are the 
antibonding dσ* orbitals related to the metal-ligand σ-bonding interactions. (Figure 1.1).  
 
Figure 1-1 Simplified molecular orbital energy diagram for [Ru(bpy)3]2+ transition Metal Complexes 
 
The ground state of transition metal complexes is usually studied by absorption spectroscopy 
where the spectra are characterized by a low energy MLCT band and some higher energy ligand 
cantered bands. According to the nature of frontier orbitals, three main optical transitions may 
arise: (1) the lower energy parity forbidden, metal-centered transition 3MC (the d-d transition) 
(2) the higher energy π-π* transition localized on the ligand, and (3) the 1MLCT transition (d-
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π*). All these transitions are spin allowed, but only the latter two are observed in the UV-vis 
absorption spectrum of most of the transition metal complex. Note that in some transition metal 
complexes the 3MLCT band also exhibits as a low energy tail that stems from the spin-
forbidden 3MLCT transitions. The spin forbidden absorption populates the 3MLCT directly 
from the ground state and is readily observed because of the large spin-orbital coupling effect 
that results from the heavy metal atom.23-25 
 At ambient temperatures solutions of [Ru(bpy)3]
2+ exhibit a broad absorption band centered at 
450 nm (MLCT) corresponding to a transition from one of the d-orbitals of Ru2+ ion to the 
ligand π∗ -orbitals. During this transition the electron is moved from the HOMO, which is the 
t2g metal orbital in this case into the LUMO which is a ligand π∗ orbital. As a result, the 
transition metal ion oxidation state changes to Ru3+. The UV range (200-300 nm) is dominated 
by strong transitions involving ligand orbitals (π and π∗ orbitals). They can be grouped into 
ligand-centered (LC, < 300 >260 nm) and (LMCT, 220-260 nm) transitions. In the case of 
LMCT transition, the absorption involves the π orbital and the antibonding metal d-orbitals . 
According to von Zelewsky, the 300-360 nm band can be assigned to the MC states,25 which 
strongly overlaps with the MLCT states. Therefore, the MC absorption bands are hidden below 
the strong background absorption of the MLCT states (which in general have larger absorption 
cross sections than MC states).26 Upon photoexcitation in the region 380-490 nm into MLCT 
band, the long-lived triplet 3MLCT state is formed, which exhibits visible luminescence 
centered at 620 nm, as shown in Figure 1.2.  
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Figure 1-2 Electronic absorption (solid line) and emission spectra (dotted line) of [Ru(bpy)3]2+  in acetonitrile at room 
temperature. Reprinted from Ref,27 with permission from Energy & Environmental Science  . 
 
The effective population of the 3MLCT state becomes possible due to a large spin-orbit 
coupling, which results in the significant mixing of the singlet and triplet states. The studies on 
Ru complexes opened the approach to the design of luminescent complexes based on other 
d6 metal complex systems. A very typical example comes from cyclometalated iridium(III) 
systems. Even these species are very similar from the assembly point of view to the Ru 
complexes but are more emissive and tunable. Cyclometalated iridium(III) complexes have 
some important features over classical ruthenium complexes that allow for further development 
and the amendment of their optical characteristics. As [Ru(bpy)3]
2+ is used to represent the 
ruthenium polypyridine complexes, Ir(ppy)3 may be used to represent the cyclometalated 
iridium(III) complexes. While the LUMO is localised on the neutral pyridine fragment, the 
HOMO of this type of complexes have metallic d-orbital character with a significant 
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contribution from the π-system of the aryl rings.28 An electronic absorption spectrum of 
Ir(ppy)3 exhibits an intense LC transition in the UV region with two MLCT (
1MLCT and  
3MLCT ) transitions in the visible region. The complex displays a visible broad and asymmetric 
emission centred at 515 nm,29 as shown in Figure 1.3. 
 
Figure 1-3 Electronic absorption (dotted line) and emission spectra (solid line) of Ir(ppy)3 in dichloromethane at room 
temperature. Reprinted from Ref,29 with permission from the Royal society of chemistry. 
 
It is possible to modulate the optical features of Ir complexes by moving from neutral Ir(ppy)3 
to cationic [Ir(ppy)2(bpy)]
+.  This varying in ligand will permit a modification of the HOMO-
LUMO energy gap (∆E). In these type of complexes the HOMO is localised across the metal 
center and the (C^N) ligand while the LUMO is localised on the 2,2’-bipyridine ancillary 
ligand.30 The orbital distribution is the key for predictable and accessible tuning of 
[Ir(ppy)2(bpy)]
+ based hetroleptic complexes, due to the ability to functionalise individually the 
two types of ligands.31 Alexander Jablonski (1898-1980) came up with the Jablonski-
Diagram32 which assists with the process through which the theoretical concept for 
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comprehending photophysical features as explained in Figure 1.4 The traditional Jablonski 
diagram generally assumes a largely isostructural set of ground and excited states and does not 
take into account changes in the geometry of the complex. According to Jablonski theory, when 
irradiated with light the complex absorbs energy and the electrons are excited from lower 
singlet state (S0) to higher singlet excited state orbital (S1), which is the lowest energy features 
in the visible region of the optical absorption spectra of d6 metal complexes (1MLCT) character. 
The initial photoexcited singlet state undergoes rapid intersystem crossing (ISC) which is a 
process where there is a crossover between different multiplicity electronic states such as the 
singlet state 1MLCT to a triplet state 3MLCT (S1 to T1). The photo excited state is generally 
short lived (10-12 s). The complex will relax from the 3MLCT state to the ground state (S0), 
which is observed as emission exhibited by these complexes. The emissive states for 
cyclometalated complexes will also have additional 3ILCT, this process occurs when there is 
the movement of an electron within one ligand, mostly referred to as π → π* and/or 3LLCT 
character, which takes place when an electron moves from one coordinated ligand to another 
ligand. The relaxation to the ground state takes place with the excited energy being lost by 
either I) Radiative decay, II) Non-radiative decay.33  
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Figure 1-4 Summary of the Various Pathways Available to an Excited Molecule as From Jablonski Diagram.- 
 
1.2.1 Radiative Decay 
Luminescence (radiative decay) is a process when the excited electrons relax from their excited 
state to the ground state and emit a photon of light. In general, luminescence can be categorized 
by looking at a way through which it is generated. 33 These can be of two types, and that are 
the fluorescence and phosphorescence. 
1.2.1.1 Fluorescence:  
 
 Is a process through which there is the emission of a photon coming from an electronic state 
to one that has the same multiplicity. When looking at Figure 1.4 it is evident that this process 
in solution occurs from the first singlet excited state to the ground state, which is also singlet 
excited state multiplicity. It can be explained as (S1 → S0). The excited mode is seen to relax 
at a point of the lowest vibration state of S1. Because the singlet excited state and the ground 
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state have the same multiplicity (spin-allowed), the lifetime of this specific emission is usually 
very short being at a scale of about 10-9 s or shorter. The fluorescence process comes from a 
thermal equilibrated excited state which is at the lowest energy vibration state. This type of 
radiative decay mostly occurs within the organic compounds and is not often seen for late 
transition metal complexes. 
1.2.1.2 Phosphorescence: 
 
 Is the process through which there is the emission of a photon while electrons move between 
states of different multiplicity such as (T1 → S0). There is a parallel spin of electrons in the 
ground state to the excited represented as either (↑↑) or (↓↓). Even though we have a forbidden 
spin population of a triplet state, where there are heavy atoms in the spin-orbit coupling. 
Phosphorescence is a spin forbidden process.  Therefore decay rate is several orders of 
magnitude smaller than those for fluorescence. Figure 1.4 shown in Jablonski diagram and has 
been stated in Hund’s rule. S1 a singlet state will be of higher energy than a triplet state T1 in 
the same configuration. That, therefore, states that phosphorescence will come about at lower 
energy, therefore, having the longer wavelength that than fluorescence from a given molecule. 
1.2.1.3 Excited state lifetime: 
 
As mentioned before for [Ru(bpy)3]
2+
 complex absorption of a photon elevates an electron from 
the ground state (GS) to the spin-allowed 1MLCT level. Then intersystem crossing allows for 
population of the 3MLCT level. The excited electrons may relax back to the GS either without 
emission (non-radiative decay) or with emission (phosphorescence) or populate the 3MC level 
(non-radiative decay). Because phosphorescence is spin forbidden, it is longer lived than 
fluorescence. There is also the rate constant that is found helpful while characterizing every 
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step of decay experienced by an excited molecule. Lifetime (τ0) is also seen describing the 
excited state and can be well expressed as:  
(τ0)  =
𝟏
𝒌𝒓+𝒌𝑢+𝒌𝒏𝒓
 
This equation has kr, ku, and knr which refers to the rate constant for radiative deactivation 
unimolecular photoreaction and non-radiative deactivation respectively. 
1.2.1.4 Quantum yield ɸ: 
 
Quantum yield (ɸ): is the ratio of photons absorbed to photons emitted through radiative decay 
(e.g Phosphorescence in metal complexes). When the complex absorbs a photon of light, the 
excited state is formed, with the end of result being that, the electron loses energy and returns 
to the GS. Some of this energy is lost through intersystem crossing (ISC) or through internal 
conversion (IC) and vibration relaxation as heat (non-radiative decay) but deactivation also 
takes place through emission (phosphorescence). 
For the [Ru(bpy)3]
2+
 complex which is used as a standard complex, the quantum yield ɸ can be 
calculated as a ratio of radiative and total non-radiative decays  
(ɸ)  =
𝒌𝒓
𝒌𝒓+𝒌𝒏𝒓+𝒌𝒖
 
 The absolute value of quantum yield ɸ for any complex can be expressed as:  
ɸ𝒙 = ɸ𝑺𝑻(
𝐄𝒙
𝐄𝑺𝑻
)(
𝟏 − 10𝐴𝑆𝑇
𝟏 − 10𝐴𝒙
)(
ƞ2𝒙
ƞ2𝑆𝑇
) 
Where X and ST, refer to the tested and standard complexes respectively, E refer to the 
emission intensity of the complexes, A refer to the absorbance and ƞ refractive index of the 
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solvent. knr include the deactivation by means of 
3MC state, which can be thermally accessed 
from the 3MLCT state and will give rise to rapid excited state decay and photochemical 
instability. It is important that any 3MC state is at a higher level than the emitting level when 
photoluminescence is desired.   
1.2.2 Non-Radiative Decay:  
The process through which an excited molecule emits heat while resuming to the lower energy 
state or the ground state is referred to as non-radiative decay. This process can be classified 
into three types: Internal conversion (IC) is composed of non-emissive relaxation between two 
states that have equivalent spin multiplicity; it may involve relaxation of the vibrationally 
excited state to vibrational levels of the ground state; intersystem crossing (ISC) which involves 
the non-emissive relaxation between states with non-equivalent spin multiplicity. It is a process 
where there is a crossover between different multiplicity electronic states as revealed in the 
singlet state 1MLCT to a triplet state 3MLCT (S1 to T1) on Figure 1.4. (
3MC) states which lie 
at higher energies and accompany population of the dσ* ligand-field antibonding orbitals, this 
occurs readily. If the energy barrier on the triplet potential energy surface to their population 
from 3MLCT states is low enough. 
1.2.2.1 O2 quenching:  
 
One of the important additional non-radiative proceses is quenching of the MLCT state in the 
presence of molecular oxygen. Because the ground state of oxygen is triplet state (3O2), it can 
quench the triplet state of the metal complex, which deactivates the complex and produces 
singlet oxygen (1O2). This character gives advantage for transition metal complexes to act as 
photosensitizer (PS) in photodynamic therapy (PDT). Photodynamic therapy (PDT) uses light 
to activate a photosensitizer (PS) which is an otherwise nontoxic drug as seen from scheme 
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below. This technique has advantage over other available therapies due to its inherent ability 
to induce highly localized cytotoxicity by a point at which photosensitizer and light spatially 
overlap. The process paves the way for the removal of unwanted cells with little to no damage 
to the surrounding tissue.34 
PS + hv → PS* + 3O2 → PS + 1O2  
1.3 Application of d6 transion metal complexes 
 
Due to their attractive photophysical and photochemical properties, d6 transition metal 
complexes have been of extensive interest in a number of areas for the past few decades. 
Applications of the transition metal complexes can be divided in to several sections according 
to the way they are used. 
1.3.1 Transition metal complexes in photocatalysis 
 Due to their high thermal stability, electronic and electrochemical properties, metal complexes 
can act as a catalyst.35 The reduction of CO2 and photoproduction of hydrogen from the splitting 
of water using solar energy as the driving force, has been a goal of scientists and engineers 
since the early 1970s when Fujishima and Honda (1972) reported the generation of hydrogen 
and oxygen in a photoelectrochemical cell. 36 Since then there has been an explosion of 
scientific interest and experiments. Now that more than 45 years has elapsed, it is appropriate 
to take a critical look at the prospects for the solar generation of hydrogen fuel from water. 
[Re(bpy)(CO)3Cl]
37 and [Re(bpy)(CO)3{P(OEt)3}]
+38 complexes were applied by Raymond 
Ziessel and Ibusuki as a photocatalyst for the reduction of CO2 to CO. The complexes indicate 
high chemical specificity under visible light with quantum yield of CO production of 14 % and 
38 % respectively. Morimoto and co-worker39 investigated the photocatalytic abilities of a 
Ru(II)−Re(I) binuclear complex (RuReCl) in an aqueous solution, where Ru(II) acts as a 
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photosensitizer and Re(I) catalyst units were connected with a bridging ligand. The complex 
showed low photocatalytic efficiency. Further studies of the photochemical electron-transfer 
process revealed back-electron transfer from the one-electron-reduced species (OERS) of the 
photosensitizer unit to an oxidized ascorbate proceeded efficiently, and this should be one of 
the main reasons why the photocatalytic efficiency was lower in the aqueous solution. 
 
 
Figure 1-5 Examples of metal complexes used as photocatalysts  
 
1.3.2 Transition metal complexes in light-emitting electrochemical cells LEECs 
and OLEDs 
Light-emitting electrochemical cells LEECs were introduced in 1995 by Pei et al., who mixed 
a conjugated luminescent polymer with an inorganic salt and an ionic conductive polymer.40 In 
1996 Maness et al., applied [Ru(vbpy)3](PF6)2 complex (vbpy = 4-vinyl-4′-methyl-2,2′-
bipyridine) as the single active component in the light-emitting layer.41 Nowadays, ionic 
transition metal complex LEECs are mostly based on luminescent ionic biscyclometalated 
Ir(III) complexes, which like the original Ru(II) complex, may sustain charge injection and 
transport while affording light emission  at the same time.42 The use of ionic transition metal 
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complexes in LEECs allows novel device fabrication developments, such as soft contact 
lamination,43 as well as the development of large-area illumination panels.44  
 
Figure 1-6 Examples of metal complexes used in LEECs 
 
1.3.3 Transition metal complexes in photovoltaic applications 
The luminescent properties of d6 transition metals complexes has also allowed for use in 
photovoltaic applications like dye-sensitized solar cells (DSSCs),45 as they allow for a light-
driven charge separation by a metal-to-ligand charge transfer (MLCT) to exploit the charge-
separated triplet excited state (3MLCT), photo- and redox-stability as well as sufficiently long 
excited-state lifetimes.46 DSSCs have a possibility of generating photovoltaic energy with a 
very low cost. DSSCs belong to a group of solar cells with thin films. The dye in Dye-sensitized 
solar cells can be modified to improve the performance of DSSCs. The cis-[Ru(dcb)2(NCS)2] 
(referred to as N3) (λem = 715 nm, ϕ = 0.4 %) was the first ruthenium complex used in DSSCs. 
A thin-layer photoelectrochemical cell based on this system reached a η = 10% solar-to-
electric conversion yield when applied in a DSSC device on laboratory scale.47 The most 
efficient dyes reach values of around 10-12%. The benchmark dye used in DSSC is N749 
(referred to as black dye) with (η = 10.4%).48 Figures 1.7 
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Figure 1-7 Examples of metal complexes used in DSSCs 
 
1.3.4 Transition metal complexes in cell imaging and PDT 
Transition metal complexes have a remarkable place within medicinal biochemistry.49 
Research has revealed significant progress in application of transition metal complexes as 
drugs to treat several human diseases like lymphomas, carcinomas, infection control, anti-
inflammatory, diabetes, and neurological disorders. Transition metal complexes have been 
applied in the inorganic medical field including diagnostic or therapeutic purposes.50 The 
results observed from metal complexes in medical field show that metals can play an 
increasingly important role of in the design of anticancer agents.51 There has been a suggestion 
that derivatives of such d6 polypyridyl complexes would assist with the process lumphores in 
fluorescence cell microscopy. However, until recently there were a few reported examples of 
this kind of applications. Fluorescent imaging offers a one of a kind course to identify metal 
cation in cells through a contactless and harm free route. Cellular imaging probes have been 
examined based on d6 transition metals such as iridium,52, 53 ruthenium,54, 55 rhenium56, 57 and 
Osmium poly pyridyl.58 Osmium(II) polypyridyl complexes share many of the photophysical 
advantages of their ruthenium(II) analogues.12 
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Figure 1-8 Examples of successful therapeutic and diagnostic metal complexes 
 
Although their emission quantum yields and lifetimes tend to be lower, they have two key 
additional benefits; firstly, osmium(II) polypyridyl complexes typically exhibit emission 
maxima in the NIR spectral region below 700 nm, i.e. strongly coincident with the biological 
optical window. Secondly, because of their increased crystal field that splits the osmium d-d 
states, they lack the ability to gain access to the metal centered excited state by a thermal 
crossover that originates from the MLCT as in cases for ruthenium,59 therefore, this implies 
that osmium(II) polypyridyl complexes show exceptional photostability and favorable 
luminescence properties.60 This condition is necessary when referring to cell imaging, 
especially when there is cell incubation at 37 °C. Ever since the discovery of cisplatin more 
than four decades ago, there has been great achievement in cancer therapy and some efforts 
that investigate other non-platinum and platinum metal complexes for their potential use in the 
treatment of cancer.61 The success of platinum complex in cancer therapy brings about 
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increased interests associated with coming up with a new metal complex that shows anti-cancer 
activity reported by Sadler and Lippard,62, 63 the chemistry community have had a lot of 
growing interest that assist with examination of anti-cancer activities of ruthenium(II, III), 
gold(I-II), iron(II), platinum(II) complexes and antiviral activities of vanadium(IV) complexes. 
Some metals have improved to a level that they reach clinical trials.Anticancer therapy has 
metal-based therapeutics at the forefront having compounds such as that have proven essential 
in the chemotherapy treatments.64 Anti-proliferative and potent cytotoxic complexes have been 
developed based on some transition metals involving iridium,65 ruthenium,66 osmium,67 
cobalt,68 vanadium,69 and platinum.70 The desired photophysical and photochemical properties 
can be achieved by manipulating both ligands and metal, for this reason several ligands have 
been developed that bear extended π systems. There are several synthetic strategies available 
for the development of ligands. The intense studies relies on the reaction of CuAAC (Copper 
Catalysed Azide-Alkyne Cycloaddition) to produce the 1,2,3-triazole in regulating solar 
radiation conversion process into electrical energy in the device.71 A wide range of triazole-
based ligands are avialable, and this makes it possible to have a wide range of information in 
metal coordination chemistry. 1,2,3-Triazole and its derivatives are an important class of 
nitrogen containing aromatic heterocyclic compounds and have attracted a great deal of interest 
due to their diverse biological activities.  
 
 
 
 
 
 
Chapter 1: Introduction 
19 
 
1.4 Click-Chemistry 
 
Click Chemistry explains the reaction of a pair of functional groups which react rapidly and 
selectively with each other in mild and aqueous conditions72. The concept of Click Chemistry 
reactions is based on the activation and click coupling of compatible click-functional groups 
because of their high selectivity. The possible plethora of reactions that fit the required 
reactivity, biocompatibility and selectivity for the Click Chemistry include Cu (I) catalyzed 
Azide-Alkyne Click Chemistry reaction (CuAAC), the Strain-promoted Azide-Alkyne Click 
Chemistry (SPAAC) and the Tetrazine-Alkene Ligation reactions. Click Chemistry, as first 
coined by Sharpless and co-workers in the year 2001 defined stringent principles for a reaction 
to be called a “click” chemistry reaction.73 According to Sharpless and co-workers, a click 
reaction produces high yields with high efficiency, modular and wide scope and the products 
can be isolated with ease.72 1,2,3-Triazoles have become the most recent product in Click 
Chemistry also forming the new advances and applications of the chemical agent in 
photodynamic therapy and imaging microscopy. The click chemistry approach is based on the 
Huisgen’s dipolar cycloaddition reactions in which an alkyne and an azide is reacted to form 
the 1,4 and 1,5-triazole regioisomers.74 The click –chemistry has been used to control the 
regioselectivity and also to improve the conditions of the reaction. Many of the products have 
been used for photodynamic therapy and imaging microscopy, these one of the recent 
applications.75 
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Figure 1-9 Some of the reactions which match the “click chemistry” standard75 
 
1.4.1 Copper catalysed azide-alkyne cycloaddition (CuAAC) 
 (CuAAC) reaction for the synthesis of 1,2,3-triazoles which occurs by the 1,3-dipolar 
cycloaddition of organic azides to terminal alkynes is the most widely known and utilised 
‘click’ reaction. The use of copper-based reducing agent as a stabilizing ligand improves the 
reaction outcome supported by different solvents such as water, with a miscible organic solvent 
while stating the reagent needs for the successful reaction process that produces pure filtration 
solution as the primary purification steps.76-79  Since the middle of the 20th Century, the use of 
copper as a catalyst as a reagent in the organic synthesis experiments has been documented as 
it also underwent rapid development. Copper(I) had observed to be the most effective catalysts 
in the click chemical reactions that lead to the formation of 1,2,3-triazoles.80 For instance, when 
forming allenyl azide, a methanesulfonate form 3-hydroxyl-1,3-diphenylprop-1-yne is reacted 
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with lithium azide at low temperature and catalyzed by copper(I) chloride. In their experiment, 
Sharpless and the Fokin group made use of copper(II) sulfate and sodium ascorbate and also 
included the copper(I) acetylides.81 The functionalized azide molecules react with the 
functional terminal alkyne molecule to form a stabilized conjugate of both molecules through 
the triazole moiety as illustrated below. 
 
 
Scheme 1-1 The copper catalysed azide-alkyne cycloaddition (CuAAC) resulting in the formation of exclusively the 1,4-
disubstituted-1,2,3-triazole regioisomer. 
 
The efficiency of the CuAAC reaction increases because the alkynes and the azides are 
relatively unreactive and also depends on the metal catalyst present. Depending on the copper 
source available, the reaction completion varies with the concentration and source of copper 
catalyst. The toxicity of the copper(I) ions prevents the use of the copper(I)-catalyzed alkyne-
azide reactions in live cells during photodynamic therapy and because of this the use of 
copper(I) chelating ligands has been implemented to overcome the problem.82 Copper-
Catalysed Azide-Alkyne Cycloaddition reaction (CuAAC) is used to produce a better reaction 
with enormous reaction acceleration and also with few or no side products.83  
1.4.2 General CuAAC reaction conditions 
The copper (I) catalyzed click chemistry reaction has frequently been utilized in connecting the 
molecular entities of all sizes in copper- catalyzed azide-alkyne cycloaddition reaction. A 
CuAAC reaction occurs under special conditions which qualify the reaction to be a good 
“click” chemistry reaction that reacts with high efficiency without a co-catalyst to produce the 
desired product.83 This type of click reaction is highly robust which has numerous successful 
experiments that have been carried out proving the efficiency of the methodology. The general 
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conditions; i) copper(I) salts or complexes which act as a catalyst of this reaction. ii).84 room 
temperature reaction, although microwave heating can be used to improve the reaction.85 The 
aqueous copper(II) ascorbate methodology is simple, efficient and an economical way of 
preparing 1,4-disubstituted-1,2,3-triazoles.86 The regiospecific copper(I)-catalysed azide-
alkyne cycloaddition (CuAAC) click chemistry reaction has attracted considerable interest as 
more other researchers look onto it. The characteristics of the reaction include high yield, 
presence of mild conditions and also it has an excellent functional group tolerance regarding 
functionality. The triazole is easy to prepare and also offers the ability of a fully functional 
group of substituents proving a good route for the ligand design. There is a capability of the 
triazoles derived from copper(I) azide-alkyne cycloaddition reaction to having two nitrogen 
atoms and also an essential N3-position in its structural composition.80  
1.4.3 One-Pot CuAAC reactions 
In the CuAAC click chemistry reaction, the mild and aqueous Cu(I)-catalyzed 1,3 –
cycloaddition reaction of the alkynes and organic azides result been the formation of the 
functional groups of 1,4-disubstitured-1,2,3-triazole.87 The reactions of CuAAC considers the 
nature and properties of the reactions of the Cu(I) species and the different kinds of alkynes in 
a click chemistry reaction. In the Cu(I)-catalyzed 1,3-cycloadition reaction, the alkynes and 
organized azides are thermally induced using the Huisgen’s approach leading to the synthesis 
of a mixture of the 1,4-disubstited-1,2,3-triazole and other products. As a result, it is possible 
to exploit the CuAAC “click” chemistry reaction so as to generate the functionalized groups of 
ligand architectures essential for their numerous potential uses.80 The one-pot CuAAC method 
is one of the “click” methodologies that has been established so as to increase the levels of 
efficiency and safety of the CuAAC reaction during the synthesis of the copper(I) azide-alkyne 
cycloaddition or click chemistry reaction. In one-pot CuAAC methodologies either the reactant 
from the alkyne or the azide is generated during the reaction promptly and it does not require 
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an isolation or purification process.88 According to Fletcher and co-workers, it is possible to 
deprotect the TMS-protected alkynes and react in a click reaction with azides generating bi-
ligand triazoles that produce excellent yields of the product.89 
 
Scheme 1-2 Tandem in situ deprotection of bis(trimethylsilyl)butadiyne and “click” reaction to synthesise 4,4’-bis-1,2,3-
triazolyl ligands 
  
Initially, the azide and alkyne reactants were prepared separately for the use in the CuAAC 
reactions but in the One-Pot CuAAC methodology there is no isolation or separation of the 
reactants prior to the click chemistry reaction. The One-Pot CuAAC “Click” methodologies 
have proved successful especially due to their recent application in generating benzyl-, alkyl-, 
and the aryl-substituted 2-(1H-1,2,3-triazol-4-yl) pyridine (pytz) and 2,6-bis(1H-1,2,3-triazol-
4-yl) pyridine ligands83 (dtzpy) Figure 1-10. 
 
Figure 1-10 Structures of pyridyltriazole (pytz) and ditriazolylpyridine (dtzpy) ligands  
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1.5 Coordination chemistry and photophysics of CuAAC derived ligands 
 
The coordination chemistry of 1,2,4-triazoles and the unsubstituted parent 1H-1,2,3-triazole 
are rich and extensive.86 Figure 1.11 
 
Figure 1-11 The two isomers of triazole 1,2,3-triazole (left), and 1,2,4-triazole (right) 
 
Discovery of the CuAAC reaction, synthetic approaches to substituted 1,2,3-triazoles led to 
production of one isomer. The most significant property of the mild and modular copper(I)-
catalyzed alkyne-azide cycloaddition click chemistry with organic azides is that it readily 
allows the functionalized regiospecific 1,4-disubstituted-1,2,3-triazole. As a result of this vital 
property has triggered the rapid and increased interested in the coordination chemistry of these 
ligands.83 Many reports of the CuAAC reaction had used the 1,2,3-triazole moiety as a stable 
linker unit for two chemical or biochemical components, with little attention being paid to the 
heterocycle itself.83 The triazole can participate in hydrogen bonding interactions as a donor or 
acceptor depending on the interacting partner. The weakly hydrogen bond donating property 
of the C5-H group is evident in interactions with anions90 and intramolecularly with methoxy 
or tert-butoxy groups.91 Exceedingly more common is the hydrogen bond accepting nature of 
the N2/ N3 atoms. Additionally, the Lewis basic nature of N2 and N3 allows for 1,2,3- triazoles 
to behave as efficient coordination ligands with a range of different metal ions.92 Simple 
pyridyl-conjugated 1,2,3-triazoles have been shown to form metallic complexes that display 
intricate supramolecular interactions in the solid state. The simplicity involved in preparing the 
various varieties of 1,2,3-triazole-based ligands makes it possible to have a wide range of metal 
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coordination chemistry. The chemical coordination of triazole can act as an N-donor ligand at 
the N3 position or at the N2 atom as illustrated below 
 
Figure 1-12 Copper (I)-catalysed 1,3-dipolar alkyne/azide cycloaddition to form 1,4-disubtitued 1,2,3-triazoles. Functional 
potential of 1,2,3-triazoles for coordation chemistry83. 
 
The diagram shows the possible metal coordination site of the 1,4-disubstituted -1,2,3-riazole 
ligands. Additionally, there is also a potential that the bonding can take place at the C5 position, 
C5 is deprotonated as the ionic triazolylides and also when it is the mesoionic triazolylide 
NHCs as illustrated in Figure 1- 12. The area of “Click” chemistry especially the CuAAC has 
undergone tremendous development with an increased application of the CuAAC derived 
ligands such as 1,4-disubstituted-1,2,3-triazole. Because of the attractive photophysical 
properties of their resultant complexes, a number of reports on the coordination chemistry of 
triazole ligand have appeared.83 Numerous83, 86, 93 groups have compared metal triazole 
complexes to bipyridyl (bpy) and terpyridyl (tpy) complexes. Complexes of the bidentate (pytz, 
btz) and terdentate ligands (dtzpy) have been prepared with a set of transition metals including 
Ru(II) ,Re(I), and Ir(III). The electron rich triazole moiety in these ligands leads to higher 
energy LUMOs. This subsequently leads to destabilised MLCT excited states for their 
complexes when related to well-known bpy and tpy analogues.94 Largely or totally quenched 
phosphorescence and a blue shift in MLCT absorption bands resulted when bpy ligand changed 
to pytz in [Ru(bpy)3-n(ptz)n]
2+ complexes. This quenching of emission is possible due to the 
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destabilised MLCT states approaching into closer energy to non-radiative metal-centred (MC) 
states, allowing for efficient thermal population.95 A good luminescent performance is 
observed from complexes with metals that have a larger ligand field and hence higher energy 
MC states. Luminescence of [Re(pytz)(CO)3Cl] complexe is higher in energy than its bpy 
analogue, with longer lifetime and higher quantum yield when recorded under same 
conditions.96 Even with a blue-shifted and hence diminished optical absorption in the visible 
region, pytz complexes of ruthenium have demonstrated to produce efficient dye-sensitised 
solar cells (DSSC).97 
The rest of this section forms a systematic review of the employment of triazole based “click” 
chemistry in coordination chemistry. Various researchers and scientists have come up with 
some reports on the coordination chemistry of ligands especially those derived from copper 
(I)-catalyzed Alkyne-Azide cycloaddition click chemistry reactions. For instance, the N^C^N 
pincer platinum(II) and palladium(II) complexes which has a series of the monodentate triazole 
ligands that show a coordination at N3-Position.80  
1.5.1 1,4-Disubstituted-1,2,3-Triazoles as N-Donor Ligands 
1.5.1.1 1,4-Disubstituted-1,2,3-Triazoles as Monodentate N-Donor Ligands 
 
In 2011 Elliott and coworkers98 applied the 1,4- disubstituted-1,2,3-triazole unit as a 
monodentate ligand in a series of cationic Re(I) complexes. Cationic Re(I) complexes were 
prepared by stirring [Re(bpy)(CO)3Cl] with AgPF6 in dichloromethane in the presence of 
ligands. The complexes were characterised by NMR, UV-visible absorption spectroscopy, IR, 
mass spectra and luminescent lifetime measurements. X-ray crystal structures were obtained, 
which confirm that the coordination of the Re(I) is through the N3 nitrogen. IR spectra suggest 
that the 1,4-disubstituted-1,2,3-triazole ligands are marginally stronger donors than pyridine. 
The complexes are luminescent in aerated dichloromethane at room temperature with emission 
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maxima at 542 to 552 nm, while the emission is blue-shifted relative to the parent chloride 
complex (612 nm). Luminescent lifetimes observed for complexes are 475 to 513 ns. 
 
Scheme 1-3 - Preparation of [Re(bpy)2(CO)3(pytz)](PF6) 
 
In general the complexes show similar photophysical properties compared with the 
monodentate pyridine (py) complex [Re(bpy)(CO)3(py)]
+. This means that the 1,4-
disubstituted-1,2,3-triazole unit as a monodentate ligand has a limited influence on the 
photophysical properties of the complex. Without photophysical investigation, other research 
studies in the same area have also been carried out by various researchers such as Van Koten 
and coworkers who applied the Copper(I)-catalyzed alkyne-azide cycloaddition reaction to 
synthesize the 1,4-disubstituted-1,2,3-triazoles which acted as the monodentate ligands for the 
aryl diamine cyclometalation pincer complexes of palladium and platinum.99  
 
 
Scheme 1-4 metal complexes containing monodentate 1,4-disubstituted-1,2,3-triazole ligand N^C^N pincer complexes (M = 
Pd , Pt)99 
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 On follow-up studies made by Astruc100 and Crowley101 on Van Koten’s work, the two found 
that the 1,4-disubstituted-1,2,3-triazole ligands could coordinate and integrate with the 
palladium(II) ion in a monodentate way using the N3 nitrogen of the triazole product. When 
the two were mixed, the 1,4-disubstituted-1,2,3-triazole ligand formed the palladium(II)-1,4-
disubstituted-1,2,3-triazole complexes.  
 
Scheme 1-5 Pd(II) complexes containing monodentate 1,4-disubstituted-1,2,3-triazole ligands, 
 
In Astruc’s experiment, they used azido methylbenzene and ethynyl ferrocene was used for the 
synthesis of the three novel ligands which comprised of the 1, 2 or 3 ferrocenyl triazole 
moieties. The ferrocenyl triazole ligand was mixed with PdCl2(C6H5CN)2 which led to the 
production of a triazole complex. Osuka, Shinokuno and coworkers102 prepared the 1,4-
disubstituted-1,2,3-triazole using zinc (II)-porphyrin. The ion and metal complex coordination 
during the click chemistry reaction caused the dimerization as the 1,4-disubstituted-1,2,3-
triazole donor on the porphyrin and zinc(II) ion are brought closer to the poryphyrin. The X-
ray crystallographic studies showed coordination from the 1,4-disubstituted-1,2,3-triazole unit 
to the metal at the N3 nitrogen of the triazole. There was a wide variety of presumption of the 
number of 1,4-disubstituted-1,2,3-triazole metal complexes during the monodentate binding of 
the metal complexes, although none of them has been structurally characterized in the studies 
since the coordination occurs through the N2 nitrogen and N3 nitrogen atoms of the 1,2,3-
triazole unit.74  
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1.5.1.2 Bidentate Ligands Containing 1,4-disubstituted-1,2,3-Triazole Units 
 
In the copper(I)-catalyzed alkyne-azide cycloaddition derived ligand systems, the bidentate 
ligands which have 1,4-disubstituted-1,2,3-triazole ligands have been studied widely. The other 
well-known ligands include the 2-pyridine and pyridyle-1,2,3-triazole frameworks. As shown 
in the diagrams below of the 1,4-disubstituted-1,2,3-triazoles. 
 
Figure 1-13- Bidentate ligands containing 1,4-disubstituted-1,2,3-triazoles 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine and [2-(4-
R-1H-1,2,3-triazol-1- yl)methyl]pyridine 
 
1.5.1.2.1 Ligands Containing One 1,4-Disubstituted-1,2,3-Triazole Unit 
 
The 2-(1,2,3-triazol-4-yl) pyridine type ligands have also been a subject of research studies, 
especially in finely tuneable analogues. The influence of the triazole moiety is apparent when 
combined as the chelating N^N ligand in complexes. In this type it has a direct impact on the 
energy of the LUMO and hence the energies of the 1MLCT and 3MLCT states. In most studies, 
the 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine complexes of ligands have been compared to the 
2,2′-bipyridine complexes, despite the presence of the additional nitrogen donor atom (N2) 
within the ligand scaffold, all of these studies proved that the 2-(1-R-1H-1,2,3-triazol-4-
yl)pyridine acting as bpy-like N^N five-membered chelates. The triazole ligand coordinate 
through the pyridyl and N3 nitrogen of the 1,2,3-triazole unit with a wide range of metals ions 
including those with octahedral complexes (Re(I), Tc(I),103 Ru(II),104 Ir(III).105 Figure 1.14. 
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Figure 1-14- Some metal complexes containing the 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine 
 
Rhenium complexes [Re(Bn-pytz)(CO)3Cl]
96, 103, 106 showed a blue-shifted electronic 
absorption and emission (λabs= 333 nm, λem = 538 nm ) compared with [Re(bpy)(CO)3Cl] 
complexes (λabs= 371 nm, λem = 633 nm ) with emission coming from the mixed metal-to-
ligand-to-ligand charge transfer (MLLCT) state. Both complexes have the same HOMO level 
of energy, so the blue-shift of the MLCT means that the [Re(Bn-pytz)(CO)3Cl] has a higher 
energy level of LUMO than [Re(bpy)(CO)3Cl]. Similarly, in the excited state at room 
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temperature [Re(pytz)(CO)3Cl] showed the blue-shifted luminescence compared to 
[Re(bpy)(CO)3Cl] complex, This was further supported by the radiative lifetimes of the 
complexes. The luminescence lifetime of [Re(Bn-pytz)(CO)3Cl] (τ/μs = 8.90) is longer than 
[Re(bpy)(CO)3Cl] (τ/μs = 3.17). Changing the π-donor axial chloride ligand by a neutral 
pyridine donor leads to further blue-shift in the emission maximum to the blue-green region of 
the spectrum (496 nm).107 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine technetium-99 complexes 
were prepared by Benoist, Machura and coworkers103 which presented a suitable lipophilic 
character for its use as a CNS imaging agent. 
 [Ru(pytz)3]
2+ was prepared and compared with [Ru(bpy)3]
2+ independently by Fletcher89 and 
Schubert.94 Because of the asymmetry of the pytz ligands in the homoleptic complex the 
product results in a mixture of the fac and mer isomers which are difficult to separate, being 
possible only if a bulky substituent is present at the N1 position of the triazole heterocycle. 
Comparing with their bpy analogues the [Ru(pytz)3]
2+,  it was found that the homoleptic 
complexes are only modestly coloured and are not emissive. A family of complexes 
[Ru(bpy)3−n(pytz)n](PF6)2 (n = 1 to 3) were prepared, and the photophysical and 
electrochemical properties were characterised. Complexes show a progressive blue-shift in the 
UV-visible absorption spectra on increasing the pytz ligand content, [Ru(pytz)3](PF6)2 exhibits 
a very large blue shift (λabs= 384 nm) compared with [Ru(bpy)3](PF6)2 (λabs= 461 nm)  and the 
energy of the LUMO is increased, as observed by cyclic voltammetry.94, 108 Cyclometallated 
Ir(III) complexes with pytz ancillary ligands of type [Ir(ppy)2(pytz)]
+ and [Ir(F2ppy)2(pytz)]
+ 
(where ppy = 2-phenylpyridine and F2ppy = 2-(2,4- difluorophenyl)pyridine) have been 
prepared and their photophysical and electrochemical properties have been examined by De 
Cola and coworkers.105, 109-111 The compounds display excellent structured emission bands, 
often indicative of the presence of a large amount of ligand-centred character in the emissive 
excited states, with emission maxima at (λmax =475) for [Ir(ppy)2(pytz)]+ and (λmax =450 nm) 
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for [Ir(F2ppy)2(pytz)]
+  and quantum yields, (0.16-0.23 in degassed dichloromethane) for both 
complexes respectively, long luminescent lifetimes, (0.53-1.3 μs) and reversible oxidation 
behaviour observed from these complexes. Emission is also blue shifted through perturbation 
of the bpy-centred LUMO to higher energy when compared with [Ir(ppy)2(bpy)]
+ complex 
which displays emission maxima at (λmax =580 nm).  Also, compounds exhibited 
electrochemiluminescence where the emission colour can be modulated from green to blue by 
ligand modification, and authors suggest that this can be exploited in the development of 
eugenic labels for bioanalytical applications.105 
Square planar complexes of 2-(1,2,3-triazol-4-yl) pyridine type ligands with Pd and Pt have 
been prepared and crystallographically characterized.112-114Palladium “click” complexes, 
which were prepared by Milani and coworkers113 demonstrated the ability to act as an active 
catalyst for styrene carbonylation producing low-molecular-weight products. In general 
complexes display absorption spectra, with bands in the region 270–285 nm being associated 
with π-π* pytz-localised IL transitions and weaker absorbances at lower energy (360–380 nm) 
which are assigned to MLCT transitions  with a degree of chloride-to-pytz charge transfer 
contributions. These features are also shifted to higher energy, [Pt(Bn-pytz)Cl2] ( λabs = 330 
nm) compared with  [Pt (bpy)Cl2] (λabs = 389 nm). The other well-known ligand is [2-(4-R-1H-
1,2,3-triazol-1-yl) methyl]pyridine frameworks Figure 1-15. Complexes based on this ligand 
have a higher energy LUMO over that of complexes with bpy ligand. The 1MLCT absorption 
and 3MLCT emission bands are observed to blue-shift on increasing pytz ligands comparing 
with bpy based ligand complexes.115, 116  
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Figure 1-15- some metal complexes containing the [4-R-1H-1,2,3-triazol-1-yl)methyl]pyridine ligand.
86 
1.5.1.2.2 Bidentate Ligands Containing Two 1,4-Disubstituted-1,2,3-Triazole Units 
The last class of this type of ligands which has received keen interest in is the ligands that are 
bi-1,2,3-triazoles.89, 117-121 Most researchers have therefore attempted to examine the 
symmetrical structure of the ligands which have portrayed the stable metal complexes. The 
ligands have five membered rings. 
 
Figure 1-16- Structure of bidentate 4,4’-bis-1,2,3-triazolyl ligands 
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Figure 1-17 Some metal complexes containing the 4,4’-bis-1,2,3-triazolyl ligands 
 
With the bis-triazole ligands Konig, Monkowius, and coworkers formed stable complexes with 
Ru(II), Cu(I), and Re(I).118 They confirmed the bidentate coordination of the ligands through 
the N3 atoms of the triazoles to form five-membered chelate rings. The bi-1,2,3-triazole 
complex’s electronic absorptions are significantly higher in energy than the corresponding bpy 
complexes, but they are not emissive in solution or the solid state. A family of complexes 
[Ru(bpy)3−n(btz)n](PF6)2 (n = 1 to 3) were prepared by the Elliott group.
119 The photophysical 
and electrochemical properties were characterised. Complexes show a progressive blue-shift 
in the UV-visible absorption spectra on increasing the btz ligand content with a very large blue-
shift observed on replacement of the final bpy ligand by btz when compared to [Ru(bpy)3].
2+ 
The energy of the LUMO is increased as observed by cyclic voltammetry. The Elliott group 
applied the same ligand to prepare and characterised a series of osmium(II) complexes120 
[Os(bpy)3−n(btz)n](PF6)2. These Os complexes also show a progressive blue-shift in the UV-
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visible absorption and in the photoluminescence emission spectra on increasing the btz ligand 
content with a very large blue-shift observed on replacement of the final bpy ligand by btz 
when compared to [Os(bpy)3],
2+ which  indicates the much higher energy LUMO of the btz 
ligand over that of bpy. The homoleptic complex appears to display extremely weak room 
temperature emission, but on cooling to 77 K the complex exhibits highly intense blue 
emission. The complexes were used in light-emitting electrochemical cell (LEEC) devices. All 
LEECs display electroluminescence in the deep-red/near-IR. Elliott121 used the same ligand to 
synthesise complexes of the form [Ir(R-ppy)2(btz)]PF6,( R-ppy = 4-(pyrid-2-yl)benzaldehyde, 
2-phenylpyridine and 2-(2,4-difluorophenyl)pyridinethe complexes.  The complexes show 
luminescence with emission wavelengths tunable through variation of the aryl substituents of 
the cyclometalated ligands but are independent of the ancillary btz ligand with emission 
maxima about (λ max = 452-500 nm). The authors suggest that this type of  complex are 
promising candidates for further development as phosphors in light emitting devices and in 
other applications such as biological imaging. Table 1-1 summarises the absorption and 
emission data of some metal complexes based on the 4,4’-bis-1,2,3-triazolyl ligand compared 
to the bpy based ligand complexes.  
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Table 1-1: Absorption and emission data of some metal complexes based on the 4,4’-bis-1,2,3-
triazolyl ligand compared to the bpy based ligand complexes.  
Complex λabs /nm λem/ nm 
[Ru(bpy)3]
2+ 452 610 
[Ru(btz)3]
 2+ 303 Not observed 
[Cu(phen)(DPEphos)]+ 391 700 
[Cu(btz)(DPEPhos)]+ 307 Not observed 
[Re(bpy)(CO)3Cl] 371 633 
[Re(btz)(CO)3Cl] 302 Not observed 
[Os(bpy)3]
 2+ 450 732 
[Os(btz)3]
 2+ 422 Not observed 
[Ir(ppy)2(bpy)]
 + 405, 377 580 
[Ir(ppy)2(btz)]
 + 382, 332 476, 508 
 
1.5.1.3 Tridentate Ligands Containing 1,4-Disubstituted-1,2,3-Triazole Units 
 
Some the tridentate “click” ligands have also been a subject of scholarly work and research 
studies and experiments aiming at the synthesis and characterization of their structural 
formation and also coordination. Although most of the ligands have two or three 1,4-
disubstituted-1,2,3-triazole units, some other tridentate ligands have only one triazole unit. 
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1.5.1.3.1 Tridentate Ligands Containing One 1,4-Disubstituted-1,2,3-Triazole Unit 
 
The click-to-chelate concept was first written by Mindt and Shibli122-127 who have synthesized 
a series of amino acids generated from the tridentate ligands that contain one 1,4-disubstituted-
1,2,3-triazole. Complexes containing tridentate ligands of Re(I) and also 99Tc(I) developed in 
radiopharmaceuticals (which can be used as potential imaging agents in PET scans). They 
generated both the ‘regular’ and the ‘inverse’ ligands although they realized that the regular 
ligands were more stable compared to the inverse ligands. However, no photophysical studies 
were revaled in this work. One of the methods used in the synthesis is the mild click method 
which enabled conjugation of a variety of biotargeting molecules such as phospholipids, 
carbohydrate, thymidine, bombesin, and folate.128 Similar ligands used by Adolfsson and co-
workers129 to prepare  rhodium complexes which  have been shown to be effective as a catalyst 
in organic reactions. A hybrid NHC-1,2,3-triazole tridentate ligand and its Ag(I), Pt(II) and 
Pd(II) complexes were synthesized and characterised by Chen and coworkers130 Figure 1-18. 
The palladium complex, was found to be a very active catalyst for the Suzuki-Miryaura cross-
coupling reactions. The last example of the complexes that use this kind of ligands are “super-
hybrid” Fe(II) complexes which prepared by Chandrasekher and co-workers131 in this complex 
tridentate ligands contain pyridyl, pyrazolyl, and triazolyl N donors. X-ray crystal structures at 
100 K (the temperature of the X-ray data collection) showed the octahedral Fe(II) complexes 
to be low spin and deep red. Photophysics of complexes using this type of ligand investigated 
by Strassert and co-workers132 who used a triazole containing terdentate cyclometalate ligand 
(TzPyPh) in order to obtain room temperature luminescence in Pt(II) complexes. All complexes 
display absorption spectra band between 300 nm–450 nm, which are assigned to mixed singlet 
metal-to-ligand charge transfer/ligand-centred (1MLCT/LC) excitations. Complexes exhibit 
structured vibrational emissions at about 500 nm. 
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Figure 1-18 Some metal complexes containing One 1,4-Disubstituted-1,2,3-Triazole Unit 
 
1.5.1.3.2 Tridentate Ligands Containing Two 1,4-Disubstituted-1,2,3-Triazole Units 
 
The tridentate 2,2’:6’,2”-terpyridine ligads (tpy) is another ligand which has been widely 
studied in the area of coordination chemistry. This has triggered several researchers to apply 
the CuAAC reaction in the synthesis of analogues of this ligand starting from 2,6-
diethynylpyridines. It has also been reported that most of these ligands behave like the tpy 
tridentate ligands bridging through the pyridyl and the N3 nitrogen atoms position of the 
triazole rings. Various metal ions have been found useful in the synthesis of tridentate 2,6-
Chapter 1: Introduction 
39 
 
bis(1,2,3-triazol-4-yl)pyridine (btzpy) metal complex such as Fe(II),133-135 Cu(II),88, 136 Ag(I)88 
and Ru(II), Figure 1-19.135, 137, 138 The first synthesis of the 2,6-bis(1,2,3-triazol-4-yl) pyridine 
type of ligands was reported to have a coordination to the Eu(III) and the ferrous(II) metal 
ions.133 The reaction of the ligands with the metal ions produced octahedral complexes which 
when characterized by the X-ray crystallography showed that they were less sterically strained 
compared to the tpy analogues. The photophysical and electrochemical properties were 
characterised. Complexes showed a blue-shift in the UV-visible absorption and in the emission 
spectra compared to tpy complexes, this is due to the LUMO of the btzpy ligand being higher 
in energy than the tpy ligand. [Fe(btzpy)2]
2+  complex display  a broad MLCT band at (λabs = 
432 nm), which is  significantly shifted to the blue region of the visible spectrum compared to 
that of [Fe(tpy)2]
2+ complex (λabs = 552 nm).  A heteroleptic Ru(II) complexes containing a 
terpy and a 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligand, was synthesized in a stepwise 
manner via a [Ru(L)Cl3]
2+ intermediate species by Schubert and coworkers.137, 139 This 
octahedral complex displays intermediate electronic properties comparing to the related 
homoleptic species. The heteroleptic Ru(II) complex displays a band at (λabs = 432 nm) in 
absorption spectra, which is located  between the MLCT bands of the homoleptic complexes  
Ru(tpy)2 (λabs = 475) nm and Ru(btzpy)2 (λabs = 394). The blue shift of the MLCT, when 
exchanging the tpy ligands by btzpy, can be attributed to energetically because the btzpy ligand 
has a higher energy π* orbitals (lowest unoccupied molecular orbital, LUMO), which means 
bigger ∆E. Complexes are not emissive at room temperature, but bright orange emission has 
been observed for the heteroleptic complex at 77 K in a matrix of n-butyronitrile glass (λem= 
583). Which blue-shifted of about 20 nm, compared to the homoleptic Ru(tpy) complex (λem= 
604). O'Reilly140reported a similar approach to the synthesis of metallostar complexes of Ru(II) 
and Eu(III). Photophysical data for Ru(II) whith two 1,4-Disubstituted-1,2,3-triazole units 
based complexes summarised in Table 1-3. 
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 Table 1-2: Photophysical data for Ru(II) whith two 1,4-Disubstituted-1,2,3-Triazole Units 
based complexes at room tempreture 
Complex λabs /nm λem/ nm 
[Ru(tpy)2]
2+ 475 604 
[Ru(tpy)(dpb)] 2+ 499 Not observed 
[Ru(tpy)(btzpy)] 2+ 432 583 
[Ru(btzpy)2]
2+ 394 Not observed 
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Figure 1-19- Some metal complexes containing 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine 
 
The more flexible 2,6-bis(4-R-1,2,3-triazol-1-ylmethyl)pyridine ligands related to btzpy have 
also been studied by  Crowley and co-workers88 who explored the synthesis and 
characterization of their structural formation and also coordination of these types of ligands 
with Ag(I) and Cu(II), Figure 1-20. The silver complex was found to be polymeric in the solid 
state with the tetrahedral Ag(I) centres coordinated to the pyridyl and triazolyl nitrogens from 
one ligand along with the other two nitrogen donors from a second identical ligand resulting in 
a 4,4 net structure. From the same ligand Zhu and coworkers141 prepared complexes of Cu(II), 
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Fe(II), and Co(II). X-ray structures of these showed them have the expected octahedral 
structures. 
 
Figure 1-20- 2,6-bis(4-R-1,2,3-triazol-1-ylmethyl)pyridine inverse “click” metal complexes 
 
1.5.1.3.3 Tridentate Ligands Containing Three 1,4-Disubstituted-1,2,3-Triazole Units 
 
Another type of tridentate click chelates in click chemistry are the ligands with three 1,4-
disubstituted-1,2,3-triazole units. In a research study conducted by Pericas and coworkers,142 
they prepared the copper chloride compound which demonstrated the excellent catalyst 
properties of CuAAC, Figure 1-21. Conclusively, based on the discussion and the review of 
literature in research studies conducted in the past by other researchers, it is evident that the 
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mild function group or CuAAC reaction has proven to be a reliable robust for the synthesis of 
the functionalized ligands.  
 
Figure 1-21- CuCl-tris(1-benzyl-1H-1,2,3-triazol-4-yl) methanol CuAAC catalyst 
 
Recently Didier Astruc and co-workers143 prepared tris-1,2,3-triazole-Stabilized Gold 
nanoparticles. The authors mentioned that a water-soluble complex contains amphiphilic 
ligand containing hydrophobic tris(1,2,3-triazolyl) on the one side and a hydrophilic 
polyethylene glycol 2000 chain on the other side to stabilize AuNPs. And the formation of the 
micellar AuNP catalyst, would further improved catalytic efficiency. The complexe exhibit 
absorption band at 515 nm.  
 
Figure 1-22- PEG-tristrzAu-Cl 
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1.5.2 1,4-Disubstituted-1,2,3-Triazoles as C^N-Donor and N^C^N-Donor  Ligands 
Another type of triazole ligand that has been widely studied is the C^N donor ligand such as 
the 4-phenyl-1,2,3-triazoles which researchers have extensively studied their application as 
precursors for cyclometallation. A experiment conducted by Schubert,144 revealed that the 
reflux method in which 4-phenyl-1,2,3-triazole was heated at reflux with IrCl3
. 3H2O in 
ethoxyethanol led to the synthesis of the biscyclometalated chloro bridged dimer which could 
be treated with a wide variety of neutral and anion ligands such as acac and pic forming 
monomeric complexes.110, 144 One of the optical-electronic characteristics and behavior of the 
complexes is the color-tuning of emission, which could be produced by changing the 
substituent on the ancillary ligand. Using functional groups with electron withdrawing on ancillary 
ligands leads to stabilisation of the LUMO. While applied functional groups with electron donating on 
ancillary ligands leads to higher energy in LUMO All the complexes exhibit blue shifted emission 
comparing with Ir(ppy)3 complex (= 530) except the bpy complex. Emission was revealed to 
be easily tunable on the basis of the nature of the auxiliary ligand L^L, Figure1-23. Following 
the same reaction conditions, DeCola and coworkers110, 145 synthesized and characterized the 
iridium dimers bearing 4-(2,4-difluorophenyl)-1,2,3-triazolyl)pyridine (dfptz) which contained 
an almost similar chemical structure and characteristics. Comparing with Ir(ppy)2 complexes 
showed similar absorption features with strong π-π* transitions and weaker MLCT. Emission 
bands were significantly shifted to the blue region of the visible spectrum compared to that of 
the non-fluorinated analogue.  
Cyclometalated ruthenium(II) complexes bearing aryltriazole-based ligands have been 
prepared and characterised by Wenwen Yang  and Yuwu Zhong.146 The complex showed red 
shifted in absorption relative to that of [Ru(bpy)2(pytz)](PF6)2 and extends beyond 600 nm. 
The HOMO of this type of complexes is not localised on the metal centre only, but is localised 
over the ruthenium and cyclometalated ligand, therefore the HOMO energy can be controlled 
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by changing the R group on the cyclometalated ligand. In 2011, Yao, Zhong, and coworkers138 
reported heteroleptic Ru(II) complexes by reacting Ru(terpy)Cl3 with the bis (triazolyl)benzene 
ligand, to give an octahedral cycloruthenated complex. 2,6-bis(1-R-1,2,3-triazol-4-yl)pyridine 
ligands, also used to prepare cyclometallated complexes and metallostar complexes. The 
UV/vis absorption spectra of cyclometallated complexes  were compared with [Ru(tpy)2](PF6)2 
and [Ru((dpb)2](PF6)2  where dpb =  1,3-di(2-pyridyl)benzene ligand. While [Ru(tpy)2](PF6)2 
complex shows (MLCT) transition at λabs = 475 nm, the MLCT absorptions of cyclometalated 
[Ru(tpy)(dpb)](PF6)2 complex are red shifted  at λabs = 499 nm, extended, and slightly reduced 
in intensity. The complexes which contained 2,6-bis(1-R-1,2,3-triazol-4-yl) pyridine ligands, 
as cyclometallated triazole complexes display significantly different UV/vis absorption 
spectra. Blue shifted, the complexes exhibit absorption bands between 340 and 420 nm which 
are assigned as MLCT from metal center to N^C^N ligand. Obata, Kakuchi and co-workers104 
reported that they prepared a four-arm metallostar architecture from reacting Ru(II) with the 
ligand resulting from reaction of  an azido functionalised polystyrene polymer with 2,6-
diethynylpyridine. 
 
Figure 1-23 Some metal complexes containing the 4-phenyl-1,2,3-triazole ligands as C^N donor 
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Table 1-3: photoluminescence data of some iridium(III) and ruthenium(II) complexes 
containing the 4-phenyl-1,2,3-triazoles ligands as C^N and 2,6-bis(1-R-1,2,3-triazol-4-
yl)phenyl ligand as N^C^N –donor at room temperature. 
Complex λem/ nm 
[Ir(ppy)3]
 + 530 
[Ir(ppy)2(bpy)]
 + 580 
[Ir(ptz)2(bpy)]
+ 560 
[Ir(ptz)2(acac)]
+ 435 
[Ir(dfptz)3]
+ 392, 418 
[Ir(dfptz)2(bpy)]
+ 514 
[Ir(dfptz)2(ppy)]
+ 480, 510  
[Ir(dfptz)2(dfppy)]
+ 465, 489 
[Ru(tpy)2]
2+ 604 
[Ru(tpy)(dtab)] 2+ Not observed 
[Ru(bpy)2(Butab)](PF6) Not reported 
 
1.5.3 1,4-Disubstiuted-1,2,3-Triazoles as C-Donor Ligands 
In most cases, the most preferred metal coordination sites are the N2 and N3 nitrogen atom 
positions of the 1,4-disubstituted-1,2,3-triazole although from the previous discussion there is 
a possibility for metal coordination  at the C5 carbon position. Copper triazolide is thought to 
be key intermediates in CuAAC reaction. The formulation of a Cu(I) triazolide in the CuAAC 
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reaction  gives rise to valuable modifications of the catalytic cycle. With stoichiometric 
quantities of Cu and in the protons absence, the Cu(I) triazolide is obtained as product, that 
permitting the following transmetalation of the triazolide to other metal centers.147 The 
alkylation or protonation of 1,4-Disubstituted-1,2,3-triazole ligand occurs selectively at the 
N(3) position to make1,3,4-trisubstituted-1,2,3-triazolium salts, which are known as  
mesoionic or ‘abnormal N-heterocyclic carbene (aNHC). 
1.5.3.1 Triazolide complexes 
 
The coordination of the triazole ring with C5 as a monodentate ligand demonstrated by Gray 
and coworkers who in their experiment synthesized a series of luminescent gold-1,2,3-
triazolide complexes in a click chemistry reaction, Scheme 1-6. The complexes are luminescent 
in THF at room temperature and showed dual singlet- and triplet-state luminescence from 
excited states localized on the aromatic fragment with the shorter-wavelength emission peaks 
at 383 nm; and a longer-wavelength  emission maxima at 498, 536, and 579 nm,. Luminescence 
lifetimes observed for complexes are from hundreds of microseconds to tens of milliseconds. 
148   
 
Scheme 1-6 Copper-Catalyzed Gold(I) Triazolide Synthesis148 
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Copper(I) triazolides that are typically formed as intermediates in CuAAC reactions, were 
generated and used as a bidentate C^N donor ligands in the formation of neutral iridium(III) 
pyridyltriazolide complexes by Swager and co-workers, Figure 1-24.147 The complexes showed 
structured bands in their emission spectra indicating phosphorescence from 3MLCT/3ILCT 
states. These complexes were found not to be stable, and could be readily converted into their 
cationic N^N-pytz analogues through UV photolysis or through heating in glycerol solutions. 
By using RuAAC Schubert and his group prepared the ligand 6-(1-octyl-1,2,3-triazol-5-yl)-
2,2-bipyridyl in which tridentate N^N^N coordination including to the triazole is not possible. 
Reaction with [Ru(tpy)(NCMe)3]
2+ leads to cyclometalation to form the triazolide complex.149 
The absorption and emission bands are shifted to lower energy (λabs = 520 nm, λem = 730nm) 
compared to [Ru(tpy)2]
2+ complex (λabs 452 = nm, λem =610). The HOMO of the triazolide 
complex has contributions from the metal as well as the triazolide p-system and is destabilised 
with respect to that of [Ru(tpy)2]
2+. Methylation of the N(3) position of the triazolide complex 
using methyl iodide lead to  production of the mesoionic triazolylidene complex . 
 
Figure 1-24 Structures of iridium(III), ruthenium(II) triazolide complexes. 
 
1.5.3.2 Carbene complexes 
 
As mentioned above, Schubert and his group prepared a mesoionic triazolylidene rhuthenium 
complex by methylation of the N(3) position of the triazolide complex using methyl iodide. 
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The HOMO is stabilised in 1,2,3-triazol-5-ylidene complexes relative to that of triazolide 
complexes, because of the overall charge neutrality of the carbene donor, and poor π-donor 
properties compared with triazolide complexes. This leads to shifted absorption and emission 
to higher energy.83  
The increasing of the energy gap between the 3MLCT and 3MC states can be amended by using 
stronger σ-donating ligands as well as auxiliary substituents.150 Also, using strong π-donors 
within the ligand set can be lead to deactivation of 3MC states. Long lived phosphorescence 
from tpy based 3MLCT states is observed as a result of the strong ơ-donor character of the 
triazolylidene ligands and the consequential destabilisation of emission-deactivating 3MC 
states. Protonation and deprotonation of triazolide complexes shift the 3MLCT emission band 
to 648 nm. The absorption spectra of the complexes are shifted to higher energy (λabs = 480 
nm) comparing to Ru(tpy)2  (λabs = 474 nm) and triazolied complex (λabs =520 nm). While 
rhuthenium catalyzed Azide-Alkyne Cycloaddition (RuAAC) was chosen by Schubert to 
produce 1,5-disubstituted 1,2,3-triazolylidene,149 CuAAC was selected by Berlinguette to 
prepare 1,4-disubstituted 1,2,3-triazolylidene ligands.151 Berlinguette and his group reported 
the series of bi(triazolylidene) ruthenium(II) complexes, Figure 1-25. The two strong carbene 
donors in the complex leads to an extremely long lived 3MLCT state (τ = 7.9 μs), amongst the 
longest recorded for a bis(tridentate) ruthenium(II) complex. A terdentate bis-2,6-
(triazolylidene)pyridine Fe(II) complex has been synthesised by Sundström and coworkers.152 
The first known examples of bis(triazolylidene)pyridine coordination to Pt(II) have recently 
reported by Hwang et al.153 These complexes which containing different X ligands (X = Cl, 
NCCH3, CN) are emissive in MeCN solutions, with (X = Cl λem = 504 nm, τ= 6.93 µs) and X= 
NCCH3 (λem = 494 nm, τ = 1.68 µs) giving broad bands while the complex with X= CN is more 
structured with λmax = 490 nm and 522 nm (τ= 5.58 µs).  
Chapter 1: Introduction 
50 
 
 
Figure 1-25-Some bis(tridentate) complexes based on 1,2,3-triazolylidene ligands 
 
The bidentate triazolylidene ruthenium complex has been reported by Albrecht Figure 1-26.154 
Due to the slight anionic charge on the abnormal carbene ligand donor C-atom, this complex 
exhibits a slightly destabilised HOMO comparing to [Ru(bpy)3]
2+ complex. The resultant 
reduction of the HOMO–LUMO gap results in a slight red-shift in the emission band, (λem= 
648 nm). Bis(1,2,3-triazol-5-ylidene) Fe(II) complexes having been synthesised by 
Sundström.155 The red-shift of the lowest-energy MLCT band observed in the visible region 
from 520 nm of [Fe(bpy)3][PF6]2 to 609 nm, with long 
3MLCT lifetime of 13 ps, significantly 
longer than the lifetime of  [Fe(bpy)3]
2+ (τ = 130 fs). Recently Wärnmark and coworkers 
prepared bis(1,2,3-triazol-5-ylidene) ligands which have been used within low-spin complexes 
of Fe(III). Most remarkably, the resulting 2LMCT excited states are emissive at room 
temperature (λ= 600 nm) with a lifetime of 100 ps. Albrecht reported BODIPY-functionalised 
triazolylidene complexes of Pd(II).156 This complex displays BODIPY-derived 
photoluminescence (emission around 545 nm, quantum yields in the 0.35−0.7 range, and 
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excited-state lifetimes between 3 and 7 ns). Replacing DMAP ligand in this complex by 
acridine allows for an observation of the exchange of emission-quenching constants were 
determined as KSV = 0.86  
 
Figure 1-26 Some metal complexes 1,2,3-triazole-based aNHC ligands 
 
1.5.4 1,2,3-triazole moiety as a supramolecular linking unit. 
Synthesis of metallosupramolcular compounds has to be based on the preparation of bridging 
ligands with various coordination sites into which can then be incorporated metal centers. This 
methodology has major defects with complications in the selectivity and control of the metal 
binding when, for example, heterometallic complexes are demanded and where the bridging 
ligand is non-symmetric. “Expanded ligand” based approaches157 have also been reported in 
the complexes that are prepared and modified at their periphery in order to graft onto the 
complex a second binding domain. One method for such architectures involves a separately 
preformed coupling of superamolecular complexes under mild conditions, which require as 
few as possible steps. Such process would necessitate a coupling reaction of high productivity 
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and highly efficient, for this, functional groups are required which can be easily inserted into 
the periphery of the metal complex components. With this methodology in place and a library 
of appropriately derivatised transition metal complex components, this would allow easy 
access to supramolecular architectures with remarkable diversity of structure. For this purpose 
The CuAAC reaction is an excellent candidate. A number of groups have reported “click” 
ligands158-160 in the formation of coordination polymers. 
 
Figure 1-27- Click ligands used as bridging ligands on the preparation of metallosupramolcular materials 
 
 The tris(benzyltriazolylmethyl) amine (TBTA) which used as a co-ligand in CuAAC reaction 
is  the most common ligand used in this type . Donnelly, Williams, and coworkers161 have 
reacted The tris(benzyltriazolylmethyl)amine (TBTA) with [Cu(MeCN)4]BF4 in acetonitrile to 
give a dinuclear cation complex, Figure 1-28. From X-ray crystallography they found that each 
Cu(I) ion is coordinated by three N3 triazole donors from one ligand and an N2 donor from a 
second ligand. 
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Figure 1-28- Dinuclear cation complex of TBTA CuII complexes. 
 
Potential bis-tridentate ligands have been formed by incorporating triazole units into a pyrene 
skeleton by Yao, Zhong, and coworkers162 by reacting two equivalents of dicycloruthenated 
complex, where each octahedral Ru(II) center is coordinated by three N donors from a terpy 
ligand and  two triazole N donors as well as  a carbon donor from the pyrene core Figure 1-29. 
The UV–visible absorption spectrum of the dinuclear complex is very like to that of its 
mononuclear complex proposing that in the ground state there is little communication between 
the two metal centres. Upon one-electron oxidation of the dinuclear complex there is a new 
LMCT band detected at around 730 nm along with an intervalence charge transfer (IVCT) 
transition. When a second electron is removed from the dinuclear complex, this IVCT band is 
noted to disappear. 
 
Figure 1-29- Linear dimetallic biscyclometalated Ru (II) complex using 1,3,6,8-tetrakis(1-butyl- 1H-1,2,3-triazol-4-
yl)pyrene as bridging ligand 
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Ulrich S. Schubert and co-workers163 apply [1,1′-(9,9-Dioctyl-9H-fluorene-2,7-diyl)bis(1H-
1,2,3-triazole-4,1-diyl)]bis{3-[(4-nitrophenyl)ethynyl]pyridine}ligand as bridging ligand to 
synthesise the ruthenium dinuclear complex [Ru(dmbpy)2]2{μ-2,2′-[1,1′-(9,9-dioctyl-9H-
fluorene-2,7-diyl)bis(1H-1,2,3-triazole-4,1-diyl)](dipyridine)}(PF6)4, Figure 1-30. The 
complex shows a typical absorption band for ruthenium(II) polypyridine complexes around 
450 nm, which assigned to MLCT transitions. Even though the pytz moiety and lead to 
quenched emission, this complex is emissive in dichloromethane solutions at room temperature 
(λem = 593 nm). 
 
Figure 1-30 Heteroleptic ditopic ruthenium(II) complexes 
 
Crowley and co-workers164 have shown that poly-2-(1-R-1H-1,2,3-triazol-4-yl)  pyridine 
ligands will form metallomacrocycles Figure 1-31. Crowley react of the ligands, with AgSbF6 
to form the metallosupramolecular architectures. Characterisation of complexes indicate that 
these complexes are stable in solution. The structure of the silver (I) metallomacrocycle, was 
confirmed using X-ray crystallography. 
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Figure 1-31 bis-bidentate “click” silver (I) metallomacrocycle 
Crowley and co-workers165 also applied the same ligand to prepare an iron complex. UV-vis 
absorption spectroscopy of the complex revealed absorption features in the UV-visible region 
of the spectrum (300–450 nm) with maxima observed at 420–430 nm. These absorption 
maxima are assigned as MLCT bands which are blue-shifted relative to related bipyridine based 
iron(II) complexes, (λmax = 500–540 nm) but occur in a similar region to complexes 
containing pyridylpyrazole chelators (λmax = 423 nm). This shift to lower wavelength for the 
MLCT band of the “click” complexes compared to these other systems is consistent with the 
reduced π-acceptor nature of the triazole unit. Hor and coworkers159 have formed an elegant 
helical Cu(II) coordination polymer from reaction of 1-(2-picolyl)-4-(1-(methoxyl)-
benzotriazole)-1H-1,2,3-triazole with CuCl2. 2H2O Addition of one equivalent of CuCl2 gave 
a mixture of green and blue crystals, Figure 1-32. 
 
Figure 1-32- 1-(2-picolyl)-4-(1-(methoxyl)-benzotriazole)-1H- 1,2,3-triazole as bridging ligand in Helical Cu(II) Polymers 
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Recently A. Wiehe and co-workers166 used the copper(I)-catalyzed 1,3-dipolar cycloaddition 
(CuAAC) to prepare a functionalized symmetric dimer as a biocompatible carrier system for 
photodynamic therapy (PDT). 
 
Figure 1-33- Structure of Porphyrin dimer using triazole ligand as bridging ligand 
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1.6 Aim of the project 
 
The main goal of the project in this thesis is the synthesis, structural investigation, 
photophysical and electrochemical properties of new triazole-containing transition metal 
complexes and their possible use in applications, such as light-emitting diveces, imaging in 
living cells and photodynamic therapy (PDT) as photosensitizer (PS). The desired 
photophysical and photochemical properties of a complex can be achieved by use of synthetic 
chemistry and molecular design to manipulate ligands and metal. The increased used of 
luminescent complexes in these applications depend on the lifetime regarding biological 
applications for instance phosphorescence often displays a longer lifetime compared to 
autofluorescence emanating from the natural or organic compounds of emissive complexes 
amenable to time-gated imaging microscopy and therapy. In this project osmium(II) will be 
used as a central metal. The osmium(II) complexes allow excitation at lower energy. The 
principle sustains efficient excitation at low energies that eliminate the possibility of cellular 
damage and negates the auto-fluorescent and necessity of additional expensive time gated 
apparatus. The osmium(II) complexes are inert to ligand photo substitution. The intensity of 
phosphorescence is dependant upon the concentration of oxygen in the system due to 
quenching through conversion of ground state 3O2 to the reactive 
1O2, thus supporting 
exploitation of the complex for photodynamic therapy (PDT).  Therefore reactions that enable 
facile routes to the modular construction of new ligands and these architectures are particularly 
useful in the development of such materials. The influence of the supermolecular architecture 
is that it controls the photophysical properties of the complex which allows to design it for 
certain application. In this project 1,4-disubstituted 1,2,3-triazoles will be used as a ligand, 
prepared by the CuAAC reaction. In general, triazoles, which are formed from this reaction 
contain two nitrogen atoms that can coordinate with metals, with N3-position acting as the 
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more basic site. On the other hand, the R and R’ groups of the alkyne and azide precursors can 
also feature coordinating fragments, which allows for the access to numerous chelating ligands, 
while C-H activation of position-5 gives access to anionic triazolides. Also triazoles can be 
used as a linker to develop di and trinuclear complexes (oligonuclear, organometallic) 
complexes of diverse architectures. The potential of the CuAAC in coordination chemistry has 
only just begun to be fully exploited. This work will investigate the following aims: 
1- Synthesis and characterisation of different types of 1,2,3-triazole containing ligands 
including 2-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine as bidentate ligand , 2,6-bis(1-
phenyl-1H-1,2,3-triazol-4-yl)pyridine as tridentate ligand  and 1,4-bis((4-(pyridin-2-
yl)-1H-1,2,3-triazol-1-yl)methyl)benzene which will be applied as a bridging ligand.  
 
2- Investigation of the coordination of  2-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine and  
2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine as bidentate ligand with rhenium 
transition metal, then  investigate the influence of (N^N) ligands on the photophysical 
and electrochemical characteristics of complexes comparing with bipyridine  and 
terpyridine derivatives. In 2-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine rhenium 
complex, different types of monodentate pyridine based ligands as axial ligands (X) 
will be used, to investigate the effect of axial ligands on the photophysical properties 
of the complex. The potential of these complexes to be used in light-emitting devices 
will be assessed. 
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3- Prepare osmium complexes using triazole ligands of different types including  2-(1-
benzyl-1H-1,2,3-triazol-4-yl)pyridine as a bidentate ligand and 2,6-bis(1-phenyl-1H-
1,2,3-triazol-4-yl)pyridine as tridentate ligand as its hexafluorophosphate and chloride 
salts complex and study the photophysical and electrochemical properties of these 
complexes and ability to sensitise 1O2 production. 
 
 
4- The water soluble chloride salts of these osmium(II) complexes will be subject to 
preliminary cellular uptake and luminescence imaging studies. 
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5- Formation of complexes using 1,4-bis((4-(pyridin-2-yl)-1H-1,2,3-triazol-1-
yl)methyl)benzene as the bridging ligand to synthesize organometallic homodinuclear 
and heterodinuclear complexes of Ru, Os, and Ir, then characterize their photophysical 
as well as electrochemical properties. In the end, the products might find useful 
applications in catalytic reactions, and industrial as well as biological applications.  
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Synthesis, characterisation and photophysical investigation of 
Rhenium 4-(pyrid-2-yl)-1,2,3-triazole complexes  
2.1 Introduction: 
 
The d6 metal/diimine combinations are valuable as they can allow: i) prolonged excited-state 
lifetimes, ii) strong absorption of light in visible-region, iii) photochemical stability and iv) 
noticeable visible-region luminescence. Substantial attention has been attracted by rhenium(I) 
tricarbonyl diimine complexes167 in the last few decades for their luminescent and 
photophysical properties and the complexes have been used as photocatalysts for CO2,
168-170 
emitters for electroluminescent devices,171, 172 biological imaging agents173-175and as 
supramolecular building blocks.176 As a result many compounds of the form fac-[ReI(CO)3 
(N^N)(L)]n have been studied in an effort to understand their photophysical processes and their 
functions.177 Photophysical properties of rhenium(I) carbonyl complexes usually include 
tunable metal-ligand charge transfer (MLCT) (dπ(M) to π*(L)) and  3MLCT emission 
wavelengths as well as their quantum yields and room-temperature luminescence7 from low-
lying states. Typically, in this type of complex fac-[Re(N^N)(CO)3(X)]
0/+, the HOMO is 
dominated by a Re 5d-orbital (with additional carbonyl π* contributions as well as p-orbital 
contributions where X is a halide e.g. Cl). On the other hand, the LUMOs are essentially the 
π* orbital of diimine ligands. As these characteristics are influenced by solvent environment,178 
ligands and metal, desired photophysical and photochemical properties can be achieved by 
manipulating these factors, which can be modified by changing the electron donating character 
of ancillary ligands and/or diimine  ligand substituents of these complexes. In particular, light-
emitting electrochemical cells, LECs, and organic-light-emitting diodes, OLEDs, promise to 
be efficiently compared with incandescent and fluorescent lamps and can be exploited in 
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electroluminescent displays. The effective OLED requires facile and stable charge transfer as 
well as a high conversion efficiency of excitation to light.179 As electrons and holes are 
transported through the LUMOs and HOMOs, respectively, in OLED components, the relative 
band gap ∆E, HOMO and LUMO energies of these materials is of critical importance to the 
efficiency of an OLED.180 Due to their chemical stability, redox and luminescent properties, 
which can also be exploited on photoswitches, Re(I) complexes have attracted a great deal of 
recent attention and recently, have been used as emissive species due to their higher emission 
efficiency when compared to the polymers.181-183 In order to achieve higher emission yields in 
metal complexes based OLEDs, two strategies have been employed: (i) use of different diimine 
ligands to tune the photophysical and electrochemical properties, (ii) attachment of electron-
withdrawing or electron-donating groups to ligands.184 Rhenium(I) coordination complexes of 
1,2,3-Triazoles have been widely utilised within bidentate chelating ligands with fac-[Re(Bn-
pytz)(CO)3Cl] displaying an electronic absorption band with a maximum at 333 nm, slightly 
higher in energy than that observed for the bpy analogue (371 nm) and emission at 538 nm 
which is blue shifted compared with [Re(bpy)(CO)3Cl] (633 nm).
96 Replacement of the halide 
ligand by a neutral pyridine donor in [Re(bpy)(CO)3(py)]
+ complex results in a blue-shift in 
emission of 42 nm over that of [Re(bpy)(CO)3Cl].
107 In this chapter the use of the 4-(pyrid-2-
yl)-1,2,3 triazole and 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine ligands within bidentate 
donor ligand is explored to investigate the influence of (N^N) ligands on the photophysical and 
electrochemical characteristics of complexes; these are compared with bipyridine and 
terpyridine derivatives after synthesizing a series of rhenium(I) tricarbonyl diimine complexes 
fac-[Re(L)(CO)3Cl], and [Re(L)(CO)3(py)] (L= 1-benzyl-4-(2-pyridyl)-1,2,3-triazole, 2,6-
bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, 2,2′-bipyridyl, 1,10-phenanthroline). Synthesis of 
rhenium (I) complexes having 1,2,3-triazole ligand as a bidentate donor ligand with different 
types of monodentate pyridine based ligands as axial ligands (X) (X = Pyridine, 4-tert-
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Butylpyridine, 4-Methylpyridine, 3-Methylpyridine, 4-Dimethylaminopyridine, 3,5-
Dimethylpyridine) to study the photophysical and electrochemical properties of the these 
complexes (study the effect of axial ligands on the photophysical properties. Some of these 
complexes will be subjected to preliminary tests, on their use in LEECs as blue emitting 
complexes 
 
2.2 Synthesis and characterisation 
2.2.1 Synthesis and characterisation of triazole Ligands 
Ligand 1-benzyl-4-(2-pyridyl)-1,2,3-triazole (Bn-pytz) was prepared by a modification of the 
method98 reported from isolated benzyl azide. Benzyl azide was synthesied through reaction of 
benzyl bromide with an excess of sodium azide in water and acetone. Upon completion, the 
reaction was quenched with water, and the azide extracted into diethyl ether. Benzyl azide was 
kept at -4°C and used in following reactions. In THF and water, with the presence of one 
equivalent of CuSO4, two equivalents of sodium ascorbate and 2,6-lutidine, the benzyl triazole 
was prepared by reaction of the azide with an excess of 2-ethynylpyridine. After stirring at 
room temperature, isolation of the product was completed by partitioning between an aqueous 
ammonia and chloroform to remove copper (Scheme 2.1). 
 
Scheme 2-1 Synthesis of triazole Ligand (bnpytz) 
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 Column chromatography was used to purifiy the crude product which give a white solid 
isolated in good yield. 
The ligand 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, (btzpy)88 was prepared in a two-
step reaction (Scheme 2.2). Firstly 2,6-bis[(trimethylsilyl)ethynyl]pyridine was prepared 
through palladium-catalysd Sonogashira coupling of 2,6-dibromopyridine with ethynyl 
trimethylsilane. The crude product was purified by column chromatography to give a white 
solid.  
 
Scheme 2-2- Synthesis of 2,6-bis [(trimethylsilyl) ethynyl] pyridine 
 
In the second step (Scheme 2.3) aniline was added to acetonitrile. The mixture stirred in ice 
bath then tert butyl nitrite and trimethylsilylazide were added to generate the corresponding 
phenyl azide in-situ. The mixture was then stirred for 2 hours and allowed to warm up to room 
temperature. Upon completion of the substitution reaction 2,6-
bis[(trimethylsilyl)ethynyl]pyridine was added along with catalytic quantity of CuSO4 and 
sodium ascorbate. The resulting precipitate of the Cu complex was decomposed by addition of 
aqueous ammonia. The product was extracted into CHCl3, washed and drid. The solvent was 
removed under reduced pressure. The crude product was purified by column chromatography. 
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Scheme 2-3- Synthesis of 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, (btzpy) 
 
The triazole ligands 1-benzyl-4-(2-pyridyl)-1,2,3-triazole (Bn-pytz) and 2,6-bis(1-phenyl-1H-
1,2,3-triazol-4-yl)pyridine (btzpy) were fully characterised by 1H and 13C NMR spectroscopy 
and mass spectrometry. The data are in agreement with a literature data.98 The 1H NMR 
spectrum for the (Bn-pytz) free ligand shows a distinct diagnostic signal for the C-H proton of 
the triazole ring (0) (Figures 2.1, 2.2).  
 
Figure 2-1-Number of protons of triazole Ligand (Bn-pytz) 
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Figure 2-2-1H NMR (400MHz) spectrum of free ligand (Bn-pytz) in CD3CN 
 
This appears as singlet resonances at δ 8.26. This signal shows nOe interactions in the two 
dimensional NOESY spectrum with correlation to the methylene protons of the benzyl 
substituent (1) which appears as a singlet resonance at δ 5.60. The methylene protons of the 
benzyl substituent (1) shows another nOe interactions in the two dimensional NOESY 
spectrum with correlation to the the phenyl protons which appears as multiplet at region δ   
7.41–7.30 (6). (Figure 2.3) 
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Figure 2-3-2D H-H NOESY NMR spectrum of free ligand (Bn-pytz) in CD3CN 
 
From the spectrum the proton next to the N atom of the pyridyl ring (2) is the most down field 
which appears as a doublet resonance at δ 8.53. This proton displays a COSY correlation with 
the signal which appears at region δ 7.28-7.24 (3). Proton (3) also displays strong COSY 
correlation with the signal appears at δ 7.76 (4). (Figure 2.4). 
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Figure 2-4-2D H-H COSY NMR spectrum of free ligand (Bn-pytz) in CD3CN 
 
 
In the 1H NMR spectrum for 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, contains a 
resonance for the triazole ring proton at δ 8.97, Figure 2.5 and resonance for the pyridyl protons 
in the range of δ 8.13–7.99, the phenyl rings shows 8 protons in the range of δ 7.93–7.63 and 
2 protons at δ 7.53 The ESI mass spectrum of 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, 
(btzpy) shows a peak at m/z = 388.1285, assignable to the species [M+Na]+. These results are 
in full agreement with previous results for the same compound.88 
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Figure 2-5- The 1H-NMR spectrum (400 MHz, CD3CN) of free ligand 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine 
 
2.2.2 Synthesis and characterisation of cationic rhenium(I) triazole complexes 
The rhenium(I) complexes, were prepared by firstly isolating the starting material fac-
[Re(L)(CO)3Cl] using a similar procedure to that of Meyer et al.
185 by heating rhenium 
pentacarbonylchloride with a slight excess of diimine ligand (L= 1-benzyl-4-(2-pyridyl)-1,2,3-
triazole, 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, 2,2′-bipyridyl and 1,10-
phenanthroline) at reflux in toluene. The yellow precipitate was collected and used without 
further purification. The strongly bound Cl atom was removed by reaction of fac-
[Re(L)(CO)3Cl] with silver hexafluorophosphate (AgPF6) in dichloromethane. The relevant of 
pyridine based ligands as axial ligand (X) (X=pyridine, 4-tert-butylpyridine, 4-methylpyridine, 
3-methylpyridine, 4-dimethylaminopyridine, 3,5-dimethylpyridine) were added to the solution 
and the mixture was stirred in the dark at room temperature for 48 h. Pure complexes were 
obtained after purification by column chromatography and subsequent recrystallisation from 
hexane / dichloromethane and were isolated as yellow to green crystalline solids, depending on 
the nature of the N^N as well as  X ligands. (Scheme 2-5) 
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Scheme 2-4- Synthesis of cationic rhenium (I) triazole complexes 
 
The identities of the complexes were confirmed by 1H NMR, 13C NMR, HRMS mass 
spectrometry and FT-IR spectroscopy. The free ligand Bn-pytz and corresponding Re 
complexes were characterised by 1H NMR spectroscopy and the corresponding spectra are 
shown in Figure 2.6. The 1H NMR spectra  shows that the triazole proton resonance at δ  8.57 
is shifted to higher field by 0.31 ppm for fac-[Re(Bn-pytz)(CO)3Cl] complex comparative to 
the corresponding resonance for the free ligand at δ  8.27. While Replacement of Cl by pyridine 
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in fac-[Re(Bn-pytz)(CO)3(py)]
+ does not affect the triazole environment, a shift to higher field 
for other protons of pyridine of the pytz ligand.  
 
 
Figure 2-6-1H NMR (400MHz) spectrum of free ligand (Bn-pytz), fac-[Re(L)(CO)3Cl], fac-[Re(L)(CO)3(py)] in CD3CN 
 
While the btzpy ligand shows a one singlet resonances for the triazole ring protons at δ 9.40 in 
1H NMR spectrum in dimethyl sulfoxide-d6, as a result of the complexation split symmetry the 
1H NMR spectrum of [Re(CO)3(btzpy)Cl] complex shows two singlets for the triazole ring 
proton at δ 10.08 and δ  9.33.  This indicates that one of the triazole rings is coordinated to the 
metal center which appears at δ 10.08 and other one is free. This confirmed the expected bytz- 
like coordination mode with a pendant triazole. The corresponding spectra are shown in Figure 
2.7. 
Chapter 2: Rhenium 4-(pyrid-2-yl)-1,2,3-triazole complexes 
74 
 
 
Figure 2-7-1H NMR (400MHz) spectrum of free ligand (btzpy), [Re(btzpy)(CO)3Cl], in DMSO 
 
The infrared spectra of the rhenium chloride complexes which recorded in acetonitrile show 
three bands corresponding to the vCO stretching modes with the symmetric stretch appearing at 
~2025 cm-1 with the closely spaced asymmetric stretches centred at ~1920 cm-1and 1897cm-1. 
(Figure 2.8). From the figure we can note that the Bn-pytz and btzpy ligands indeed appears to 
have little effect on the vCO when compared to bpy and phen.  
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Figure 2-8-The infrared spectra of the complexes Re(N^N)(CO)3Cl] in CH3CN 
 
The replacement of chloride in complex [Re(N^N)(CO)3Cl] with pyridine in the complexes 
[Re(N^N)(CO)3(py)]
+ results in the appearance of two bands corresponding to the vCO 
stretching modes with the symmetric stretches appearing at ~2036 cm-1 with the approximately 
coincident asymmetric stretches centred at ~1932 cm-1, (Figure 2.9). These are slightly higher 
in energy than those observed for the chlorine complexes due to loss of the π-donor chloride 
for a π-acceptor pyridine leading to reduced e- density of the metal center. FT-IR data for all 
complexes are shown in Table 2.1.  
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Figure 2-9- The infrared spectra of the complexes [Re(N^N)(CO)3(py)]+ in CH3CN 
 
Table 2-1: FT-IR data for complexes in acetonitrile 
Complex vCO (cm-1) 
[Re(bpy)(CO)3Cl] 2023, 1920, 1897 
[Re(bpy)(CO)3(py)]
+ 2036, 1932 
[Re(phen)(CO)3Cl] 2024, 1920, 1897 
[Re(phen)(CO)3(py)]
+ 2036, 1932 
[Re(Bn-pytz)(CO)3Cl] 2023, 1920, 1897 
[Re(Bn-pytz)(CO)3(py)]
+ 2036, 1932 
[Re(btzpy)(CO)3Cl] 2025, 1920, 1903 
 
The effect of changing the X group in X-py as an axial ligand was found to be minimal effect 
with respect to the vCO stretching. All complexes of the type [Re(Bn-pytz)(CO)3(X)]
+ showed  
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two bands corresponding to the vCO stretching modes with the symmetric stretches appearing 
at ~2036 cm-1 with the approximately coincident asymmetric stretches centred at ~1932 cm-1. 
(Figure 2.10). 
 
Figure 2-10- The infrared spectra of the complexes [Re(Bn-pytz)(CO)3(X)]+ in CH3CN 
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2.3 Electrochemical studies 
2.3.1 Electrochemical properties of complexes with different diimine ligands 
The electrochemical properties of the complexes in distilled acetonitrile were investigated by 
cyclic voltammetry. Typically, for the known models of rhenium(I) complexes, the reversible 
redox wave can be attributed to the reduction of the ligand, 186 the wave at positive potential 
can be assigned as rhenium-based oxidation (ReI/ ReII) and that is  observed in bpy and phen 
complexes. The electrochemical data for complexes [Re(N^N)(CO)3Cl] are summarized in 
Table 2.2. 
 
Table 2-2:  electrochemical data for complexes [Re(N^N)(CO)3Cl] IN acetonitrile, 0.2 M 
[NBu4 ][PF6 ], 100 mVs
-1,at room temperature 
No Complex 
Reduction E1/2 V vs. 
Fc/Fc+ 
Oxidation Epa V vs. 
Fc/Fc+ 
2 [Re(bpy)(CO)3Cl] -1.78(0.066)
a 0.99 
6 [Re(phen)(CO)3Cl] -1.73(0.091)
a 0.99 
 Re(Bn-pytz)(CO)3Cl] -2.20 1.00 
 Re(btzpy)(CO)3Cl] -2.00 0.95 
E1/2 = ( Epa+ Epc) /2 , Epc are anodic and cathodic peak potentials respectively. a = reversible. (  ) = ∆EPa,c 
Figure 2.11 presents the cyclic voltammograms for the chloride complexes. Anodic scans 
reveal a single irreversible oxidation at about 1 V vs Fc/Fc+ in acetonitrile. This is assigned to 
the Re(I)/Re(II) redox couple. Both [Re(bpy)(CO)3Cl] and [Re(phen)(CO)3Cl] complexs  
display quasi-reversible reduction couple which occurs at almost the same potential -1.8 V vs. 
Fc/Fc+ which is assigned as N^N ligand centered reduction. The fact that the potentials for 
oxidation of Re are very similar for all complexes is reasonable in view of the fact that the 
HOMO is Re based with little influence from N^N ligands. This strongly suggests that any 
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differences in the MLCT absorption and emission energies (see later) between the complexes 
are primarily due to differences in the π* level of the N^N ligands. The [Re(Bn-pytz)(CO)3Cl] 
and [Re(btzpy)(CO)3Cl] have a higher energy LUMO than  another complexes including 
[Re(terpy)(CO)3Cl] which displays ligand centered reduction at -1.74 V.
187 They  are better σ-
donorS compared to other N^N ligand.188 Replacement of bpy by Bn-pytz or btzpy ligands 
result in more negative and irreversible reductions. The negative shift is due to the higher 
energy π* ligand centred LUMOs localised on these ligands.  
 
 
 
Figure 2-11- Cyclic voltammogram of complexes [Re(N^N)(CO)3Cl] in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −
1 . Potentials V are reported against ferrocene (Fc/Fc + = 0.0 V) 
 
 It is generally accepted that the main features include an irreversible anodic peak at vs 
Ag/AgCl, assigned to the one-electron oxidation, which was characteristic of all known 
-2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5
Potential/ V vs FC/FC+
[Re(bpy)(CO)₃Cl]
[Re(phen)(CO)₃Cl]
[Re(Bn-pytz)(CO)₃Cl]
[Re(btzpy)(CO)₃Cl]
Chapter 2: Rhenium 4-(pyrid-2-yl)-1,2,3-triazole complexes 
80 
 
complexes of the type [Re(N^N)(CO)3Cl]. Its production involves a unimolecular process in 
which the chloride ligand serves as a one-electron reductant toward the electrogenerated 
rhenium(II) center, resulting in the loss of chlorine radical from the complex (which then forms 
molecular chlorine) and subsequent coordination by the solvent . For all the rhenium 
complexes, the one-electron oxidation showen in the (eq 1) is followed by a rapid loss of a 
chlorine atom to form [Re(N^N)(CO)3(CH3CN)]
+. 
 
For the reduction process, a one-electron ligand based reductions leads to the loss of the 
chloride ligand. This is followed either by solvation or fast dimerization as follows:189, 190 
The losing of a chloride ligand from the reduced Re complex to generate a 17-electron 
intermediate 
 
The resulting Re-carbonyl complex fragments can undergo in two possible reactions. (I) they 
can react with the solvent (CH3CN) to form a solvent-coordinated complex: 
 
(II) The resulting Re-carbonyl complex fragments can also combine to form a Re-Re bonded 
dimer: 
 
Because these features are well known for bpy containing complexes, therefore, it is speculated 
that, this also acurs here for triazole containing complexes. 
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2.3.2 Electrochemical Properties of complexes with different axial ligands 
The electrochemistry of the rhenium compounds [Re(Bn-pytz)(CO)3(X)]
+ in using acetonitrile 
was probed using cyclic voltammetry and Bu4NPF6 as supporting electrolyte. Data are 
presented in Table 2.3.  
Table 2-3: Electrochemical data for [Re(Bn-pytz)(CO)3(X)]+ complexes  in acetonitrile, 0.2 
M [NBu4 ][PF6 ], 100 mVs-1,at room temperature 
No Complex Reduction E1/2 V vs. 
Fc/Fc+ 
Oxidation Epc V vs. 
Fc/Fc+ 
1 [Re(Bn-pytz)(CO)3(py)]
+ -1.93 , -2.04 1.54 
2 [Re(Bn-pytz)(CO)3(t-but-py)]
+ -1.91 , -2.04 1.62 
3 [Re(Bn-pytz)(CO)3(4-picoline)]
+ -2.05, -2.26 1.59 
4 [Re(Bn-pytz)(CO)3(3-picoline)]
+ -1.93, -2.23 1.53 
5 [Re(Bn-pytz)(CO)3(3,5-lutidine)]
+ -1.95 , -2.04 , -2.23 1.52 
6 [Re(Bn-pytz)(CO)3(DMAP)]
+ -2.01 1.24 
E1/2 = ( Epa+ Epc) /2 , Epc are anodic and cathodic peak potentials respectively. 
 
Changing a chloride complex [Re(Bn-pytz)(CO)3Cl] with the [Re(bn-pytz)(CO)3(X)]
+ led to a 
positive shift in the oxidation potential. N-donor axial pyridine ligands are strong π –acceptors, 
this reduces the electron density on a metal centre and thus results in a lower energy HOMO 
compared to π-donor chloride based complexes. Both reduction and oxidation couples were 
observed in the cyclic voltammograms upon reductive and oxidative scans, respectively. All 
samples display an irreversible one-electron oxidation associated with the Re(I)/Re(II) couple 
at about +1.5 V and (+1.24) for [Re(Bn-pytz)(CO)3(DMAP)]
+ representative voltammograms 
in (Figure 2.12).  
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Figure 2-12-Cyclic voltammogram of complexes [Re(Bn-pytz)(CO)3(X)] in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 
mV s −1 . Potentials V are reported against ferrocene (FC/FC + = 0.0 V) 
 
 All of the complexes display one oxidation and two reduction processes in the potential region 
from +2.5 to -2.5 V with exception of [Re(Bn-pytz)(CO)3(DMAP)]
+ which is display one 
reduction processes in the potential at -2.01. The replacement of the chloride with a neutral 
axial ligand results in an anodic shift of Eox. The nature of the N-based axial ligand affects the 
ease with which the metal is oxidized. The two irreversible reduction waves observed in the 
cyclic voltammograms of all of the complexes at the region of (2,-2.5 V). The variation of the 
axial ligand changes the reduction potentials less than the oxidation potentials of the 
complexes. All complexes approximately have the same reduction, meaning the reduction 
potential is unaffected by changing the nature of the N-based axial ligand, this is not surprising 
because all complexes have the same diimine ligand Bn-pytz which meane have the same 
LUMO. Except of DMAP complex, [Re(Bn-pytz)(CO)3(DMAP)]
+  which has the strongly 
donating group (Me2N)
 mostly the oxidation is also unaffected by changing the nature of the 
N-based axial ligand meaning that py ligand probably has little influence on the energy of the 
HOMO.  
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2.4 Photophysical studies 
2.4.1 Effect of chelate ligands 
Table (2.4) summarizes the UV-VIS absorption, emission, and life time data for the rhenium 
chloride complexes.  
Table 2-4 : UV-vis Absorption, photoluminescence and lifetime data for the complexes [Re( 
N^N)(CO)3Cl] in aerated acetonitrile  
complex λ / nm(ε/ dm3.mol-1cm-1) 
Em λ(max) / 
nm 
Ʈ/ns 
[Re(bpy)(CO)3Cl] 
370(4041), 343(4086), 
315(11145), 290(18741) 
634 
6 (26%), 29 
(74%) 
[Re(phen)(CO)3Cl] 
367(4752), 290(15210), 
273(29558), 
622 
12 (2%), 66 
(98%) 
[Re(Bn-pytz)(CO)3Cl] 
346(5500), 337(9900), 
296(20200), 
545 47(100%) 
[Re(btzpy)(CO)3Cl] 
345(3395), 295(18930), 
247(29700), 224(34180) 
586 68 (100%) 
 
Figure 2.13 shows the UV-vis absorption spectra of the rhenium chloride complexes in 
acetonitrile at room temperature. From the figure it can be seen that all complexes have the 
dominant absorption bands in the UV region at 290- 310 nm which are assigned to intraligand 
(IL) π → π* transitions localized on the chelate ligand. All of the complexes presented here 
have an absorption maximum around 335 - 370 nm. This transition is assigned to a metal-to-
ligand charge transfer (1MLCT) from Re to the chelate ligand as has been observed for other 
rhenium N^N complexes.191-193 [Re(Bn-pytz)(CO)3Cl] and [Re(btzpy)(CO)3Cl] showed a blue-
shifted electronic absorption. Both complexes exhibit an intense absorption band in the visible 
region at 335, 345 nm respectively assignable to the 1MLCT (d π → π* ) transitions, at compared 
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with another complexes [Re(bpy)(CO)3Cl]  370 nm and [Re(phen)(CO)3Cl] 367 nm. The 
HOMO of all complexes is primarily localized on the Re(I) and Cl atoms, in both cases and so 
the energies of the HOMO orbitals for all complexes should not be expected to be significantly 
different. The large blue-shift observed for the [Re(Bn-pytz)(CO)3Cl] and [Re(btzpy)(CO)3Cl] 
complexes is therefore, consequence of the much higher energy of the LUMO associated with 
the triazole- containing  ligand  compared to the other diimine ligands.  
©
 
Figure 2-13-- UV-vis absorption spectra of complexes [Re(N^N)(CO)3Cl] ] in acetonitrile 
 
While broad emission of around 620-640 nm was observed for the [Re(bpy)(CO)3Cl] and  
[Re(phen)(CO)3Cl] complexes at room temperature in aerated acetonitrile [Re(Bn-
pytz)(CO)3Cl] and [Re(btzpy)(CO)3Cl] showed blue-shifted luminescence with a maxima at  
545 nm and 586 nm respectively (Figure 2.14). This was accompanied with increased radiative 
decay lifetimes of the complexes. This is consistent with the energy gap law.185  
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Figure 2-14-Room-temperature emission of complexes [Re(N^N)(CO)3Cl]  in aerated acetonitrile 
Compared with [Re(terpy)(CO)3Cl] which has been reported as non-luminescent in in aerated 
acetonitrile194 but showed weakly luminescent in degassed acetonitrile at room temperature 
centred at 506 nm.187 [Re(btzpy)(CO)3Cl] at room temperature in aerated acetonitrile showed 
red-shifted luminescence  at 586 nm. 
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2.4.2 Effect of axial ligands. 
All the UV-vis absorption, emission and life time data for complexes [Re(Bn-
pytz))(CO)3(X)]
+/0 are listed in Table 2.5  
Table 2-5 : UV-vis absorption, photoluminescent, data for the complexes [Re(Bn-
pytz)(CO)3(X)]
+ in acetonitrile 
No Compound λ / nm(ε/ dm3.mol-1cm-1)  ) Em λ(max) / nm ᶲ% Ʈ/ns 
1 [Re(Bn-pytz)(CO)3Cl] 
346(5500), 337(9900), 
296(20200), 276(29900), 
251(40600) 
545 0.3 47 
2 [Re(Bn-pytz)(CO)3(py)]
+ 
354(2000), 322(5700), 
296(12400), 262(19900), 
251(23000) 
499 0.7 60 
3 [Re(Bn-pytz)(CO)3(t-but-py)]
+ 
346(1900), 322(4000), 
296(9200), 262(16100), 
251(17800) 
499 0.76 66 
4 [Re(Bn-pytz)(CO)3(4-picoline)]
+ 
354(2000), 
322(5700)296(9100) 
499 1.59 67 
5 [Re(Bn-pytz)(CO)3(3-picoline)]
+ 
347(1700),326(3500), 
297(8500)287(9500), 
261(15600), 251(17600)) 
499 1.6 61 
6 [Re(Bn-pytz)(CO)3(3,5-lutidine)]+ 
322(2800), 
298(6200)278(8600), 
262(11600), 251(12700) 
499 0.71 61 
7 [Re(Bn-pytz)(CO)3(DMA-py)]
+ 
347(1700), 306(9800), 
288(18900), 251(12300) 
526 0.74 61 
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A blue-shift  of MLCT bands are deserved in UV-vis absorption spectra by changing the 
chloride ligand in [Re(N^N)(CO)3Cl] (335-370 nm) with neutral axial ligand in the 
[Re(N^N)(CO)3(X)]+ (340-360 nm) (X = pyridine, 4-tert-butylpyridine, 4-picoline, 3-picoline, 
4-dimethylaminopyridine, 3,5-lutidine) (Figure 2.14). The dominant absorption bands in the 
UV region at 290 nm are assigned to intraligand π → π* transitions localized on Bn-pytz ligand. 
From Figure 2.15 we can see that all of the complexes presented here had an absorption 
maximum around 340 -360 nm. This transition is assigned to a metal-to-ligand charge transfer 
(MLCT) from dπ (Re) to π* (Bn-pytz). The replacement of a π-donor with a π-accepting ligand 
is leading to stabilisation of the HOMO relative to the LUMO. This replacement increases the 
MLCT energy. With the exception of [Re(Bn-pytz)(CO)3(DMAP)]
+, all the complexes exhibt 
similar UV-vis absorption spectra because all of them using the same ligand Bn-pytz and the 
same metal centre, which indicated that the axial ligand has little impact on the spectroscopic 
properties. 
 
Figure 2-15-Room-temperature emission of complexes [Re(Bn-pytz)(CO)3(X)]  in aerated acetonitrile  
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There is a significant blue-shift of approxmately 50 nm for all complexes, as a result of 
changing the chloride ligand in [Re(Bn-pytz)(CO)3Cl] with pyridine based ligand in the 
[Re(Bn-pytz)(CO)3(X)].  
 
 
Figure 2-16-Room-temperature emission of complexes [Re(Bn-pytz)(CO)3(X)] in aerated acetonitrile 
 
A broad emission of around 540 nm (Figure 2.16) was observed from the [Re(Bn-
pytz)(CO)3Cl] in aerated acetonitrile at room temperature. The emission bands of [Re(Bn-
pytz)(CO)3(X)]
+ are significantly blue-shifted to 490-500 nm as a result of replacement of a π 
-donor with a π -accepting ligand which leads to stabilisation of the HOMO relative to the 
LUMO. As for the effect of the pyridine substituents on the absorption and emission properties, 
an increase in the electron accepting strength of the substituent caused shorter MLCT 
absorption and emission wavelengths (λMLCT and λem). Although the lifetime of the complexes 
is shorter for [Re(Bn-pytz)(CO)3Cl] comparing with [Re(Bn-pytz)(CO)3(X)]
+ because the 
MLCT state is higher in energy than the 3MLCT in the chloride complexes in  totally agreement 
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with the energy gap law. Except in the case of the dimethyl amino pyridine, changing the 
substituent on the axial pyridine has no significant effect on the emission spectra. The strongly 
electron donating dimethyl amino group results in destabilisation of the HOMO with respect 
to the LUMO and the lower energy 3MLCT state.   
2.5 Density functional theory (DFT) studies 
 
These calculations were carried by Dr Alessandro Sinopoli. DFT calculations were carried out 
using the NWChem 6.3 software package. Calculations were carried out using the B3LYP 
hybrid functional (20% Hartree–Fock). Benzyl side chains ligand were simplified to methyl 
groups to reduce computational expense. Stuttgart-Dresden- relativistic small core pesedo 
potentials ECP for the metal and 6-311G* basis sets used for all other atoms. Molecular 
structures and molecular orbitals were visualized by means of the ccp1 graphical user interface. 
The ground state geometries of all complexes were first optimized and molecular orbital 
energies determined. At the ground state geometries DFT calculations were then used to derive 
vertical excitation energies and hence simulated absorption spectra. DFT calculations on 
optimised structures in CH3CN by using the COSMO solvation model, built into the NWChem 
software, were used to determine the molecular orbital energy levels and localisations. 
2.5.1 Ground state properties 
In order to further understand the electronic transitions of the complexes and validate the 
interpretation of the photophysical and electrochemical results, the localisation and energies of 
the molecular orbitals were calculated by DFT and absorption spectra simulated with time-
dependent density functional theory (TDDFT). Table 2.6 shows energies of the HOMO and 
LUMO of complexes [Re(Bn-pytz)(CO)3(X)]
+ as well as the HOMO – LUMO gap. The 
HOMO of [Re(Bn-pytz)(CO)3(X)]
+ is dominated by Re d-orbital character. For the DMAP 
complex there is a significant contribution of the π system of the monodentate pyridine based 
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ligand (Figure 2.17). On the other hand, the LUMOs of all complexes are essentially the lowest 
energy π* orbital of the Bn-pytz ligands. Hence the electronic transition at the lowest energy 
region is clearly assigned to the mixed metal to ligand charge transfer (1MLCT). The HOMO 
and LUMO provide some useful insight as to the atomic contributions. Here the density 
functional calculations indicate that for all the complexes in the singlet state the LUMO orbital 
is nearly in the same energy level and the significantly higher energy level of HOMO in 
[Re(Bn-pytz)(CO)3(DMAP)]
+ (Figure 2.18). Changing of X ligand substituent genaraly results 
in no significant difference in changing in band gap between the HOMO and LUMO which 
means that these substituent have minimum electronic effect on the spectroscopic properties.  
 
Table 2-6:  Selected Calculated energies of the HOMO and LUMO orbitals of complexes 
[Re(Bn-pytz)(CO)3(X)]
+ 
Complex HOMO E/eV LUMO E/eV ∆E/eV 
[Re(Bn-pytz)(CO)3(py)]
+ -9.308 -5.465 3.843 
[Re(Bn-pytz)(CO)3(
tBut-py)]+ -9.169 -5.368 3.801 
[Re(Bn-pytz)(CO)3(4-picoline)]
+ -9.220 -5.406 3.814 
[Re(Bn-pytz)(CO)3(3-picoline)]
+ -9.246 -5.424 3.822 
[Re(Bn-pytz)(CO)3(3,5lutidine)]
+ -9.198 -5.386 3.812 
[Re(Bn-pytz)(CO)3(DMAP)]
+ -8.674 -5.219 3.455 
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Figure 2-17 the optimized ground state geometries (middle), HOMO (bottom) and LUMO (top) orbital representations for complexes [Re(Bn-pytzs)(CO)3(X)]+.  
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Figure 2-18 -Molecular orbital energy level diagram for the complexes [Re(Bn-pytz)(CO)3(Xp)]+. 
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2.5.2 Time dependent DFT (TDDFT) Calculations 
To confirm the interpretation of the photophysical results, time-dependent density functional 
theory calculations were performed to determine the absorption spectra of the complexes. 
Figure 2.19 show comparison of calculated (vertical excitations) and experimental spectra for 
complexes [Re(Bn-pytz)(CO)3(X)]. From the figure we can see that all complexes have the 
absorption bands appeared in the two obvious absorption bands in the simulated spectra are 
about the UV region at 255-265 nm which can be safely assigned to intraligand π → π* 
transitions. Furthermore, all of the complexes presented here had absorption in the lower-
energy region with bands around 340 nm. These transitions mainly originate from transition 
from HOMO to LUMO and are assigned to a metal-to-ligand charge transfer (MLCT) from dπ 
(Re) to π* (Bn-pytz). We can see that energy is slightly over estimated in the calculation spectra 
comparing with the experimental spectra but are never the less in good agreement. As with 
experiment observation substituents on the pyridine ring have no a significant effect on the 
absorption spectra which means that these substituents have minimum electronic effect on the 
MLCT energy. However, for the DMAP complex we can see that the complex display an extra 
shoulder transition at 390 nm, which DFT predicts to be of MLCT/IL character.  
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Figure 2-19 -The UV-Vis absorption spectra and electronic transitions calculated with the TDDFT/B3LYP method (bars) for [Re(L1)(CO)3(X)], L1= Bn-pytz 
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2.6 Light-Emitting Electrochemical cells 
 
Two Complexes [Re(Bn-pytz)(CO)3(py)](PF6) and [Re(bpy)(CO)3(py)](PF6) were applied in 
LEEC devices by Dr. Antonio Pertegas Ojeda from University of Valencia, giving a promising 
results. [Re(Bn-pytz)(CO)3(py)](PF6) complex exhibt weak photoluminescence in the blue-
green region with low photoluminescence quantum yield. As can be seen from the 
electrolumincence spectrum in Figure 2-20, the device’s emission data is a good match to the 
photoluminescence emission observed in this work. 
 
 
Figure 2-20 Photoluminescence (PL) Of complex [Re(Bn-pytz)(CO)3(py)]+. Excitation: 320 nm, [Bmim][PF6] = 1-butyl-3-
methylimidazolium hexafluorophosphate 
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The electroluminescence emission is red-shifted with respect to the photoluminescence 
emission (Figure 2-21). Similar effects have been observed for blue iridium emitters in 
LEECs.195 The LEEC exhibits blue- green electroluminescence with emission maxima located 
at 500 nm.  
 
Figure 2-21 electrolumincence (EL) Of complex [Re(Bn-pytz)(CO)3(py)]. 
 
 
The performance of the LEEC based on [Re(Bn-pytz)(CO)3(py)](PF6) showed better 
performance than [Re(bpy)(CO)3(py)](PF6), which was unexpected due to the lower 
photoluminescence quantum yield in thin film. While no light was emitted after >100 hours of 
operation with [Re(bpy)(CO)3(py)](PF6). Voltage drops versus time due to the formation of 
electric double layers at the electrode interface with [Re(Bn-pytz)(CO)3(py)](PF6) complex 
were obsarved. The voltage reaches a minimum at 6V, which is a high for “normal” LEECs 
(<3V) (Figure 2-22). This indicates a “high” energy barrier for electronic injection. Because 
the stability is poor, the luminance decay could be related with doping quenching as voltage 
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does not increase during the luminance decay. For this reason few examples of Re based LEECs 
have been reported. While no emission for LEEC based on [Re(bpy)(CO)3(py)](PF6) was 
observed, [Re(Bn-pytz)(CO)3(py)](PF6) complex showed weak photoluminescence.  
 
Figure 2-22 data of Light-emitting electrochemical cells based complex [Re(Bn-pytz)(CO)3(py)]. 
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2.7 Conclusions: 
 
In this chapter, a series of tricarbonyl rhenium(I) complexes[Re(N^N)(CO)3Cl], ( N^N = 1-
benzyl-4-(2-pyridyl)-1,2,3-triazole, 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, 2,2′-
bipyridyl and 1,10-phenanthroline) and [Re(CO)3(Bn-pytz)(X)]PF6 with different axial 
monodentate ligands X were successfully synthesized in good to excellent yields (70%-90%). 
A number of conclusions were reached concerning the photophysical properties of the emitting 
MLCT states of [Re(N^N)(CO)3Cl] and how their properties compare to related 
[Re(N^N)(CO)3(X-py)]
+ complexes; all the pytz complexes display 3MLCT emission which is 
blue-shifted in electronic absorption and luminescence spectra of the resulting [Re(Bn-
pytz)(CO)3Cl] and [Re(btzpy)(CO)3Cl] complexes comparing withe another 
[Re(N^N)(CO)3Cl] indicated that Bn-pytz and btzpy have higher energy level of LUMO. From 
DFT calculations the HOMO of the complexes are localized on rhenium centre, while the 
LUMO are localized on N^N ligands. In the case of the DMAPcomplex, the HOMO also has 
py character but in general the emission proparties are not affected by the nature of the ligand 
X. One candidate complex along with a model bpy complex were applied in the manufacture 
of LEEC devices. Whilst these showed poor stability and performance, EL emission was 
observed for [Re(Bn-pytz)(CO)3(py)]
+, which might be sutible for further devolpment as a 
LEEC phosphor. 
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3.1 Introduction  
 
The increase in the applications in numerous technological area of luminescent 
complexes depended on thier lifetime.196 For example, in biological applications, d-block metal 
phosphorescent probes typically have two to three orders of magnitude longer in their emission 
lifetimes in comparison to fluorescent organic molecules.48, 197, 198 Since the 1980s complexes 
of Os(II) in particular have been of significant interest, because of their advantageous 
photochemical and photophysical properties, and the complex electronic structures of their 
(MLCT) excited states,199  [Os(bpy)3]
2+, having been described in detail and compared and 
contrasted to its well-known Ru(II) analogue.200-202 The osmium(II) complexes exhibit direct 
3MLCT optical absorption bands of average extinction coefficient associated to the high spin-
orbit coupling constants for the osmium center 203-205. The principle sustains efficient excitation 
at low energies that eliminate the possibility of cellular damage and negates the autofluorescent 
requirement and additional cost of time gated apparatus.15, 206 The absorption and emission 
bands operating at wavelengths closer to the red in comparison to the common iridium(III) 
complexes facilitate the use of increased biologically transparent regions of the spectrum that 
sustain deeper penetration for excitation and imaging.207 Osmium complexes are generally 
inert to ligand photo-substitution and are highly robust, but show a sensitivity of 
phosphorescence emission to the presence of oxygen in the system, resulting in quenching 
through changing of ground state 3O2 to the reactive 
1O2. This supports their potential 
exploitation in the photodynamic therapy (PDT).208 The combination of properties maintains 
the possibility for the development of unique dual mode theranostic agents.209 A considerable 
number of reports have been issued detailing the photochemical and photophysical properties 
of triazole-based complexes of Ru(II), Re(I) and Ir(III).96, 144, 210 In this chapter we explore the 
use of 1,2,3-triazole based ligands as bidentate donors and investigate the influence of these 
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ligands on the photophysical characteristics of a series of osmium(II) complexes prepared as 
their hexafluorophosphate and chloride salts. The water soluble chloride salts have been 
subjected to preliminary cellular uptake and luminescence imaging studies and the results are 
also reported. 
3.2 Synthesis and characterisation 
3.2.1 Synthesis of osmium(II) 4-(pyrid-2-yl)-1,2,3 triazole complexes 
The complex [Os(bpy)2(Bn-pytz)](PF6)2 was prepared by adaption of an established procedure 
for the synthesis of heteroleptic osmium(II) complexes.204, 211 Briefly, [Os(bpy)2Cl2] was 
heated under reflux conditions in ethylene glycol with one equivalent of the ligand Bn-pytz. 
Subsequent counter-ion metathesis with ammonium hexaflulorophosphate then enabled 
isolation of [Os(bpy)2(Bn-pytz)](PF6)2 as a dark green solid. As the Bn-pytz ligand is not 
symmetrical the two bpy ligands give rise to two separate sets of resonances in the 1H NMR 
spectrum of [Os(bpy)2(Bn-pytz)](PF6)2 (Figure 3.1). The pyridyl triazole ligand exhibits a 
resonance for the triazole ring proton at δ 8.61, shifted by 0.34 ppm compared to the 
corresponding resonance for the free ligand at δ 8.27. Also, the methylene protons, which 
exhibits a singlet resonance in the free ligand at δ 5.60, are observed as a diastereotopic pair of 
roofed doublets centred at δ 5.49 due to the chirality of the complex.  
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Figure 3-1- The 1H-NMR spectra (400 MHz, CD3CN) of [Os(bpy)2(Bn-pytz)](PF6)2  and free ligand Bn-pytz . 
 
The complex [Os(bpy)(Bn-pytz)2](PF6)2 was prepared in a three-step procedure. Firstly 
osmium(III) chloride hydrate was allowed to react with 20 equivalents of (1,3-cyclohexadiene) 
in degassed ethanol at reflux to form [{Os(ƞ6-C6H6)Cl2}2]. This then underwent reaction with 
2 equivalents of bpy in methanol to produce [Os(ƞ6-C6H6)(bpy)Cl]+ which was isolated as its 
(PF6) salt. This was then allowed to react with Bn-pytz in refluxing ethanol to yield the final 
product which was also isolated as the hexaflulorophosphate salt. Synthesis of Os(II) 
complexes through reaction with  ligands  often requires high temperatures in solvents like 
ethylene glycol (200 OC)212 and dimethylformamide (150 OC).213 Such high temperatures can 
not be used with all types of ligand, because some decompose at high tempreture. Via the 
[Os(ƞ6-C6H6)(bpy)Cl]+  intermediate, the  synthesis of Os(II) complexes can be achieved in the 
mild temperature (EOH-79 oC). This brings a wide ranging synthetic approach to heteroleptic 
osmium(II) complexes under relatively mild conditions. 
Chapter 3: Synthesis, characterisation and cellular uptake studies of osmium (II) 4-(pyrid-2-yl)-1,2,3 triazole complexes 
103 
 
 
Scheme 3-1- Synthesis of [Os(bpy)(Bn-pytz)2](PF6)2 
 
Due to the asymmetry of the Bn-pytz ligand, the complex is produced as a mixture of three 
isomers, cis, cis, cis, trans and trans, cis dependent on the respective regiochemistry of the 
pyridyl and triazole moieties respectivly of the two Bn-pytz ligands (Scheme 3.1). In cis, trans 
and trans, cis isomers, the complexes are C2 symmetric and should each show one singlet 
triazole resonance, while the cis, cis isomer is not symmetrical and then the two triazole 
resonance are unique and should show two singlets in its 1H NMR spectrum. The complex 
isomers could not be seperated despite repeated efforts and four resonances are obtained from 
the 1H NMR spectrum at δ 8.63, 8.62, 8.61 and 8.63 for the triazole ring protons of the 
regioisomers. In the cis, trans and trans, cis isomers, where the complexes are C2 symmetric, 
the two pyridine rings in bpy ligands are equivalent and should show four set of NMR 
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resonance for each 2 protons in each isomer, while the cis, cis isomer the two pyridine rings in 
bpy ligands are magnetically inequivalent and should show 8 resonances with one for each 
proton. Because the complex isomers could not be separated and the bpy proton resonances 
are overlaping with the protons of py rings protons in Bn-pytz the NMR spectra of the complex 
is complicated. (Figure 3.2). Four multplet resonances are therefore obtained in the 1H NMR 
spectrum in the ranges of δ 8.45-8.37, 8.1-8.05, 7.65-7.61 and 7.30-7.10, for the bpy protons. 
Similarly the benzylic methylene protons should show four singlets resonance, one singlet for 
each C2 symmetric isomer (cis, trans and trans, cis isomers) and two singlets for the cis, cis 
isomer which is not symmetrical but this is complicated by the fact that they can appear 
diasterotopic as multplet resonances in the rang of  δ 5.55-5.46. Due to the difficulty in 
separating the three isomers, the photophysical electrochemical data are henceforth presented 
for the mixture of the three isomers.   
 
Figure 3-2- The 1H-NMR spectra (400 MHz, CD3CN) of mixture of isomers for [Os(bpy)(Bn-pytz)2](PF6)2 
 The homoleptic complex [Os(Bn-pytz)3](PF6)2 was prepared by reaction of [(NH4)2OsCl6] 
with three equivalents of Bn-pytz in ethylene glycol under refluxing conditions followed by 
counter-ion metathesis. Due to the asymmetry of the Bn-pytz ligand the 1H NMR spectrum of 
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the initial product understandably shows signals for both meridional and facial isomers of 
[Os(Bn-pytz)3](PF6)2 in an approximate 1: 0.8 ratio (Scheme 3.2, Figure 3.3) 
 
Scheme 3-2 Synthesis of [Os (Bn-pytz)3](PF6)2 
 
Separation of the two isomers again proved extremely difficult with both co-eluting in column 
chromatography with a wide range of solvent systems. Successful separation was possible but 
only on a small scale by preparative thin-layer chromatography yielding only very small 
quantities of each isomer, only enough to allow spectroscopic characterisation. Figure 3.3 
shows the 1H NMR for complex [Os(Bn-pytz)3](PF6)2 as a mixture and the meridional and 
facial isomers. For mer-[Os(Bn-pytz)3](PF6)2 where the three Bn-pytz ligands are magnetically 
unique and so three singlet resonances are observed at δ 8.63, 8.61 and 8.60 corresponding to 
the triazole ring protons. The 1H NMR spectrum of fac-[Os(Bn-pytz)3](PF6)2 is much simpler 
than that of its meridional isomer due to the C3 symmetry of the cation. A singlet resonance is 
observed at δ 8.61 for the triazole ring proton along with a resonance at δ 5.50 for the benzylic 
methylene protons. These are accompanied by four multiplets deriving from resonance for the 
pyridine and benzylic phenyl rings (Figure 3.3).  
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Figure 3-3- The 1H-NMR spectra (400 MHz, CD3CN) of [Os (Bn-pytz)3](PF6)2   and the pure mer and fac  isomers 
 
From nOe correlation NMR spectroscopy of mer-[Os(Bn-pytz)3](PF6)2 (Figure 3.4) the 
methylene protons of the benzyl substituent corresponding to each of the triazole ring protons 
were identified. The diastereotopic doublet at δ 5.51 shows correlation with the triazole at δ 
8.60. The triazole protons in the same ligand which are appeare at δ 8.61 and 8.63 correlate 
with the multiplet at δ 5.54 for those methylene protons.  
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Figure 3-4- 1H/1H NOESY spectrum (400 MHz, (CD3CN) of mer-[Os(Bn-pytz)3](PF6)2 
 
The chloride salts of complexes which are soluble in water are obtained by stirring the PF6
- 
salts in methanol with Amberlite IRA-400 (chloride form) anion-exchange resin. The resultant 
solutions were then filtered and evaporated, taken up into water and freeze dried. The 
successful counter ion metathesis and formation of chloride salts was confirmed by the 
complete absence of resonance for the PF6
- counerion in the 19F and 31P NMR spectra. The 
chloride salts were then characterized by 1H-NMR, UV/vis absorption and emission 
spectroscopy. 
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3.3 Electrochemical studies 
 
Cyclic voltammetry experiments were carried out on the complexes in order to characterise 
their electrochemical properties. Electrochemical data for the various complexes as obtained 
are summarized in Table 3.1. Figure 3.5 shows the cyclic voltammagrams of complexes in 
acetonitrile. For the homoleptic complex [Os(Bn-pytz)3]
2+, this was recorded on the mixture of 
fac and mer isomers. 
Table 3-1- electrochemical data for complexes in CH3CN, 0.2 M [NBu4][PF6], 100 mVs
-1, at 
room temperature  
No Complex Reduction E1/2 V vs. Fc+/Fc Oxidation E1/2 V vs. Fc+/Fc 
1 [Os(bpy)3)](PF6)2 -1.85(0.078)
a, -1.665(0.083)a 0.436(0.078)a 
2 [Os(bpy)2(Bn-pytz)](PF6)2 -1.93(0.094)
a, -1.72(0.083)a 0.441(0.075)a 
3 [Os(bpy)(Bn-pytz)2](PF6)2 -1.79(0.09)
a 0.438(0.078)a 
4 mix-[Os(Bn-pytz)3](PF6)2 
====== b 0.453(0.089)a 
E1/2 = (Epa+ Epc) /2, Epa and Epc are anodic and cathodic peak potentials respectively. a = reversible, b = 
reduction couples are outside the available electrochemical window. ∆EPa,c = (Epa- Epc) are inparentheses   
 
The observed couples are all reversible, where reversibility as used here implies that the 
separation between the anodic and cathodic peak potentials was less than 100 mV and no 
degradation products were observed on the following scan. The general behaviour is quite 
similar for all complexes. A cyclic voltammogram of all complexes gave the Os3+/2+ metal-
based redox processes with an E1/2 around +0.44 V with little variation and the an indicates that 
HOMO is located on the metal center. [Os(bpy)3]
2+ gave two one electron bipyridine ligand 
based reduction processes, with E1/2 values of −1.66 V (bpy0/1−), and −1.85 V (bpy1−/2−) (the 
third reduction was not observed in the the solvent window). As more Bn-pytz ligands are 
incorporated, the bpy based reduction potantials are shifted to more negative potential. This is 
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due to Bn-pytz ligand not being as good a π acceptor leading to more back bonding to bpy. 
Because the Bn-pytz ligand has higher energy π* orbital, the pytz-based reduction for the 
complex mix-[Os(Bn-pytz)3](PF6)2 are not be seen which confirms that the reduction values 
noticed here belong to the bpy ligand This strongly suggests that any differences in the MLCT 
absorption and emission energies between the complexes (see later ) are primarily due to 
differences in the energy of the ligand centred   π* orbitals.  
 
Figure 3-5- Cyclic voltammogram of complexe in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1. Potentials V are 
reported against ferrocene (Fc+/Fc= 0.0 V) 
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Chapter 3: Synthesis, characterisation and cellular uptake studies of osmium (II) 4-(pyrid-2-yl)-1,2,3 triazole complexes 
110 
 
3.4  Photophysical studies 
 
Table 3.2 summarizes the UV-vis electronic absorption data for the complexes, UV-Vis 
absorption spectra of complexes in acetonitrile are shown in Figure 3.6. 
Table 3-2- The UV-vis electronic absorption data for the complexes in aerated acetonitrile 
Compound λ / nm(ε/ dm3.mol-1cm-1) 
[Os(bpy)3)](PF6)2 246(19460), 255(16929), 290(62491), 331(7040), 372(7315), 
392(6840), 437(8820), 487(8712), 667(1940) 
[Os(bpy)2(Bn-pytz)](PF6)2 240(19605), 279 (34054), 290(42108), 327(6179), 372 
(8716),  356(6772), 386(7767), 421(6848), 468(7625) 
[Os(bpy)(Bn-pytz)2](PF6)2 237(20868), 274(29949), 288(20694), 380(7296), 459(4620) 
mix-[Os(Bn-pytz)3](PF6])2 235(30277), 273(51121), 308(7534), 373(11684), 
402(10929), 484(3492), 530(2589) 
mer-[Os(Bn-pytz)3](PF6])2 235(28966), 273(50240), 308(6976), 373(11500), 
402(10429), 484(3288), 530(2535) 
fac-[Os(Bn-pytz)3](PF6)2 235(27377), 273(48693), 308(6360), 373(10763), 
402(10475), 484(3110), 530(2207) 
 
The UV-vis absorption spectrum of [Os(bpy)2(Bn-pytz)](PF6)2 in acetonitrile exhibits a sharp 
and intense band at 290 nm ascribed to singlet ligand-centered π → π* transition centred on 
bpy ligands. [Os(bpy)3)](PF6)2 also has the 290 nm transition which confirms that this 
absorption is bpy localised π → π* transition. The intensity of this band is seen to decrease 
when bpy ligands are replaced with Bn-pytz until disappears for [Os(Bn-pytz)3](PF6)2. This 
reduction in absorbance with increased Bn-pytz ligands is accompanied by the growth of an 
intense band at 280 nm reflective of Bn-pytz centered π → π* transitions. In the visible region 
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the complexes exhibit panchromatic absorption with moderately intense absorption bands 
between 370 and 520 nm with absorptions of lower intensity at longer wavelength tailing off 
towards 700 nm. The more intense, higher energy bands in the visible are assigned to spin-
allowed 1MLCT transitions whereas the weaker and lower energy bands are assigned to spin-
forbidden 3MLCT transitions. The spin forbidden absorption populates the 3MLCT state 
directly from the ground state and is readily apparent because of the large spin-orbital coupling 
effect that results from the heavy osmium atom.214 Since the LUMO of the Bn-pytz ligand is 
significantly destabilised relative to that of bpy, the replacement of one of the bpy ligands by 
Bn-pytz leads to the shift of the 1,3MLCT bands to higher energy. The LUMO of isomers of 
[Os(Bn-pytz)3](PF6)2 (meridional, facial) are heavily destabilised relative to those of 
[Os(bpy)(Bn-pytz)2](PF6)2, [Os(bpy)2(Bn-pytz)](PF6)2 and [Os(bpy)3]
2+. As a result, the blue 
shift is very large from the [Os(bpy)(Bn-pytz)2](PF6)2 to [Os(Bn-pytz)3](PF6)2, because the 
LUMO previously localised on the bpy ligands most now localise on Bn-pytz. These data are 
in agreement with the electrochemical data which indicate an increased HOMO-LUMO gap as 
the Bn-pytz content increases. From the Figure 3.6 we can note that the UV-Vis absorption 
spectra of the isomers of [Os(Bn-pytz)3](PF6)2 complexes  (meridional, facial) are largely 
indistinguishable from each other.  
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Figure 3-6- UV–visible absorption spectra of complexes in aeriated acetonitrile at 295 K. 
 
All of the complexes exhibit broad featureless emission bands at room temperature which are 
assigned to emission from a 3MLCT state (Figure 3.7). In the room temperature spectrum, the 
complex [Os(bpy)2(Bn-pytz)](PF6)2 exhibits phosphorescence with a broad, featureless band in 
the red/near-infrared region of the spectrum (λ max = 730 nm, Table 2). Because the pytz ligand 
is less π-accepting than bpy, then bpy recieves more back bonding, which leads to a higher 
LUMO energy. This results in the emission being slightly blue-shifted relative to that of 
[Os(bpy)3]
2+  (λ max = 737 nm).215 Emission from [Os(bpy)(Bn-pytz)2](PF6)2 (λmax = 720 nm) is 
blue shifted even further. [Os(Bn-pytz)3](PF6)2 exhibits a very big blue shift (λmax = 615 nm) 
due to the LUMO being necessarily localised on Bn-pytz, which has a higher energy LUMO. 
Comparing the osmium complexes to the ruthenium(II) analogues [Ru(bpy)3−n(pytz)n](PF6)2, 
the  1MLCT absorption and 3MLCT emission bands (at 77 K) are also observed to blue-shift 
on increasing pytz content, howevere,  ruthenium(II) complexes  show little or no emission at 
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room temperature.94 Increasing the pytz content leads to a quenching of emission presumably 
due to 3MC states becoming more accessible and reduced 3MLCT / 3MC separation. Even at 
77 K emission is not observed from the homoleptic complex [Ru(pytz)3](PF6)2. Osmium 
complexes are emissive at room temperature with the emission being characterized by a broad 
featureless band attributed to an emissive 3MLCT state. This is because the ligand-field 
splitting is much larger leading to destablsation of the 3MC state which become thermally 
inaccessible. 
 
Figure 3-7- Emission spectra of the complexes in aerated acetonitrile at room temperature 
 
 
Osmium complexes with btz ligand have been studied.120 Increasing btz ligand content leads 
to a progressive blue-shift in the 1MLCT and 3MLCT-based absorptions compared to the 
absorption for [Os(bpy)3]
2+. The shift in the MLCT bands is highly noticeable upon 
replacement of the final bpy by btz. Heteroleptic osmium(II) btz complexes [Os(bpy)2(btz)]
2+ 
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and [Os(bpy)(btz)2]
2+ where the ligand containing two triazole rings display emission at 724 
and 713 nm respectively this means that these complexes exhibit emission bands at higher 
energy than Bn-pytz complexes.  The homoleptic complex [Os(btz)3]
2+ appears to display 
extremely weak emission at room temperature, while the homoleptic [Os(Bn-pytz)3]
2+ complex 
is emissive at room temperature 615 nm. This is because the Bn-pytz LUMO destablsation is 
not big enough for quenching of emission while the btz ligand has higher energy LUMO 
enough to quenched the emission. 
 The emission spectrum was also recorded in a 4:1 EtOH/MeOH glass matrix at 77 K. All 
complexes display structured emission bands with vibronic progressions relative to the 
emission spectrum at room temperature. Figure 3.8. The emission for all complexes undergo a 
rigdochromic blue-shift of approximately 35 nm. This is typical for metal-to-ligand charge 
transfer band emission, due to the frozen solvent molecules matrix where stabilization of the 
charge transfer states through relaxation of the geometry of the complex and solvent shell 
rearrangement cannot occur, and therefore the HOMO–LUMO gap is effectively increased. 
The photophysical data are summarized in Table 3.3. As with room temperature solution 
spectra increasing the number of Bn-pytz ligands leads to blue shifts in the emission with 
increasing in the lifetime and quantum yield ɸ. The bigest change is again obsarved for the 
complex [Os(Bn-pytz)3]
2+.This data is consistent with the energy gap law. 
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Figure 3-8- Emission spectra of the complexes in rigid matrix (4:1 EtOH/MeOH) at 77 K. 
 
 
Table 3-3- Luminescence data and lifetime of the complexes at room temperature (acetonitrile) 
and 77 K (4:1 EtOH/MeOH glass matrix) 
Compound 
At room temperature 
 
At 77 k 
 λ max (nm) Ʈ ns 
φ% In aerated 
MeCN* 
λ max (nm) 
[Os(bpy)3)](PF6)2 737 37 0.56 702 
[Os(bpy)2(Bn-pytz)](PF6)2 730 43 0.54 698 
[Os(bpy) (Bn-pytz)2](PF6)2 721 53 0.59 683 
mix-[Os (Bn-pytz)3](PF6)2 615 52 1.35 574 
mer-[Os (Bn-pytz)3](PF6)2 615 50 1.27 574 
fac-[Os (Bn-pytz)3](PF6)2 615 50 1.59 576 
* Relative to [Ru(bpy)3](PF6)2ᶲ= 0.018  
Changing the counter-ion from PF6 to chloride deos not effect significantly the photophysical 
properties of these complexes as we can note from Figures 3.9-3.10 which respectively are 
showing the UV-vis absorption spectra and the emission spectra of complexes with chloride 
counter-ions. The complexes are still emissive in water negligible changes in spectra are 
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observed in changing the solvent from acetonitrile to water. Because the water is more polar 
and increasing polarity of the solvent shifts π-π* to higher energy, red shift was expected but 
the aqueous solution spectra here are near identical to those of the PF6 salts in acetonitrile. 
Table 3-4   
 
Figure 3-9- UV–visible absorption spectra of complexes with chloride counter-ion in water at 295 K. 
 
 
Table 3-4 UV-vis absorption and luminescence data of the complexes with chloride counter-
ion at room temperature in water  
Compound λabs / nm(ε/ dm3.mol-1cm-1) λem  (nm) 
[Os(bpy)3)]Cl2 
244(26057), 256(20703), 289(82743), 329(9133), 
369(9553), 390(8938), 437(11362), 486(11912), 
670(2321) 
735 
[Os(bpy)2(Bn-pytz)]Cl2 
237(21907), 275 (31928), 289(20292), 331(5772), 
357(6957), 373(7631), 468(3700) 
729 
[Os(bpy)(Bn-pytz)2]Cl2 
239(31753), 274(46097), 289(65528), 
383(12290), 464(11827) 
719 
mix-[Os (Bn-pytz)3]Cl2 
235(23240), 273(36558), 309(5620), 372(8716), 
403(7715), 484(2196), 529(15002) 
624 
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Figure 3-10- Emission spectra of the complexes with chloride counter-ion in water at 295 K 
 
3.5 Luminescence Quenching by Oxygen 
 
As oxygen is introduced to the complex, the lifetime and emission intensity decrease.216 This 
is because the triplet ground state of O2 (
3O2) can quench the phosphorescence from the 
3MLCT 
state of the complex through triplet-triplet annilation (TTA)217 when collision of these 
molecules occur. The quenching efficiency and consequently, the luminescence intensity or 
lifetime will be determined by the concentration of the ambient oxygen.218 Thus, the lifetime 
and intensity of the luminescence is inversely proportional to the amount of oxygen present. 
This relationship can be quantified by the Stern-Volmer equation:  
𝐼𝑜/𝐼 = 1 + 𝐾𝑠𝑣[O₂] 
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Here Io is the intensity (or lifetime) of the complex in an oxygen free environment, I is the 
measured intensity (or lifetime) at a given oxygen concentration (O2), and Ksv is the derived 
Stern-Volmer constant that quantifies the relationship between the two variables. The changes 
in the emission spectra of the complexes are measured in acetonitrile. The intense 
phosphorescence was observed in the absence of oxygen, whereas increasing the oxygen 
concentration led to a decrease in the phosphorescence intensity. The responses of 
phosphorescence to molecular oxygen obeyed Stern–Volmer relationships. Generally, a more 
sensitive system will have a steeper slope and, as a result, a higher Ksv value. Table 3.5 
summarise the emission life times of the complexes in the presence of different concentations 
of oxygen: 
Table 3-5- Life time (ns) of the complexes in different concentation of oxygen in acetonitrile: 
Compound 0 atm 0.21 atm 1.0 atm 
[Os(bpy)3)](PF6)2 1674 37 11 
[Os(bpy)2(Bn-pytz)](PF6)2 1726 41 16 
[Os(bpy) (Bn-pytz)2](PF6)2 1518 53 11 
mix-[Os (Bn-pytz)3](PF6)2 1809 56 14 
mer-[Os (Bn-pytz)3](PF6)2 1571 45 12 
fac-[Os (Bn-pytz)3](PF6)2 1384 29 11 
 
Figure 3.11 shows the emission intensities at the different oxygen concentrations for the 
complexes. Generally, replacement of the bpy ligand by Bn-pytz gives more efficient 
quenching. This shows that [Os(bn-pytz)3]
2+ is more potent at 1O2 production than [Os(bpy)3]
2+ 
complex and the other bpy containing complexes. 
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Figure 3-11  Emission response of complexes to varying [O2] IN CH3CN 
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The sensitivity of emission from the complexes to [O2] was determined through the Stern-
Volmer quenching constant (Ksv). As shown in Figure 3.12, the oxygen concentration was 
proportionate to the ratio of the phosphorescent intensities I0/I. As seen in Table 3.6, which 
show the Ksv values of the complexes, replacement of one of the bpy ligands by Bn-pytz leads 
to more 3O2 quenching until the biggest  
3O2 quenching observed in [Os(Bn-pytz)3](PF6)2 
complex.   
Table 3-6- Stern-Volmer quenching constant (Ksv) for the complexes  
Compound 
Ksv/atm-1 for the complexes 
as PF6 salts 
1O2 quantum yield %   
as Cl salts 
[Os(bpy)3)]
2+ 2.2  
[Os(bpy)2(Bn-pytz)]
 2+ 2.7 19 
[Os(bpy)(Bn-pytz)2]
 2+ 8.3 32 
mix-[Os(Bn-pytz)3]
 2+ 83 62 
mer-[Os(Bn-pytz)3]
 2+ 83  
fac-[Os(Bn-pytz)3]
 2+ 89  
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Figure 3-12- Ksv plot for all complexes 
 
Generally, there is a significantly higher sensitivity to [O2] observed with [Os(Bn-pytz)3](PF6)2 
complexes (Ksv = 88 atm-1) compared with other complexes and we can see that [Os(bpy)(Bn-
pytz)2](PF6)2 has higher Ksv = 8.29 atm
-1 comparing with [Os(bpy)2(Bn-pytz)](PF6)2 Ksv = 
2.69 atm-1 which means that Bn-pytz complexes are more sensitive than bpy-containing  
complexes. Singlet oxygen quantum yields were determined by Luke K. McKenzie (University 
of Sheffield) for the chloride salts of complexes in acetonitrile, by massuring the near-IR 
luminescence from (1O2) relaxation. The (
1O2) quantum yield data is in agreement with the Ksv 
data. High quantum yields of singlet oxygen 19% for [Os(bpy)2(Bn-pytz)]
2+ and 32 % for 
[Os(bpy)(Bn-pytz)2]
2+ are observed with the highest quantum yield of 62% observed for 
[Os(Bn-pytz)3]
2+ in agreement with the quenching data for the hexafluorophosphate salts. This 
is because the Bn-pytz ligand has higher LUMO than bpy ligand and the so the triplet ground 
state of O2 (
3O2) can quench the phosphorescence of the (
3MLCT) of complex when collision 
of these molecules occurs increasing the quenching efficiency  
 
0
10
20
30
40
50
60
70
80
90
100
0 0.2 0.4 0.6 0.8 1 1.2
I 0
/I
O2%
[Os(bpy)₃](PF₆)
[Os(bpy)₂(pytz)](PF₆)
[Os(bpy)(pytz)₂](PF₆)
mix-[Os(pytz)₃](PF₆)
mer-[Os(pytz)₃](PF₆)
fac-[Os(pytz)₃](PF₆)
Chapter 3: Synthesis, characterisation and cellular uptake studies of osmium (II) 4-(pyrid-2-yl)-1,2,3 triazole complexes 
122 
 
3.6 Density functional theory (DFT) studies 
 
In order to further understand the electronic transitions of the complexes and validate the 
interpretation of the electrochemical and photophysical results density functional theory (DFT) 
studies were undertaken. Calculations were preformed by Dr Nathan Patmore and the result 
presented and interpreted here. 
3.6.1 Ground state properties: 
Density functional theory (DFT) calculations were carried out to study the nature, localisation 
and relative energies of the frontier orbitals in addition to simulate the optical absorption 
spectra of the complexes. The calculations optimised the geometries of the ground states in 
acetonitrile by using PCM solvation model with the SDD effective core potential for osmium 
and 6-311G* basis sets for all other atoms. Here the density functional calculations indicate 
that for all the complexes in the singlet ground state the HOMO orbital is of approximately in 
the same energy which is in agreement with the obtained CV data. In all complexes the HOMO 
is predominantly of Os dz
2 orbital character, (Figure 3.13). On the other hand, the LUMOs are 
essentially the π* orbital of ligands. For the bpy-containing complexes the LUMO is localised 
on the bpy ligands, having π* character. For the homoleptic complex [Os(Bn-pytz)3](PF6)2 the 
LUMO is distributed over the three Bn-pytz ligands predominantly over pyridine rings. 
Progressing across the series the LUMO is destabilised (Table 3.7), resulting in an increased 
HOMO–LUMO gap as the bpy ligands are replaced by Bn-pytz with a big jump in energy 
observed for the LUMO and HOMO–LUMO gap for [Os(Bn-pytz)3](PF6)2 in agreement with 
the experimental electrochemical data.  
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Table 3-7- Calculated HOMO and LUMO energies and HOMO-LUMO gap ∆E for [Os(bpy)3-
n(Bn-pytz)n](PF6)2 complexes (n =1, 2, 3) 
Complex HOMO /eV LUMO /eV ∆E/eV 
[Os(bpy)2(Bn-pytz)](PF6)2 -6.20 -2.67 3.53 
cis-cis-[Os(bpy)(Bn-pytz)2](PF6)2 -6.18 -2.57 3.61 
cis-trans-[Os(bpy)(Bn-pytz)2](PF6)2 -6.18 -2.53 3.65 
trans-cis-[Os(bpy)(Bn-pytz)2](PF6)2 -6.19 -2.60 3.59 
mer-[Os(Bn-pytz)3](PF6)2 -6.17 -2.22 3.95 
fac-[Os(Bn-pytz)3](PF6)2 -6.17 -2.21 3.96 
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Figure 3-13:  HOMO (bottom) and LUMO (top) orbital representations for complexes in the singlet ground-state in acetonitrile (PCM)
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Figure 3-14: Molecular orbital energy level diagram of complexes (PCM, acetonitrile)
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3.6.2 Time dependent DFT (TDDFT) Calculations 
 To confirm the interpretation of the photophysical results, time-dependent density functional 
theory calculations performed to determine the absorption spectra of the complexes. In general 
the calculated absorption spectra from time-dependent DFT calculations are in good agreement 
with experimental spectra.  Figure 3.15 shows comparison of calculated vertical excitations 
and experimental spectra for complexes. In the UV region at 290 nm transitions can be safely 
assigned to intraligand π → π* transitions. Furthermore, all of the complexes presented here 
had absorptions at the low-energy between 370 nm to 500 nm. These mainly originate from 
HOMO-2/HOMO to LUMO/LUMO+1 based transitions and are assigned to metal-to-ligand 
charge transfer from an Os d orbital to bpy-π* for the bpy-containing complexes. For [Os(Bn-
pytz)3](PF6)2 the LUMO is predominantly distributed over the pyridine rings of the 
three pytz ligands and is destabilised by approximately 0.42 eV compare to that 
of [Os(bpy)2(Bn-pytz)](PF6)2 complex indicative of the significantly higher energy LUMO of 
the pytz ligand compared to bpy. Consequently the lowest energy transisions are distablishied 
and blue shefted relative to [Os(bpy)2(Bn-pytz)](PF6)2. 
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Figure 3-15 Calculated TDDFT optical absorption spectra for complexes overlaid with experimental UV-Visible absorption data in acetonitrile (PCM)
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3.7 Cellular uptake and imaging microscopy studies 
 
Based on the promising photophysical data described above, the water soluble chloride form 
of the complexes were subjected to preliminary cellular uptake and luminescence imaging 
microscopy studies in collaboration with Luke K. McKenzie, Dr Helen E. Bryant, and 
Professor Julia A. Weinstein at the University of Sheffield. The results from these studies show 
that complexes are successfully taken up by two cancer cell lines HeLa (human cervical cancer) 
and EJ (bladder carcinoma). Figure 3.16 shows the MTT assay results for dark toxicity of the 
complexes as well as preliminary PDT toxicity results. The results indicate that the complexes 
have relatively low dark toxicity in both cell lines, however, a relative cell survival of ~80 % 
is observed for [Os(Bn-pytz)3]
2+ in the bladder carcinoma cell line at a relatively concentration 
of 100 µM.  
 
Figure 3-16  MTT assays and PDT toxicity and dark toxicity imaging samples for complexes 1 to 4 with EJ bladder 
carcinoma and HeLa cell lines.   
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Confocal imaging microscopy studies demonstrate that the two complexes [Os(bpy)3]
2+ and 
[Os(bpy)2(Bn-pytz)]
2+ did not go in cells at any appreciable degree. The complex [Os(bpy)(Bn-
pytz)2]
2+ does enter cells but [Os(Bn-pytz)3]
2+ is the only one to go into cells to any appreciable 
degree, with the bright emission which can be seen by confocal microscopy. This could 
therefore explain the higher toxicity of the latter observed in the MTT assays. Confocal images 
for various incubations periods for [Os(Bn-pytz)3]
2+ in both cell lines are presented in Figure 
3-17. Colocalisation studies were hampered by overlap of the 3MLCT/ 1MLCT bands with 
those of Mito tracker dye used, but the complex [Os(Bn-pytz)3]
2+ appears to localise at 
lysosomes, despite the high singlet oxygen quantum yields for these complexes, no significant 
photo-cytotoxicity is observed indicative that [Os(Bn-pytz)3]
2+ is a poor PDT agent. This 
possibly stems from the envelopment of the complex within a biological molecular mating 
which excludes it from local O2 thereby preventing 
1O2 generation. The complexes presented 
here therefore provide an excellent platform for the development of luminescent cellular 
imaging agents. This results indicate that the triazoles really help cell uptake and might be a 
good future design strategy. Beyond application in biological imaging, the complexes and 
modified derivatives may also offer probable applications as phosphors for deep-red/near-IR 
light emitting devices.120 
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Figure 3-17- Confocal images of complex [Os(Bn-pytz)3][Cl], following 4 h incubation Both cell lines HeLa (human 
cervical cancer) (left) and EJ (bladder carcinoma) (right) cells co-localised with central overlaid image, scale bars 20 µm. 
Left hand pane = luminescence imaging. Right hand pane = bright field imaging. Middle pane = merger of these two. 
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3.8 Conclusions: 
 
In this chapter, a series of heteroleptic osmium(II) Bn-pytz complexes [Os(bpy)2(Bn-pytz)]
2+ 
and [Os(bpy)(Bn-pytz)2]
2+and homoleptic osmium(II) complexes [Os(bpy)3]
2+ and [Os(Bn-
pytz)3]
2+ were successfully synthesized in good to yields (60%-70%). The resulting osmium(II) 
complexes were characterized by 1H and 13C NMR spectroscopy, and mass spectroscopy HR-
ESI-MS. The photophysical properties of these systems were investigated by UV-VIS, 
emission and lifetime spectrometry. All the complexes display 3MLCT emission, that blue-
shift as a result of replacing bpy with Bn-pytz. The blue-shift in electronic absorption and 
luminescence spectra of the resulting complexes indicative of the Bn-pytz ligands having a 
higher energy LUMO than bpy. In the presence of oxygen one of the complexes [Os(Bn-
pytz)3](PF6)2 was shown to display significant quenching of luminescence intensity, presenting 
the possibility of applying complexes based on [Os(bn-pytz)3]
2+ as potential 1O2 sensitizers for 
photodynamic therapeutic applications. The increased celluler uptake of the complex [Os(Bn-
pytz)3]
2+, which is the only one to go into cells, localises at lysosomes, could be due to the 
increased the lipophilicity of the benzyl side chains; however, no PDT activity is observed. 
This result indicates that the triazoles help cellular uptake and they might be a good future 
design strategy. The use of CuAAC coupling reaction in the ligand preparation opens up 
various ways for tailored derivitisation and bioconjugation that would enable the optimisation 
of cellular uptake and a wider scope for organelle targeting within cells. I would like to thank 
Luke K. McKenzie, Dr Helen E. Bryant, and Professor Julia A. Weinstein University of 
Sheffield, for the collaborative biological studies reported in this chapter. 
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4.1 Introduction  
 
Photodynamic Therapy (PDT) 
Photodynamic therapy (PDT) is a technique that uses light to activate an otherwise nontoxic 
drug, often referred to as a photosensitizer (PS), generally in the presence of oxygen.219 PDT 
involves irradiation of a tissue-bound photosensitizer which goes to its triplet excited state and 
generates, upon energy transfer to oxygen, the cytotoxic singlet oxygen (1O2) resulting in cell 
necrosis.220 This techniques advantage over other available therapies comes from its inherent 
ability to induce highly localized cytotoxicity in the targeted tissues when light activated. In 
terms of definition, photosensitizers are light-sensitive compounds which are able to absorb 
light-specific wavelengths (chromophores) and convert it  into useful energy leading to the 
formation of singlet oxygen, which produces peroxidative reactions that can cause cell damage 
and death.221 Consequently, unwanted cells can be effectively removed while incurring little to 
no damage on the surrounding tissue. It is generally accepted that a good photodynamic therapy 
PS should: (i) be known composition, chemically pure, with good stabilization, (ii) be collected 
preferentially and kept by target tumor tissue, (iii) be cytotoxic only upon photoactivation, and 
have minimal toxicity in the dark, (iv) have high quantum yield of 1O2 and (v) have high 
absorbance and high molar extinction coefficient, particularly in the red and near IR spectral 
regions (600–800 nm). This last property is related with light penetration into the tissues, which 
is associated with the wavelength; for example, the light depth penetration at λ = 500 - 600 nm 
is about 4 mm, while in the range 600-800 nm it is about 8 mm.222 Over the last 40 years, 
transition metal-based coordination compounds have been investigated for their therapeutic 
properties in several fields of medicine. Among others, a major advantage of metal-based drugs 
over the more common organic therapeutic agents is the ease at which changes in the chemical 
and physical properties of the drug can be brought about by modifying ligands in the 
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coordination sphere.51 In recent years, transition metal-based drugs have played a particularly 
important role in the clinical treatment of cancer.223, 224  many complexes exhibit luminescent 
emission which presents the potential for use as imaging agents, since phosphorescence is 
longer-lived than the autofluorescence from biological organic compounds.15 While direct 
population of the low-lying 3MLCT state is spin-forbidden and rarely observed in metal 
complexes.225 These spin-forbidden transitions are more common in osmium complexes due 
to an increase in spin orbit coupling.205, 206, 226 Consequently, Os(II) complexes often exhibit 
absorbance well into the red and occasionally, near-IR region.227 All of these combined 
properties present considerable opportunities for the development of unique dual-mode 
theranostic agents. This chapter will explore the use of the 2,6-bis(1-phenyl-1,2,3-triazol-4-
yl)pyridine (ptzpy) ligand as a tridentate donor ligand to investigate the influence of (N^N^N)  
ligands on photophysical characteristics of an osmium(II) complex compared with terpy 
derivatives. We report the synthesis of the orange-emissive bis(terdentate) osmium(II) complex 
[Os(btzpy)2]
2+ as its hexafluorophosphate  and chloride salts. The water soluble chloride salt of 
the osmium(II) complex was subject to preliminary cellular uptake and luminescence imaging 
studies and the data were also reported. The results in this chapter have been published.228    
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4.2 Synthesis and characterisation 
4.2.1 Synthesis of Ligand 
The synthesis of the btzpy ligand is discussed in Chapter 2 
4.2.1.1 Synthesis of 4'-(p-tolyl)-2,2':6',2''-terpyridine 
 
The ligand 4'-(p-tolyl)-2,2':6',2''-terpyridine was synthesized as follow.229 At room 
temperature, the reaction of 2-acetylpyridine and 4-methylbenzaldheyde was performed in 
ethanol under basic reaction conditions to afford a white solid (Scheme 4.1). The off-white 
solid was collected by filtration and washed with ice-cold EtOH. Recrystallisation from EtOH 
afforded a white crystalline solid. The 1H NMR spectra was in agreement with a literature 
data.229  
 
Scheme 4-1 - Synthesis of 4'-(p-tolyl)-2,2':6',2''-terpyridine 
 
The tridenate ligands 4'-(p-tolyl)-2,2':6',2''-terpyridine was fully characterised by 1H and 13C 
NMR spectroscopy and mass spectrometry. The 1H NMR spectrum of 4'-(p-tolyl)-2,2':6',2''-
terpyridine (Figure 4.1) shows pyridyl protons in the range of δ 8.74-7.26. The proton signals 
were fully assigned by using 1H-1H correlation (COSY) spectroscopy the methyl group gives 
a singlet resonance at  δ 2.42 of the methyl protons (Figure 4.2) The ESI mass spectrum of 4'-
(p-tolyl)-2,2':6',2''-terpyridine shows a peak at m/z = 323.1428 assignable to the species (M2+). 
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Figure 4-1- The 1H-NMR spectrum (400 MHz, CDCl3) of free ligand 4'-(p-tolyl)-2,2':6',2''-terpyridine 
 
Figure 4-2- The 1H-1H COSY spectrum (400 MHz, CDCl3) of free ligand 4'-(p-tolyl)-2,2':6',2''-terpyridine 
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4.2.2 Synthesis of osmium (II) complexes  
4.2.2.1 Synthesis of [Os(toltpy)2](PF6)2  
 
The complex [Os(toltpy)2](PF6)2 was prepared by reaction of (NH4)2[OsCl6] with two 
equivalents of 4'-(p-tolyl)-2,2':6',2''-terpyridine in ethylene glycol under refluxing conditions 
followed by counter-ion metathesis and was isolated in the solid state as its 
hexafluorophosphate salt.   
 
Scheme 4-2 Synthesis of [Os(toltpy)2](PF6)2 
 
Due to the symmetry of the (toltpy) ligands the 1H NMR spectrum of the product (Figure 4.3) 
shows 7 aromatic signals in the range of δ 9.01-7.10 The spectrum is completed by one singlet 
at δ 2.57 coresponding to the methyl protons The ESI mass spectrum of the complex shows a 
peak at m/z = 419.1238 assignable to the species M2+. 
 
Figure 4-3- The 1H-NMR spectrum (400 MHz, CD3CN) of [Os(toltpy)2](PF6)2 
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4.2.2.2 Synthesis of [Os(btzpy)2](PF6)2 
 
The complex [Os(btzpy)2](PF6)2 was prepared by reaction of (NH4)2[OsCl6] with two 
equivalents of ligand btzpy in ethylene glycol under refluxing conditions followed by counter-
ion metathesis. The complex was isolated in the solid state as its hexafluorophosphate salt then 
redissolved in acetonitrile. The acetonitrile solution was cooled in the fridge overnight and 
filtered and the filtrate recrystallized on addition of diethyl ether to remove unwanted ligand. 
 
Scheme 4-3 Synthesis of [Os(btzpy)2](PF6)2 
 
Due to the a symmetry of the btzpy ligands the 1H NMR spectrum (Figure 4.4) of the product 
shows one singlet resonance at δ 9.13 for the triazole ring protons which is shifted by 0.86 ppm 
relative to the corresponding resonance for the free ligand (δ 8.97). The ESI mass spectrum of 
the complex shows a peak at m/z= 461.1192 assignable to the species [Os(btzpy)2]
2+. 
 
 
 
 
 
 
Chapter 4: Synthesis, characterisation and cellular system of a osmium (II) 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-
yl)pyridine, (btzpy) complex 
139 
 
 
Figure 4-4-The 1H-NMR spectra (400 MHz, CD3CN) for free ligand btzpy and [Os(btzpy)2](PF6)2 
 
The chloride salt of the [Os(btzpy)2]
2+complex which is soluble in water is obtained by stirring 
the PF6
- salt in methanol with Amberlite IRA-400 (chloride form) anion-exchange resin. The 
resultant solution was then filtered and evaporated, taken up into water and freeze dried. The 
successful counter ion metathesis and formation of chloride salt was confirmed by the complete 
absence of resonance for the PF6
- anion in its 19F and 31P NMR spectra. The chloride salt was 
then characterized by 1H-NMR, UV/vis absorption and emission spectroscopy. 
4.3 Electrochemical Properties of complexes 
 
The electrochemical properties of the complexes have been investigated by cyclic 
voltammetry. The measurements were performed using acetonitrile distilled over calcium 
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hydride with 0.2 M [NBu4][PF6] as supporting electrolyte at room temperature. Ferrocene was 
added at the end of each experiment as an internal reference, and all redox potentials are quoted 
vs. the ferrocene-ferrocenium couple (Fc / Fc + = 0.0 V). The measurements were carried out 
in the region from +1.5 to -2.0V with a scan rate of 100 mVs-1. Electrochemical data for the 
various complexes as obtained by cyclic voltammetry are summarized in Table 4-1. 
Table 4-1: Electrochemical data for the complexes in CH3CN, 0.2 M [NBu4] [PF6], 100 mVs
-
1, at room temperature 
No Complex Reduction E1/2 V vs. Fc+/Fc Oxidation Epa V vs. 
Fc+/Fc 
1 [Os(toltpy)2](PF6)2 -1.87(0.086)
a, -1.605(0.075)a 0.487(0.1)a 
2 [Os(btzpy)2](PF6)2 ============
b 0.633(0.1)a 
E1/2= (Epa+ Epc)/ 2, Epc are anodic and cathodic peak potentials respectively. a = reversible.b = reduction coples are outside 
the available electrochemical window. 
 
 
For complexes [Os(toltpy)2](PF6)2  and [Os(btzpy)2](PF6)2 the observed couples were all 
reversible. Figure 4.5 shows the cyclic voltammagrams of the complexes. The cyclic 
voltammograms of two complexes gave the Os3+/2+ metal-based redox processes, which for the 
[Os(btzpy)2]
2+ complex appears at +0.64 V (Eox vs Fc/Fc
+ = 0.0 V). This is close to that 
exhibited by the known model complex [Os(toltpy)2](PF6)2 (Eox = +0.49 V) and other related 
osmium(II) complexes.230, 231 Replacing (toltpy) with (btzpy) ligand caused changes to the 
reduction potantials which are significantly more to negative. Unlike in the CV trace for 
[Os(toltpy)2]
2+, no ligand-based reductions are observed within the available electrochemical 
window (−2.0 to +1.5 V) for [Os(btzpy)2]2+, which is indicative of the higher energy lowest 
unoccupied molecular orbital localized on the btzpy ligand compared to that for the 
[Os(toltpy)2]
2+. The latter complex gave two one electron terpyridine ligand based reduction 
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processes with E1/2 values of −1.60 (mtpy0/1−) and −1.87 (mtpy1−/2−). This LUMO 
destabilisation is consistent with previously reported data of [Ru(toltpy)2]
2+ versus the 
ruthenium(II) analogue [Ru(tpy)2]
2+ (tpy = 2,2, :6 ,2,,-terpyridine based ligand).232, 233 This 
strongly suggests that terpyridine is better acceptor than triazole and differences in the MLCT 
absorption and emission energies between the complexes are primarily due to differences in 
the energy of the π* level. 
 
Figure 4-5- Cyclic voltammogram of complexes in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1. Potentials V are 
reported against ferrocene (Fc+/Fc = 0.0 V) 
 
 
 
 
 
 
-2.5 -2 -1.5 -1 -0.5 0 0.5 1 1.5
Potential/VvsFC+ /FC
[Os(toltpy)₂](PF₆)₂
[Os(btzpy)₂](PF₆)₂
Chapter 4: Synthesis, characterisation and cellular system of a osmium (II) 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-
yl)pyridine, (btzpy) complex 
142 
 
4.4 Photophysical studies 
 
Table 4.2 summarizes the UV-vis electronic absorption data for the complexes, UV-Vis 
absorption spectra of the complexes, in MeCN are shown in Figure 4.6. 
Table 4-2: The UV-VIS electronic absorption data for the complexes 
Compound λ / nm(ε/mol-1dm3cm-1) 
[Os(toltpy)2](PF6)2 286(48000), 314(54300), 406(7520), 491(19250),  645(4600), 669(5070), 
[Os(btzpy)2](PF6)2 288(49015), 297(68480), 337(13475), 382(19470), 434(5700), 526(3025) 
 
The UV-vis absorption spectrum of [Os(toltpy)2](PF6)2 in acetonitrile exhibits two intense 
bands at 286 nm and 314 nm ascribed to the ligand-centered (1LC) π → π* transitions. 
[Os(btzpy)2](PF6)2 also has two intense bands at 239 nm and 297 nm and a shoulder at 285 nm 
similarly ascribed to the ligand-centred (1LC) π → π* transitions. Both complexes exhibit an 
intense absorption band in the visible region at 490 and  386 nm respectively assignable to the 
1MLCT d → π* transitions, and a broad and weaker band at 668 nm for [Os(toltpy)2](PF6)2  and  
530 nm for [Os(btzpy)2](PF6)2. These weaker and lower energy bands are assigned to spin-
forbidden 3MLCT transitions. The spin forbidden absorption populates the 3MLCT directly 
from the ground state because of the large spin-orbital coupling that results from the heavy 
osmium atom.214 Since the LUMO of the btzpy ligand is significantly destabilised relative to 
that of toltpy, the replacement of the ligands leads to shift of MLCT bands to the higher energy. 
This is analogous to the behavior observed with bidentate ligands when changing bpy in 
[Os(bpy)3](PF6)2 to Bn-pytz in [Os(Bn-pytz)3](PF6) in Chapter 3. 
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Figure 4-6- UV–visible absorption spectra of complexes in aerated acetonitrile at 295 K. 
 
The photophysical emission data are summarized in Table 4-3. Both of the complexes exhibit 
a broad featureless emission band at room temperature in aerated solvent which is assigned to 
emission from a 3MLCT state (Figure 4.7). For [Os(btzpy)2]
2+ this band appears in the orange 
region of the spectrum (λ max = 595 nm, Table 4-3) and is significantly blue-shifted relative to 
that of [Os(toltpy)2]
 2+  which is located  in the red/near-infrared region of the spectrum (λ max 
= 738 nm). 215 
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Figure 4-7- Emission spectra of the complexes in in aerated acetonitrile at room temperature 
 
The emission spectrum was also recorded at 77 K in a 4:1 EtOH / MeOH glass matrix and 
shows structured emission bands. Due to rigidochromic effects, the position of the bands is 
blue-shifted by approximately 20-30 nm compared with the spectra recorded at room 
temperature. These observations are typical for metal-to-ligand charge transfer (MLCT) based 
emissions. Since the solvent molecules are frozen at 77 K and any stabilization of the charge 
transfer transitions involving the rearrangement of solvent and geometry relaxation for the 
complex can not occur and therefore the HOMO–LUMO gap is effectively increased. (Figure 
4.8).  
Table 4-3: photoluminescence data and lifetime for the complexes in aerated acetonitrile at 
room temperature and 77 K 
Compound At room temperature At 77 K ᶲ*% 
 λ max( nm) τ (ns) λ max (nm)  
[Os(toltpy)2](PF6)2 738 72 718,795 3.2 
[Os(btzpy)2](PF6)2 595 66 564,606 9.3 
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* Relative to [Ru(bpy)3](PF6)2 ᶲ= 0.018 in air 
 
Figure 4-8- Emission spectra of the complexes in rigid matrix (4:1 EtOH/MeOH) at 77 K. 
 
Changing the PF6
-
 counter-ion to chloride appears to have no significant effect on the 
photophysical properties of these complexes as we can note from Figures 4.9-4.10 which 
respectively are show the visible absorption spectrum and the emission spectrum of the 
complexes as the chloride salts in water. The complexes are still emissive in water and the 
change in spectra is negligible when the solvent is changed from acetonitrile to water. 
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Figure 4-9-UV–visible absorption spectra of complexes as their chloride salts in water at 295 K. 
 
 
 
 
Figure 4-10- Emission spectra of the complexes as their chloride salts in water 
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4.5 Luminescence Quenching by Oxygen 
 
Table 4-4 illustrates the life time of the complexes in the presence of different ratios of oxygen: 
Emission intensity from the [Os(btzpy)2]
2+ complex is dramatically affected by the presence of 
oxygen (Figure 4.11). When recorded in air and compared to deaerated conditions, the emission 
intensity is quenched by approximately 43-fold. The responses of phosphorescence to 
molecular oxygen approximately obeyed Stern–Volmer relationships. As shown in Figure 4-
11. This sensitivity to the presence of oxygen confirms the 3MLCT character of the emissive 
state.202 This significant quenching of emission by oxygen and the long lifetime of emission in 
deaerated solution thus presents the possibility of employing complexes based on 
[Os(btzpy)2]
2+ as a potential 1O2 sensitizer for photodynamic therapeutic applications.  
Table 4-4: Life time (ns) of the complexes at different concentation of oxygen in acetonitrile: 
compound 0 atm 0.21 atm 1.0 atm 
[Os(toltpy)2](PF6)2 339 72 22 
[Os(btzpy)2](PF6)2 937 66 12 
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Figure 4-11- Emission response of complexes to varying [O2] 
 
Generally, as seen in Table 4-5, replacement of the (toltpy) ligand by (btzpy) gives more 
quenching efficiency. This means that [Os(btzpy)2]
2+ is more potent for 1O2 production than 
[Os(toltpy)2]
2+ complexes indicated by the 10-fold increase in the Ksv cinstant for the complex. 
Table 4-5: Ksv for complexes as hexafluorophosphate salt and quantum yield for 
[Os(btzpy)2]
2+ complex as chloride salts 
Compound 
Ksv for PF6
- form 1O2 quantum yield% for Cl
- 
form 
[Os(toltpy)2]
 2+ 13  
[Os(btzpy)2]
 2+ 110 57 
 
The singlet oxygen 1O2 quantum yield was measured in collaboration with Luke K. McKenzie 
at University of Sheffield and is appreciably high and 57%.  
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4.6 Density functional theory (DFT) studies 
 
In order to further understand the electronic transitions of the complex [Os(btzpy)2]
2+ and 
validate the interpretation of the electrochemical and photophysical results density functional 
theory (DFT) studies were undertaken by Professor Paul Elliott and the result presented and 
discussed here. 
4.6.1 Ground state properties: 
Density functional theory (DFT) calculations were used to study the nature, localisation and 
relative energies of the frontier orbitals of complex [Os(btzpy)2]
2+ and in addition to simulate 
the optical absorption spectrum. The geometry was obtained in the gas phase with the phenyl 
substituent replaced by methyl to reduce the computational cost. The data show that with a 
small contribution from the π-systems of the four triazole rings, the HOMO is localized 
primarily on the osmium(II) centre as expected (Figure 4.12 a). The LUMO is localised on one 
of the btzpy ligands, mainly on the central pyridine ring and with a minimal contribution from 
the triazole rings (Figure 4.12 b) but also a small metallic d-orbital contribution. In agreement 
with the experimental electrochemical data. The HOMO of [Os(btzpy)2]
2+ is slightly stabilized 
(−10.63 eV) relative to that of [Os(toltpy)2]2+ (−10.35 eV). On the other hand the LUMO of 
[Os(btzpy)2]
2+ (−6.95 eV) is significantly destabilized relative to that of [Os(toltpy)2]2+ (−7.32 
eV) due to the presence of the electron rich triazole moieties and due to the smaller π-system 
associated with the btzpy ligand compared to toltpy. This results in a larger HOMO–LUMO 
gap for [Os(btzpy)2]
2+ of 3.68 eV compared to that for [Os(toltpy)2]
2+ (3.03 eV) reflecting the 
significantly blue shifted absorption and emission data (Table 4.6). 
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Table 4-6: Selected calculated energies of the HOMO and LUMO orbitals and the HOMO–
LUMO gap ∆E of complexes 
Complex HOMO E/eV LUMO E/eV ∆E/eV 
[Os(toltpy)2]
2+ -10.35 -7.32 3.03 
[Os(btzpy)2]
2+ -10.63 -6.95 3.68 
 
 
Figure 4-12- Plots of the HOMO (a) and LUMO (b) for the ground state and the spin density for the T1 state of 
[Os(btzpy)2]2+  
 
4.6.2 Time dependent DFT (TDDFT) Calculations 
To confirm the interpretation of the photophysical results, time-dependent density functional 
theory calculations were performed to determine the absorption spectrum of the complex 
[Os(btzpy)2]
2+. The lowest energy 30 singlet state vertical excitations at the ground state 
geometry along with the lowest energy 10 spin-forbidden triplet excitations for complex 
[Os(btzpy)2]
2+ were calculated . The data agree well with the experimental spectra but with a 
slight overestimation of the energies of transitions compared to bands in the UV-visible 
absorption spectrum. Figure 4.13 shows the comparison of calculated vertical excitations and 
experimental spectrum for the complex. From the Figure we can see  that the  two strongest 
simulated transition in the same places as the strongest  bands in the experiments about the UV 
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region at 290 nm which can be safely assigned to intraligand π → π* transitions. The S27 state 
which is primarily of HOMO-4 → LUMO 1LC in character is calculated to have an energy of 
4.53 eV (274 nm). The S1 state which is primarily HOMO → LUMO 1MLCT in character, 
calculated to have an energy of 2.74 eV (452 nm). The first transition of significant intensity 
(S7, 374 nm) is consists of a HOMO → LUMO+2 transition and is similarly of 1MLCT 
character confirming our experimental assignment of the band in this region of the UV-visible 
absorption spectrum. In agreement with the assignment of the lesser intensity absorptions 
between 450 and 550 nm as arising from spin-forbidden direct 3MLCT transitions, the T1 state 
is calculated to appear at 512 nm (2.42 eV) and is of mixed HOMO-2 → LUMO+1 and HOMO-
1 → LUMO character. The optimization of the lowest lying triplet state of [Os(btzpy)2]2+ 
starting from the optimized ground state geometry is calculated to lie 2.40 eV the ground state. 
The spin density was plotted and is illustrated in Figure 4.12 c. It shows that the 3MLCT 
character of this T1 state is confirmed by unpaired electron density on both the metal and one 
of the btzpy ligands. Curiously, unlike in the case of [Os(toltpy)2]
2+, the T1 state of 
[Os(btzpy)2]
2+ undergoes a puckering like distortion of the btzpy ligand in which the unpaired 
electron density is localized. Such distortions have been observed, however, in theoretical 
calculations of the T1 states of [Os(terpy)2]
2+234 and bis(tridentate) ruthenium(II) 
cyclometalated complexes.235  
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Figure 4-13- Calculated TDDFT optical absorption spectra for complexes overlaid with experimental UV-Visible absorption 
data in acetonitrile solution 
 
4.7 Cellular uptake and imaging microscopy studies 
 
Based on the encouraging photophysical data reported above, the water soluble chloride form 
of the complex [Os(btzpy)2]
2+ was subjected to preliminary cellular uptake and luminescence 
imaging microscopy studies in collaboration with  Luke K. McKenzie, Dr Helen E. Bryant, 
and Professor Julia A. Weinstein from the University of Sheffield. The results from these 
studies reveal that the complex is successfully taken up by two cancer cell lines, HeLa (cervical 
cancer) and U2OS (osteosarcoma) and shows mitochondrial localization. Following a short 
incubation time of 4 h and at concentrations as low as 1 µM colocalisation with the 
mitochondrial stain MitoView 633 with the bright emission was seen by confocal microscopy 
(Figure 4.14). Pearson’s correlation coefficients of r = 0.7 and 0.85 for U2OS and HeLa cells 
respectively.  
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Figure 4-14  Confocal images of complex [Os(btzpy)2] Cl2  (green) following 4 h incubation in HeLa and U2OS cells co-
localised with Mitoview 633 (red) with central overlaid image, scale bars 20 µm.228 
 
 
Figure 4.15 shows the MTT assay results for dark toxicity of the complex as well as preliminary 
PDT toxicity results. The results indicate that the complex at a concentration effective for 
luminescence imaging microscopy the complex is non-cytotoxic, giving support to potential 
application as a PDT cellular imaging agent. Unfortunately, preliminary PDT studies revealed 
no significant photo-toxicity. This is again possibly due to the envelopment of the complex and 
exclusion for interaction with molecular oxygen.  
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Figure 4-15 (A) MTT and (B) Clonogenic survival assays following incubation of HeLa cells with increasing concentrations 
of complex, [Os(btzpy)2][Cl]2 in the dark. In each case, mean and standard deviation of at least 3 independent repeats.228 
 
4.8 Conclusions: 
 
 In this chapter, two homoleptic osmium(II) complexes [Os(toltpy)2]
2+, [Os(btzpy)2]
2+ as 
tridentate osmium(II) complexes were successfully synthesized in good yields (60%-70%). 
The resulting osmium(II) complexes were characterized by 1H and 13C NMR spectroscopy, and 
mass spectroscopy HR-ESI-MS. The photophysical, properties of these systems were 
investigated by UV-vis, emission and their emissive lifetimes. A number of conclusions were 
reached concerning the photophysical properties of the emitting MLCT state of the complexes 
and how their properties compare to each other. The complexes are emissive at room 
temperature in air in the orange to red region of the visible spectrum. Triazole moities are 
destabilising compared with pyridines with respect to the energy of the LUMO resulting in 
higher energy MLCT state. The triazole complex also shows are increase sensitivity to O2. The 
novel luminescent osmium(II) triazole-based complex [Os(btzpy)2]
2+ was shown to exhibit 
significant quenching of luminescence intensity in aerated acetonitrile solution compared to 
degassed solution and has a high quantum yield for singlet oxygen sensitization as its chloride 
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salt, indicating potential applications in photodynamic therapy. The complex was also 
investigated in cancer cells by luminescence imaging microscopy. The results from these 
studies reveal that the complex is successfully taken up by two cancer cell lines with a high 
degree of mitochondrial localization and low dark toxicity. Inclusion of the triazole donor leads 
to increase in the quantum yield of emission, lifetime, sensitivity to oxygen and cellular uptake. 
Utilization the Cu(I)-catalysed-cycloaddition (the CuAAC reaction) coupling to synthesise the 
triazole based ligands opens up various ways to prepare many kinds of transition metal 
complexes which can use in specific application based on photochemical, electrochemical and 
photophysical properties of these complexes. The triazole based complex described in this 
chapter gives a good example of the complexes that can be worked on for development in order 
to improve the photophysical properties to get the preferable complex which can be used as 
luminescence imaging/singlet oxygen sensitisation photodynamic theranostic complex. I 
would like to thank Luke K. McKenzie, Dr Helen E. Bryant, and Professor Julia A. Weinstein 
from the University of Sheffield. 
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5.1 Introduction  
 
The design and synthesis of metallosupramolcular and multicomponent molecular systems 
have attracted a great deal of recent attention, largely due to their potential as the basis of novel 
functional materials. The synthesis of metallosupramolcular materials has depended on the 
preparation of bridging ligands with multiple coordination sites into which can then be 
integrated into metal centers. In recent years a lot of bridging ligands have been used, especially 
those containing pyridine-type coordinating units which are either directly connected or 
separated by a set of spacers. Rigid spacers are much preferred than non-rigid bridging ligands 
for energy and electron transfer applications, as the geometry (metal-to-metal distance) of the 
system is better defined. However, while scientists have an abundance of diverse of bridging 
ligands available to use in the metallosupramolecular field, either a large number of those 
ligands are expensive and time-consuming in their preparation via many steps, or under specific 
conditions and some of them to produced bridging ligands in limits that allow minimal 
incorporation of interesting functional groups.157 Fundamentally, it is advantageous to have 
new methodologies to prepare bridging ligands, which are high yielding, easy, and versatile. 
Also to be able to use preformed components, coupling them together under moderate reaction 
conditions in as few steps as possible. Such processes would require a coupling reaction that is 
highly efficient and high yielding, for this, functional groups are required which can be easily 
inserted into the periphery of the metal complex components. Cu(I)-catalysed-cycloaddition 
(the CuAAC reaction) possesses the immense ability for this case because it has moderate 
reaction conditions. A few reports have appeared on the CuAAC modification of transition 
metal complexes as bridging ligands multiple coordination sites. A number of groups are 
reported “click” ligands158-160 in the formation of coordination polymers. Generally, triazole 
ligands act as donors in ligand exchange reactions, just like imidazole and pyridine-based 
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ligands. The metal complexes developed through triazole ligand systems have unique 
photophysical properties, which attracts attention in coordination chemistry, as does their 
analogues (bpy and tpy).137, 236 There are several synthetic strategies available for the 
development of triazole complexes which use triazole as bridging ligand to allow for the study 
of specific photochemical, electrochemical and photophysical properties.237, 238 When 
synthesizing dinuclear compounds, transition metal complexes (for example, ruthenium, 
osmium, and iridium) can be used as building blocks where triazole ligands act as bridges. The 
synthesis of dinuclear transition metal complexes have been demonstrated with ease, but the 
product exhibit weak metal-to-ligand interaction, which makes it difficult to study the intrinsic 
properties of both the metal and the ligand in the complex, but strong enough to allow for the 
study of the overall characteristics of the complex.83, 239-241 However, a triazole linker can be 
used to develop di- and trinuclear complexes and organometallic complexes. Crowley and co-
workers used 1, 4-bis-({4-(pyrid-2-yl)-1, 2, 3-triazol-1-yl}methyl) benzene as bridging ligand 
in Co242 and Fe metal complex systems. The cobalt complex was tested for antimicrobial 
activity while the iron complex was tested for it’s the antifungal activity. Both complexes were 
not active against either strain of bacteria for cobalt complex and no antifungal activity against 
the yeast for the iron complex. They suggest that a high charge of the [Co2(Lpytrz)3]
6+ cylinders 
prevented them from crossing the bacterial cell membranes, rendering the compounds 
biologically inactive. Also, the poor stability of the “click” complexes in the presence of 
DMSO and the amino acid histidine found in the biological test media caused decomposition 
of the Fe(II) “click complex in the yeast S. cerevisiae media. The same group applied 1, 4-bis-
({4-(pyrid-2-yl)-1, 2, 3-triazol-1-yl}methyl) benzene ligand to synthesis ruthenium(II)  helicate 
complex.243  Compared to similar iron complexes, the more kinetically inert ruthenium(II) 
system proved stable when exposed to DMSO solution of the common biological ligand 
histidine. The ruthenium(II)  helicate complex was tested for antimicrobial activity in vitro 
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against both Gram negative (Escherichia coli) and Gram positive (Staphylococcus aureus) 
microorganisms. The Ru(II) helicate complex revealed antimicrobial activity but the minimum 
inhibitory concentrations. This chapter presents complexes using the bis-({4-(pyrid-2-yl)-1, 2, 
3-triazol-1-yl}methyl)benzene as the bridging ligand in metal complexes of Os, Ru, and Ir. and 
later characterize their photophysical as well as chemical properties. 
 
5.2 Synthesis and characterisation 
 
5.2.1 Synthesis of 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-yl methyl}benzene = L4 
The ligand 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-yl methyl}benzene (L4) was prepared in a 
two step/one-pot synthesis, starting from the corresponding halide and acetylene starting 
materials. The azide was prepared in situ from its corresponding bis(bromomethyl) substituted 
benzene analogue by nucleophilic substitution with a slight excess of NaN3 in DMSO at room 
temperature for 2 hours. Upon completion of the substitution reaction, two equivelnts of 2-
ethynylpyridine was added to the reaction vessel along with catalytic quantity of CuSO4 and 
excess sodium ascorbate along with an equivalent of 2,6-lutidine per acetylene. The compound 
L4 was purified by re-crystallisation from dichloromethane and hexane and isolated in good 
yields.  
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Scheme 5-1 One-pot synthesis of ligand 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-ylmethyl}benzene = L4 
 
Ditopic ligand L4 was fully characterised by 1H and 13C NMR spectroscopy. The symmetrical 
nature of the bis-triazole ligand results in a simple set of resonances in the 1H NMR spectrum. 
A characteristic singlet resonance arising from the triazole protons TRZ (Figures 5.1, 5.2) is 
observed at δ 8.66, and is clearly distinguishable as with other triazole signals as there is no 
coupling to any other protons evident in the COSY spectrum.  
 
Figure 5-1 - Number of protons of triazole Ligand 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-ylmethyl}benzene = L4 
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Figure 5-2 1H NMR (400MHz) spectrum of free ligand L4 in d6 DMSO 
 
This signal shows nOe interactions in its two dimensional NOESY correlation spectra with the 
methylene protons of the benzyl substituent (1) which appears as a singlet resonance at δ 5.66. 
From the COSY spectrum the proton next to N in pyridyl ring (6) is the most down field which 
appears as a doublet resonances at δ 8.57. This proton displays COSY correlation with the 
signal which appears at δ 7.32 (5). Proton 5 also displays strong COSY correlations with the 
signals appearing at δ 7.76 (4) and (6) also displays weak COSY correlation with (4) due to 
long range coupling with (4). Pyridyl ring signal appears as a doublet resonances at δ 8.10 (3). 
The L4 regio chemistry confirmed by two dimensional NOESY correlation spectra which show 
nOe interactions between the triazole protons (trz) and protons 1 and 3.  This confirms the 1,4-
disubstitution regio chemistry of the triazole rings in the product. All the spacer phenyl protons 
(2) appear as singlet resonance at δ 7.39 (Figure 5.3)  
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Figure 5-3 2D H-H COSY NMR spectrum of free ligand 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-ylmethyl}benzene = L4 
 In d6 DMSO 
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5.2.2 Synthesis and Characterisation of Dinuclear complexes  
5.2.2.1 Synthesis and Characterisation of Dinuclear Iridium Complexes 
 
 Iridium complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 were prepared by 
refluxing two equivalents of L4 (to prepare [Ir(ppy)2-L4-](PF6)), (Scheme 5-2) or one  
equivalent of L4 (to prepare [Ir(ppy)2-L4-Ir(ppy)2](PF6)2), (Scheme 5-3) with one equivalent 
of [{Ir(ppy)2Cl}2] and NaPF6 in mixture of methanol and chloroform under nitrogen for 24 hr. 
Because of the poor solubility of 1,4-bis-{4-(pyrid-2-yl)-1,2,3-triazol-1-ylmethyl}benzene in 
acetonitrile, the crude product was redissolved in acetonitrile kept in fridge for 24 hr and 
filtered to remove unwanted ligand. The solvent was then removed after filtration and the 
complex recrystallised from dichloromethane and hexane. 
 
Scheme 5-2 - Synthesis of [Ir(ppy)2-L4](PF6) 
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Scheme 5-3 -Synthesis of [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 
 
Both complexes were fully characterised by 1H and 13C NMR spectroscopy. Due to the 
symmetry of the L4 ligand in [Ir(ppy)2-L4-Ir(ppy)2](PF6) complex, two diasteroisomers pairs  
are possible to produced: the ΔΔ /ΛΛ and ΔΛ / ΛΔ. For the ΔΔ and ΛΛ isomers, the triazole 
rings protons are equivalent, showing one peak in1H NMR spectrum, while they show two 
peaks in ΔΛ isomer, due to the triazoles being magnetically inequivalent. Three singlet 
resonances are expected to be observed from the 1H NMR spectrum corresponding to the 
triazole protons from three isomers, however, it is likely the difference in chemical shift is 
small meaning that some of the resonances overlap, for this reason the 1H NMR spectrum is 
complicated. The 1H NMR spectrum (Figure 5-4) of the product shows two singlet resonances 
at δ 8.66 and δ 8.65  for the triazole ring protons which are shifted by 0.11 ppm relative to the 
corresponding resonance for the free ligand (δ 8.55). For [Ir(ppy)2-L4](PF6) the triazole rings 
protons show two singlets, one  at  δ 8.64 which is corresponds to the coordinated side and 
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second at δ 8.54 which is corresponds to the free side. The methylene protons appear as a 
singlet at δ 5.59 for all 4 protons for [Ir(ppy)2-L4-Ir(ppy)2](PF6)2, while the same protons show 
two doublets at δ 5.60 and δ 5.57 for [Ir(ppy)2-L4](PF6). The ESI mass spectrum of the 
[Ir(ppy)2-L4](PF6) complex shows a peak at m/z = 895.25890 assignable to the species 
[M]+,while the ESI mass spectrum of the [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 complex shows a peak 
at m/z = 698.17640 assignable to the species M2+.  
 
Figure 5-4 The 1H-NMR spectra (400 MHz, CD3CN) for L4 free ligand and [Ir(ppy)2-L4]+, [Ir(ppy)2-L4-Ir(ppy)2]2+ 
complexes 
 
5.2.2.2 Synthesis and Characterisation of Dinuclear Ruthenium complexes 
 
Ruthenium complexes [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 were prepared 
by heating at reflux, [Ru(bpy)2Cl2] with one equivalent of L4 to prepare [Ru(bpy)2-L4](PF6)2 
(Scheme 5-4) or half an equivalent of L4 to prepare [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 (Scheme 5-
5) in ethanol in the dark under nitrogen for 24 hr. The complexes were isolated as their 
hexafluorophosphate salts.  
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Scheme 5-4 - Synthesis of [Ru(bpy)2-L4](PF6)2 
 
 
Scheme 5-5 Synthesis of [Ru(bpy)2-L4- Ru(bpy)2](PF6)4 
 
Both complexes were fully characterised by 1H and 13C NMR spectroscopy. Two 
diasteroisomer pairs are prducsed (ΔΔ/ ΛΛ and ΔΛ/ ΛΔ). Due to the symmetry of the L4 ligand 
in [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 complex, three singlet resonances are expected to be 
observed from the 1H NMR spectrum corresponding to the triazole protons from three isomers, 
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however, it is likely the difference in chemical shift is small meaning that some of the 
resonances overlap and the 1H NMR spectrum is complicated.  The 1H NMR spectrum (Figure 
5-5) of the product shows two singlet resonances at δ 8.69 and δ 8.68  for the triazole rings 
protons which are shifted by 0.14 ppm relative to the corresponding resonance for the free 
ligand (δ 8.55). For [Ru(bpy)2-L4](PF6)2  the triazole rings protons show two singlets, first one 
at  δ 8.63 which is corresponds to the coordinated side and second one at δ 8.56 ppm which is 
corresponded to the free side. Even methylene protons show singlet at δ 5.53 for all 4 protons 
in [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 complex, while the same protons show one singlet at δ 5.62 
and one doublet at  δ 5.51 for [Ru(bpy)2-L4](PF6)2. Relative to the corresponding resonances 
for the free ligand we can see the appearance of bpy protons in both complexes in ranges of δ 
7.79–7.55 and δ 8.49–8.34. The ESI mass spectrum of the [Ru(bpy)2-L4](PF6)2 complex shows 
a peak at m/z = 404.10300 assignable to the species M2+,while the ESI mass spectrum of the 
[Ru(bpy)2-L4-Ru(bpy)2](PF6)4 complex shows a peak at m/z = 305.56216 assignable to the 
species M4+.  
 
Figure 5-5 The 1H-NMR spectra (400 MHz, CD3CN) for L4 free ligand and [Ru(bpy)2-L4]2+, [Ru(bpy)2-L4-
Ru(bpy)2]4+complexes 
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5.2.2.3 Synthesis and Characterisation of HetroDinuclear Iridium-Ruthenium complex 
 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 was prepared by reacting [{Ir(ppy)2Cl}2] with two equivalents 
[Ru(bpy)2-L4]
2+ and NaPF6 in of mixture of methanol and chloroform under nitrogen for 24 hr 
in dark. The orange precipitate was collected by filtration. The complex was isolated as the 
hexafluorophosphate salt (Scheme 5-6). 
 
Scheme 5-6- Synthesis of [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 
 
The complex was fully characterised by 1H and 13C NMR spectroscopy. Due to the asymmetry 
of the [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 complex, the 
1H NMR spectrum of the product shows one 
singlet at δ 8.69 and another one  at δ 8.52 for the triazole rings protons. The methylene protons 
show two resonances at δ 5.61 and δ 5.54. The ESI mass spectrum of the complex shows a 
peak at m/z = 436.43335 assignable to the species M3+. 
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5.2.2.4 Synthesis and Characterisation of Dinuclear osmium complexes 
 
Osmium dinuclear complexes [{Os(bpy)2}2L4](PF6)4 and [{Os(Bn-pytz)2}2L4](PF6)4 were 
prepared by reaction of L4  with two equivalents of Os(bpy)2Cl2 for [{Os(bpy)2}2L4]
4+ 
(Scheme 5-7) or [Os(Bn-pytz)2Cl2] for [{Os(Bn-pytz)2}2L4]
4+ (Scheme 5-8) and AgPF6 in 
ethylene glycol under refluxing conditions under nitrogen for 24 hr. The resulting solution was 
allowed to cool to room temperature and the precipitate was separated by vacuum filtration and 
washed with cold water and diethyl ether. The mixture then redissolved in acetonitrile and kept 
in fridge for 24 hrs, filtered through celite to remove AgCl. The product was then 
recrystallization from dichloromethane and hexane. 
 
Scheme 5-7 -Synthesis of [Os(bpy)2-L4- Os(bpy)2](PF6)4 
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Scheme 5-8 Synthesis of [Os(Bn-pytz)2- L4- Os(Bn-pytz)2](PF6)4 
 
Both complexes were fully characterised by 1H and 13C NMR spectroscopy. Due to the 
symmetry of the L4 ligand in both complexs, the 1H NMR spectrum for [Os(bpy)2-L4-
Os(bpy)2](PF6)4  shows two singlet resonances,one at δ 8.65 and a second  at δ 8.64 for the 
triazole rings protons. For [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4, There are possibility to 
produce fac or mer- like isomers for each side of the complex, for the mer isomer the complex 
is produced as a mixture of three isomers, fac / fac, fac / mer and mer / mer dependent on the 
respective regiochemistry of the pyridyl and triazole moieties respectivly of the two Bn-pytz 
ligands. Two diasteroisomeric combination of each are also possible (ΔΔ/ ΛΛ/ and ΔΛ/ ΛΔ) 
which lead to large number of isomers. The 1H NMR spectrum is complicated for this reason. 
The triazole rings protons show one multiplet at range of δ 8.64- 8.55 which is corresponded 
to the all six protons. The methylene protons show one doublet at δ 5.60 for [Os(bpy)2 -L4-
Os(bpy)2](PF6)4 complex and one multiplet at range of δ 5.54- 5.47 for [Os(Bn-pytz)2-L4-
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Os(Bn-pytz)2](PF6)4 complex, (Figure 5-6). The ESI mass spectrum of the [Os(bpy)2 -L4- 
Os(bpy)2](PF6)4  complex shows a peak at m/z = 350.0953 assignable to the species M
4+
, while 
the ESI mass spectrum of the for [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 complex shows a peak 
at m/z = 430.1275 assignable to the species M4+.  
 
Figure 5-6 The 1H-NMR spectra (400 MHz, CD3CN) for L4 free ligand and [Os(bpy)2-L4-Os(bpy)2]4+ , [Os(Bn-pytz)2- L4- 
Os(Bn-pytz)2]4+ complexes 
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5.3 Electrochemical Properties of Complexes  
 
Electrochemical data for the various complexes as obtained by cyclic voltammetry are 
summarized in Table 5.1. 
Table 5-1: Electrochemical data for the complexes in CH3CN, 0.2 M [NBu4] [PF6], 100 mVs
-
1, at room temperature 
Complex Reduction E1/2 V vs. Fc/Fc+ 
Oxidation Epa V vs. 
Fc/Fc+ 
[Ir(ppy)2-L4](PF6) -2.18 0.94 
[Ir(ppy)2-L4-Ir(ppy)2](PF6)2 -2.16 0.93 
[Ru(bpy)2-L4](PF6)2 -1.978(0.084)
a,-1.767(0.061)a 0.9(0.07)a 
[Ru(bpy)2-L4- Ru(bpy)2](PF6)4 -1.94(0.085)
a, -1.76(0.08)a 0.92(0.09)a 
[Ru(bpy)2-L4 -Ir(ppy)2](PF6)3 -2.17, -1.96(0.07)
a, 1.76(0.06)a  0.94 
[Os(bpy)2-L4-Os(bpy)2](PF6)4 -1.9(0.09)a, -1.7(0.08)
a 0.44(0.073)a 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 ============
b 0.458(0.078)a 
E1/2= (Epa+ Epc)/ 2, Epc are anodic and cathodic peak potentials respectively. a = reversible.b = reduction coples are outside 
the available electrochemical window. 
 
Figure 5.7 shows the Cyclic voltammagram of complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2 in acetonitrile. For iridium complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2 the observed couples were irreversible for [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 and 
quasi-reversible for [Ir(ppy)2-L4](PF6). Oxidation process for the two complexes gave the 
Ir3+/4+ metal-based redox processes with an E1/2 = + 0.94V for [Ir(ppy)2-L4](PF6)  and + 0.93 
V for [Ir(ppy)2-L4-Ir(ppy)2](PF6)2. The complex [Ir(ppy)2-L4](PF6) gave irreversible one 
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electron ppy ligand based reduction process, at −2.17 V (ppy0/1−), and [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2 gave one electron ppy ligand based reduction process, at −2.16 (ppy0/1−).  
 
Figure 5-7 Cyclic voltammogram of iridium complexes in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1. Potentials 
are reported against ferrocene (Fc/Fc + = 0.0 V) 
 
For the ruthenium(II) complexes [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4. The 
observed couples were all reversible (Figure 5.8). Oxidation process for the two complexes 
gave Ru3+/2+ metal-based redox couples with an E1/2 = + 0.90 V for [Ru(bpy)2-L4](PF6)2 and + 
0.92 V for [Ru(bpy)2-L4-Ru(bpy)2](PF6)4. The complex [Ru(bpy)2-L4](PF6)2  gave two one 
electron bipyridine ligand based reduction processes, with E1/2 values of −1.77 (bpy0/1−), and 
−1.98 (bpy1−/2−). [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 appeared to give two simultaneous one 
electron bipyridine ligand based reduction processes, on both sides with E1/2 values of −1.76 
(bpy0/1−), and −1.94 (bpy1−/2−). From the Figure, due to the reduction occur in the same potential 
as [Ru(bpy)2-L4](PF6)2, complex [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 gave two simultaneous one 
electron reductions which mean that the electronic communication through the bridge ligand 
is poor. 
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Figure 5-8- Cyclic voltammogram of ruthenium complexes in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1 . 
Potentials V are reported against ferrocene (Fc/Fc + = 0.0 V) 
 
 
Figure 5.9 shows the cyclic voltammagram of complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 in  
acetonitrile. A cyclic voltammogram of complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 gave the metal-
based redox processes with an E1/2 = +0.94 which was assigned to a Ir
3+/4+ pattern due to 
similarity to[Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-Ir(ppy)2](PF6)4 cyclic voltammograms. The 
complex gave two electron ligand based reduction processes, with E1/2 values of −1.76 V 
(bpy0/1−), and −1.96 V (bpy1−/2−). 
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Figure 5-9- Cyclic voltammogram of ruthenium- iridium complex in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1 . 
Potentials V are reported against ferrocene (Fc/Fc + = 0.0 V) 
 
Figure 5.10 shows the cyclic voltammagram of complexes [Os(bpy)2-L4-Os(bpy)2](PF6)4  and 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 in acetonitrile. For osmium complexes [Os(bpy)2-L4-
Os(bpy)2](PF6)4 and [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 the observed couples were all 
reversible. A cyclic voltammogram for each complex gave the Os3+/2+ metal-based redox 
processes with an E1/2 = +0.44 V for [Os(bpy)2-L4-Os(bpy)2](PF6)4 and +0.458 V for [Os(Bn-
pytz)2-L4-Os(Bn-pytz)2](PF6)4. The complex [Os(bpy)2-L4-Os(bpy)2](PF6)4  gave two one 
electron bipyridine ligand based reduction processes, with E1/2 values of −1.7 V (bpy0/1−), and 
−1.9 V (bpy1−/2−). Replacing Bn-pytz with bpy ligand caused the changing in reduction values 
to more negative values such that the ligand reduction process cannot be seen in the available 
electrochemical window for [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4. 
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Figure 5-10- Cyclic voltammogram of osmium complexes in CH3CN /0.2 M NBu4PF6; scan rate (v) = 100 mV s −1. 
Potentials V are reported against ferrocene (Fc/Fc + = 0.0 V) 
 
The cyclic voltammograms for the dinuclear complexes where the complexes are coordinated 
in both domains again shows a similar shape, with only 1 oxidation peak potential and typically 
reduction peaks potential of the bidentate donor ligand complexes.120, 121, 244 This indicates that 
both of the complex centres present are oxidised and reduced simultaneously and do not form 
an intermediate mixed valence species. It was hoped that two redox waves would be observed, 
indicative of the formation of a mixed valence in [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4, 
[Os(bpy)2-L4-Os(bpy)2](PF6)4 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4  complexes as an 
intermediate for which near infrared intervalence charge transfer transition might have been  
expected. Generaly no or at least very little communication between the two metal centers is 
observed electrochemically. This behaviour may be useful in the applications where the two 
chromophores are required to act independently. 
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5.4 Photophysical studies 
 
Table 5.2 summarizes the UV-vis electronic absorption data for the all complexes. 
Table 5-2: UV-vis Absorption data, for the complexes in aerated acetonitrile 
Compound λ / nm(ε/mol-1dm3cm-1) 
[Ir(ppy)2-L4](PF6) 249(42045), 268(31815), 272(32205), 287(20920), 314(9317), 
379(3215), 411(1995) 
[Ir(ppy)2-L4-Ir(ppy)2](PF6)2 252(84730), 268(73230), 380(8325), 411(5255) 
[Ru(bpy)2-L4](PF6)2 241(2850), 276(37850), 289(41550), 345(4348), 369(4502), 
408(6150), 441(6430) 
[Ru(bpy)2-L4-Ru(bpy)2](PF6)4 242(27575), 253(22179), 276(50932), 289(56882), 345(6217), 
371(6592), 411(9373), 440(9601) 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 250(83428), 268( 84235), 273(88342), 288(86725), 372(12337), 
408(13158), 445(9915) 
[Os(bpy)2-L4-Os(bpy)2](PF6)4 
240(72385), 278(123185), 289(143355), 326(21755), 
362(23755),  385(26250), 425(23535), 466(25610), 559(6140) 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 
236(47150), 276(67280), 307(10390), 374(15005), 392(14000), 
406(13460), 484(4625), 525(3820) 
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The UV-vis absorption spectrum of the iridium complexes [Ir(ppy)2-L4](PF6) and  [Ir(ppy)2-
L4-Ir(ppy)2](PF6)2 were recorded and show absorption features similar to those reported for 
other Ir(ppy)2 containing complexes
121 with typical strong π→π*  transitions in the UV region 
localized on the ppy and the bridging ligands at approximately 250 - 268 nm and weaker metal-
to-ligand charge transfer bands 1MLCT (d π → π* ) at lower energies between 350 and 430 nm 
(Figure 5.11). From the figure it can be seen that the absorbance for the dinuclear [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2  complex is about twice that for [Ir(ppy)2-L4](PF6) as would be expected due to 
the presence of two Ir-based chromophores in the complex. The UV-vis absorption spectrum 
of the iridium complexes [Ir(ppy)2-L4](PF6) and  [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 are also in 
agreement with the UV-vis absorption data for complex [Ir(ppy)2(pytz)]
+.111 
 
Figure 5-11 UV-vis absorption spectra of iridium complexes in acetonitrile 
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For ruthenium complexes [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 in 
acetonitrile, the dominant absorption bands in the lower wavelength region at 240-285 nm 
assigned as intraligand π → π* transitions. The low energy broad bands in the near UV region 
approximately 340-450 nm are attributed to 1MLCT (d → π*) transitions. UV-visible 
absorption spectra of the complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 shows absorption features in 
the lower region at 240-285 nm assigned as intraligand π → π*  transitions. The low energy 
broad bands in the near UV region approximately 370-450 nm are attributed to the metal to 
ligand charge transfer 1MLCT (d → π*) transitions. Due to the presence of ruthenium in the the 
MLCT band of complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3, absorbance is further into red when 
compared to those of the iridium complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2, as well as, the difference in the ligands which containing (ppy and bpy) led to 
the appearance of two intense bands in the UV region 250 -290 localized on the both ligands 
ppy and bpy. It is easy to note from the UV-vis absorption spectrum (Figure 5.12) that the 
intensity of bands are stronger in the complexes which contains two metal centers [Ir(ppy)2-
L4-Ir(ppy)2](PF6)2 for iridium complexes, [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 for ruthenium 
complexes comparing with the complexes which contains one metal center [Ir(ppy)2-L4](PF6) 
for iridium complexes, and [Ru(bpy)2-L4](PF6)2 for ruthenium complexes. Comparing data in 
Table 1 and Figures 5.11 with Figure 5.12 it can be noted that the complex [Ru(bpy)2-L4-
Ir(ppy)2](PF6)3 has two intense bands in the UV region 268 -289 nm which are assigned to 
intraligand (IL) π → π* transitions localized on ppy ligand  for 268 nm  and localized on bpy 
for 289 nm, and weaker metal-to-ligand charge transfer bands between 350 nm and 400 nm 
which are assigned to Ir 1MLCT (dπ → π* ) and the the intensity of bands between 370 nm and 
450 nm which are assigned to Ru 1MLCT (dπ → π* ). The UV-vis absorption spectrum of 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 is approxmintely the sum of those for [Ir(ppy)2-L4](PF6) and 
[Ru(bpy)2-L4](PF6)2. (Figure 5.12). 
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Figure 5-12 - UV-vis absorption spectra of ruthenium complexes and Iridium- Ruthenium complex in acetonitrile 
 
The UV-vis absorption spectrum of osmium complexes [Os(bpy)2-L4-Os(bpy)2](PF6)4 and 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 were also recorded in acetonitrile (Figure 5.13). 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 exhibits two intense bands. The first (276 nm), is 
ascribed to the pytz and L4 ligands-centered 1LC π → π*   transitions. The complex exhibits 
second intense absorption band in the visible region between 366- 410 nm assignable to the 
1MLCT (d → π* ) transitions, from the Os metal center to π* pytz (both bridging and exial 
ligands), and a broad and weak band at 530 nm. This weaker and lower energy band is assigned 
to direct spin-forbidden 3MLCT transitions. [Os(bpy)2-L4-Os(bpy)2](PF6)4, has intense on 
band at (289 nm) with a shoulder at 278 nm. From Figure 5.13 it can be seen that the intense 
bands in the UV region in [Os(bpy)2-L4-Os(bpy)2](PF6)4 289 nm localized on the bpy ligands, 
assigned as intraligand π → π* transitions, which are appeared in the Ru complexes,245 while 
the shoulder at 278 nm is assigned as intraligand π → π* transitions localized on the pytz from 
the bridging ligand. [Os(bpy)2-L4-Os(bpy)2](PF6)4, also has a second intense absorption band 
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in the visible region between 370- 410 nm assignable to the 1MLCT (d → π*) transitions, from 
Os metal center to π* of L4. This band extends to 475 nm. Compared to [Os(Bn-pytz)2-L4-
Os(Bn-pytz)2](PF6)4, assignable to the 
1MLCT (d → π* ) transitions, from Os metal center to 
bpy π*. The UV-vis absorption spectrum of [Os(bpy)2-L4-Os(bpy)2](PF6)4 has a broad and 
weak band at 650 nm, which is assigned to direct spin-forbidden 3MLCT transitions.  For both 
complexes, the spin forbidden 3MLCT band is reasonably intense because of the large spin-
orbital coupling that results from the heavy osmium atom.  
 
Figure 5-13 - UV-vis absorption spectra of osmium complexes in acetonitrile 
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Complexes [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4, exhibit a broad 
featureless emission bands at room temperature in acetonitrile, which we assigned to emission 
from 3MLCT states (Figure 5.14). In the room temperature spectra, both complexes exhibit 
emission bands in the orange region of the spectrum (λ max = 615 nm, Table 2). Compared with 
[Ru(bpy)2(bn-pytz)]
2+ which  was found to be very weakly emissive in CH2Cl2 at room 
tempreture  (quantum yield = 0.001),246[Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-
Ru(bpy)2](PF6)4 approximately exhibit the same emission bands with small quantum yield, 
which are  0.068 and 0.066 respectively. 
 
Figure 5-14 Room-temperature emission of complexes [Ru(bpy)2-L4](PF6)2, [Ru(bpy)2-L4-Ru(bpy)2](PF6)4, in aerated 
acetonitrile 
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The complex [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 exhibits an emission band in the orange 
region of the spectrum (λ max = 615 nm, Table 2 and Figure 5-15). These emission bands are in 
very similar position to those of [Os(Bn-pytz)3](PF6)2 (Chapter 3). Due to the much higher 
energy of the pytz π* orbitals compared to bpy,   the emission of [Os(Bn-pytz)2-L4-Os(Bn-
pytz)2](PF6)4 is significantly blue-shifted relative to that of [Os(bpy)2-L4-Os(bpy)2](PF6)4  
which emits in the deep red/near IR (λmax = 730 nm) and has similar emission properties to 
those of [Os(bpy)2(Bn-pytz)](PF6)2. 
 
Figure 5-15 Room-temperature emission of complexes [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4, [Os(bpy)2-L4-
Os(bpy)2](PF6)4 , in aerated acetonitrile 
 
Comparing the complexes which are reported here and related bidentate complexes  [Os(bpy)2 
-L4- Os(bpy)2](PF6)4 to [Os(bpy)3]
2+
,
228[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 to [Os(Bn-
pytz)3]
2+ (Chapter 3), and  [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 to 
[Ru(bpy)2(Bn-pytz)]
2+ [Ru(bpy)3]
2+
,
247
 it is noted that there is no a significant difference in 
emission properties. This means that the ligand 1,4-bis-{4-(pyridi-2-yl)-1,2,3-triazol-1-
yl}methylbenzene as bridging ligand has a negligable electronic effect on the MLCT 
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energy.This is confermed by electrochemistry investigation where the  oxidation and reduction 
are in the same region for both compleces. The emission spectra of the iridium complexes 
[Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 were also recorded in acetonitrile. The 
compounds display structured emission bands, often indicative of the presence of a large 
amount of ligand-centred character in the emissive excited states. These are indeed a mixture 
of 3MLCT and 3ILCT character with similar vibrational features to those reported for other 
[Ir(ppy)2]
+/0
 based complexes (λ max = 474, 503 nm).105 There is no a significant difference or 
change in emission when comparing the complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-
Ir(ppy)2](PF6)2 to [Ir(ppy)2(bn-pytz)]
2+
.
121 The heterodinuclear complex [Ru(bpy)2-L4-
Ir(ppy)2](PF6)3  shows emission features similar to those observed in the  spectra for both 
[Ru(bpy)2-L4](PF6)2 and [Ir(ppy)2-L4](PF6) (λ max = 474, 503 and 615 nm) and this shows 
dual emission. Figure 5-16. While the quantum yield of [Ir(ppy)2(pytz)]
+ is 21%144 and < 0. 1% 
for [Ru(bpy)2(pytz)]
2+,246 the quantum yield of [Ru(bpy)2-L4-Ir(ppy)2]
3+ is 0.33 % . What is 
noteworthy is that emission for iridium and ruthenium based chromophors in the complex are 
observed to be of  the similar intensity which indicates that the quantum yield of the Ir 
chromophore in  [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 is a lot less than the quantum yield for 
[Ir(ppy)2(pytz)]
+. It therefore appears that partial photo induced energy transfer from the Ir 
chromophore to the Ru chromophore occurs, which means that Ir is partially sensitising 
emission from the Ru chromophore. 
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Figure 5-16 Room-temperature emission of complexes [Ir(ppy)2-L4](PF6), [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 and  [Ru(bpy)2-L4-
Ir(ppy)2](PF6)3 in aerated acetonitrile 
 
The potential of energy transfer across the bridging ligand results in broadened emission and 
hence open up the possibility of making white light emitters. Commission Internationale De 
L'Eclairage (CIE) 1931 chromaticity coordinates were determined to establish  the perceived 
colour of the complexes [Ir(ppy)2-L4-Ir(ppy)2](PF6)2, [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 and 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 using photoluminescence spectral data in acetonitrile at room 
temperature. The calculated values of x and y are displayed in Table 5.3. From the (CIE) 
diagram (Figure 5.17) we can see that there is a straight line through color coordnate of the 
three complexes as would be expected if the emission spectrum of the hetero dinuclear complex 
was essentially a linear combination of contribution for the Ir and Ru chromophores. The 
coordinates for heteronuclear complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 appears in yellow/white.  
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Figure 5-17 Color space chromaticity CIE diagram of the complexes[Ir(ppy)2-L4 - Ir(ppy)2] (PF6)2,[Ru(bpy)2-L4- Ru(bpy)2] 
(PF6)4 and [Ru(bpy)2-L4 - Ir(ppy)2](PF6)3 
 
Table 5-3: The calculated values of x and y for complexes [Ir(ppy)2-L4-Ir(ppy)2](PF6)2, 
[Ru(bpy)2-L4-Ru(bpy)2](PF6)4 and [Ru(bpy)2-L4-Ir(ppy)2](PF6)3. 
complex X Y Colour 
[Ir(ppy)2-L4-Ir(ppy)2](PF6)2 0.206 0.458 Turquoise 
[Ru(bpy)2-L4-Ru(bpy)2](PF6)4 0.608 0.391 Orange 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 0.410 0.430 Yellow/white 
 
Chapter 5: Dinuclear supramolecular complexes using triazole based bridging ligand 
187 
 
The emission spectra of the complexes were also recorded at 77 K in rigid (4:1 EtOH/MeOH 
glass matrix). From Figures 5.18 – 5-21 it can be seen that on lowering the temperature to 77 
K, the emission undergoes a rigdochromic blue-shift of between 30-40 nm for all complexes. 
For all complexes such behaviour is again typical for metal-to-ligand charge transfer (MLCT) 
emissions, at 77 K. Also we can note that all complexes show vibronic progressions in emission 
spectra which are typical of mononuclear analogues already known109 (Chapter 3). The 
photophysical data are summarized in Table 5.4. 
Table 5-4: Photoluminescence data and lifetime for the complexes in aerated acetonitrile at 
room temperature and 77 K (4:1 EtOH/MeOH glass matrix 
Compound At room temperature At 77 k 
 λ max( nm Ʈ ns λ max (nm) 
[Ir(ppy)2-L4](PF6) 475, 503 63 468,503 
[Ir(ppy)2-L4-Ir(ppy)2](PF6)2 475, 503 65 468, 503 
[Ru(bpy)2-L4](PF6)2 615 6(75%), 14(25%), 568 
[Ru(bpy)2-L4-Ru(bpy)2](PF6)4 615 7(75%), 16(25%) 568 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 
475, 506, 
615 
5(40%), 42(60%) 468, 503, 568 
[Os(bpy)2-L4-Os(bpy)2](PF6)4 732 49 700 
[Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 617 60 570 
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The emission spectra of the complexes [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 and [Os(bpy)2-
L4-Os(bpy)2](PF6)4 were recorded at 77 K in rigid (4:1 EtOH/MeOH glass matrix), Figure 5-
18. [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 complex exhibits emission features similar to those 
observed in [Os(bn-pytz)3]
2+ (Chapter 3) and [Os(btzpy)2]
2+ (Chapter 4) complexes, while 
[Os(bpy)2-L4-Os(bpy)2](PF6)4 complex displys the same features of the complex [Os(bpy)2(bn-
pytz)]2+ in the same conditions (Chapter 3). 
 
Figure 5-18 Emission spectra of the complexes [Os(bpy)2-L4-Os(bpy)2](PF6)4 and [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 in 
rigid matrix at 77 K. 
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The emission spectra in the low-temperature experiments become well-structured for the 
iridium complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-Ir(ppy)2](PF6)2.  Figure 5-19, the 
complexes have spectra that nearly overlap in peak position and relative peak intensities. As 
expected the complexes disply the same features of the complexes [Ir(ppy)2(bn-pytz)]
2+
.
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Figure 5-19 Emission spectra of the complexes [Ir(ppy)2-L4](PF6) and [Ir(ppy)2-L4-Ir(ppy)2](PF6)2 in rigid matrix at 77 K. 
 
 
Figure 5.20 shows the emission spectra of the [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-
Ru(bpy)2](PF6)4 complexes at 77 K in rigid 4:1 EtOH/MeOH glass matrices. Again comparing 
with the spectra at room temperature (Figure 5-14), the emission spectra in the low-temperature 
experiments become well-structured. The complexes have spectra that closely overlap in peak 
position and relative peak intensities. As expected the complexes disply the same features of 
the complexes [Ru(bpy)2(bn-pytz)]
2+.94 
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Figure 5-20 Emission spectra of the complexes [Ru(bpy)2-L4](PF6)2 and [Ru(bpy)2-L4-Ru(bpy)2](PF6)4 in rigid matrix at 77 K. 
 
 [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 at 77 K in rigid (4:1 EtOH/MeOH glass matrix Figure 5-21. 
shows emission features similar to those observed in the both  spectra for [Ru(bpy)2-L4](PF6)2 
and [Ir(ppy)2-L4](PF6)complexes in the same conditions (λ max = 468, 503 and 568 nm). 
Figure 5-22. There again appears to be partial energy transfer from the Ir chromophore to the 
Ru chromophore, which means again that the Ir is sensitising emission from the Ru 
chromophore. Here, however, the intensity of emission for the Ru centre is of slightly greater 
intensity than that for Ir.   
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Figure 5-21 Emission spectra of the complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 in rigid matrix at 77 K. 
 
 
Figure 5-22 Emission spectra of the complexes [Ir(ppy)2-L4](PF6), Ru(bpy)2-L4](PF6)2  and  [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 in 
rigid matrix at 77 K. 
 
 
 
 
Chapter 5: Dinuclear supramolecular complexes using triazole based bridging ligand 
192 
 
5.5 Conclusion  
 
In conclusion homodinuclear complexes [Ir(ppy)2-L4-Ir(ppy)2](PF6)2, [Ru(bpy)2-L4- 
Ru(bpy)2](PF6)4, [Os(bpy)2-L4-Os(bpy)2](PF6)4 and [Os(Bn-pytz)2-L4-Os(Bn-pytz)2](PF6)4 
and the heterodinuclear complex [Ru(bpy)2-L4-Ir(ppy)2](PF6)3 have been successfully 
prepared and characterised . From the photophysical and electrochemical studies it was shown 
that the dinuclear species exhibit additive luminescent intensities when compared to their 
mono-nuclear analogue complexes. There is little evidence of ground state communication 
between the metal centres across the triazole based bridging ligand. However, there appears to 
be some excited state energy transfer between Ir and Ru chromophores in the heterodinuclear 
complex. It becomes clear, therefore, that the auxiliary ligands coordinated to the metal center 
play a significant role in the photophysical properties of these complexes which mean 
photophysical properties of these complexes could be improved by controlling the auxiliary 
ligands coordinated to the metal center. For the reported complex [Ru(bpy)2-L4-
Ir(ppy)2](PF6)3, dual emission resulted in near white light emission; this might be achevible 
through modification of the Ir chromophore to blue shift the emission but also through 
modification of the bridging ligand in order to tune the rates of energy transfer between 
chromophore and thus the relative contribution from Ir and Ru chromophores in the overall 
emission. 
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6.1 General conclusion  
 
The original goal of the research presented in this thesis was to study the photophysics of 1,2,3-
triazole-based luminescent complexes and explore their potential applications, for example, in 
biological imaging. In the attempt to meet the criteria put forth above, research was directed 
toward complexes containing previously under-developed ligands containing 1,2,3-triazole 
moieties. This group of ligands was chosen in part for its ease of synthesis. The copper-
catalyzed azide-alkyne cycloaddition being one of the most versatile click reactions allows 
isolation of pure products simply through filtering or other simple extraction methods not 
requiring recrystallisation or chromatography.96 In this work, different types of 1,2,3-triazole 
ligands were synthesized including 2-(1-benzyl-1H-1,2,3-triazol-4-yl)pyridine as a bidentate 
ligand, 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine as a tridentate ligand and 1,4-bis((4-
(pyridin-2-yl)-1H-1,2,3-triazol-1-yl)methyl)benzene which was applied as a bridging ligand, 
Through this work it is demonstrated that the CuAAC reaction can be utilized as an excellent 
tool for the preparation of new chelating ligands incorporating either one or multiple binding 
sites starting from benzyl azide and reacting them with 2-ethynylpyridine. 
 This work began with an investigation of rhenium tricarbonyl complexes which shows that 
1,4- disubstituted-1,2,3-triazole ligands can act as bidentate N^N donor ligands. The blue-shift 
in electronic absorption and luminescence spectra of the resulting [Re(Bn-pytz)(CO)3Cl] 
compound indicated that Bn-pytz behaves like a bipyridine imitative with strongly electron-
donating substituents. Even though Bn-pytz ligand is a poor π-acceptor, EL emission was 
observed from [Re(Bn-pytz)(CO)3(py)]
+. Absorption and emission spectra are broad and 
featureless. The HOMO localized on (Re), while the LUMO localized on (N^N). These results 
indicate that changing the diimine ligand to 1,4- disubstituted-1,2,3-triazole effects the LUMO 
of complex, and MLCT energy. The effect of changing an axial ligand was found to be minimal 
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with respect to the absorption spectra and emission maxima. The [Re(Bn-pytz)(CO)3(py)]+  
complex was applied in LEEC devices. Even with poor stability, the performance of the LEEC 
based on [Re(Bn-pytz)(CO)3(py)](PF6) showed better performance than 
[Re(bpy)(CO)3(py)](PF6). 
1,4-disubstituted-1,2,3-triazole ligands were also applied as bidentate N^N donor ligands to 
prepare osmium(II) complexes. A series of heteroleptic osmium(II) triazole-containing 
complexes [Os(bpy)2(Bn-pytz)]
2+, [Os(bpy)(Bn-pytz)2]
2+ and homoleptic osmium(II) 
complexes [Os(bpy)3]
2+ and [Os(Bn-pytz)3]
2+ as their hexafluorophosphate and chloride salts 
were prepared and characterised. Successful separation of the two isomers of [Os(Bn-
pytz)3](PF6)2 was possible but only on a small scale. All the complexes display 
3MLCT 
emission in the orange to red region, blue-shifted as a result of replacing bpy with Bn-pytz. In 
the presence of oxygen, the complex [Os(Bn-pytz)3]
2+ was shown to exhibit significant 
quenching of luminescence intensity. The water soluble chloride salts were subjected to 
preliminary cellular uptake and luminescence imaging studies. [Os(Bn-pytz)3]
2+ is the only one 
of complexes  that goes into cells and localises at lysosomes, but no PDT activity is observed, 
despite having a high 1O2 quantum yield. 
Based on promising results with [Os(Bn-pytz)3]
2+, the 2,6-bis(1-phenyl-1,2,3-triazol-4-
yl)pyridine) ligand was used as a tridentate donor ligand to prepare the orange-emissive 
bis(tridentate) osmium(II) complex [Os(btzpy)2]
2+ as its hexafluorophosphate and chloride 
salts. The photophysical properties of these systems was investigated. The complexes are 
emissive at room temperature in air in the orange to red region of the visible spectrum. In the 
presence of oxygen, the novel luminescent osmium(II) triazole-based complex, [Os(btzpy)2]
2+ 
was shown to exhibit significant quenching of luminescence intensity and a high quantum yield 
for singlet oxygen sensitization as its chloride salt. The water soluble chloride form of the 
complex was subjected to preliminary cellular uptake and luminescence imaging microscopy 
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studies. The results from these studies showed [Os(Bn-pytz)3]
2+ complex is successfully taken 
up by two cancer cell lines with a high degree of mitochondrial localization and low dark 
toxicity.228 Complexes based on this type of ligand are good candidates for development of 
cellular imaging agents. 
The CuAAC reaction was used to prepare 1,4-bis-({4-(pyrid-2-yl)-1,2,3-triazol-1-yl}methyl) 
benzene as the bridging ligand in metal homodinuclear complexes of Os(II), Ru(II), and Ir(III) 
and a heterodinuclear Ir and Ru complex. Photophysical and electrochemical studies were 
carried out. The results of these studies showed that the dinuclear species exhibit greater 
luminescent intensities than mono-nuclear model complexes. The potential energy transfer and 
dual emission for the hetrodinuclear iridium- ruthenium complex results in near-white light 
emission. The products might find useful applications in LEECs and other artificial lighting 
technologies. 
6.2 Future work 
  
The work presented in this thesis has the potential to be extended further:  
Osmium triazole complexes, which present an excellent platform for the development of novel 
theranostic agents for anticancer activity by shifting both absorption and emission in the red 
region by using more nitrogen withdrawing triazole ligand for example; pyrimidine and 
pyrazine:  
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Pyrimidine and pyrazine have a lower LUMO than pyridine. This is expected to result in a red 
shift of the emission and absorption into the more useful window, red light goes through the 
biological tissue, which is more useful for cell imaging and also, gives greater depth of light 
penetration for single oxygen sensitisation. The study in this work indicates that maintaning 
localization of the excited state on the triazole containing ligand is important for the high 3O2 
quenching to 1O2 with a high quantum yield of 
1O2. The kind of nitrogen withdrawing ring will 
give the ability to control the photophysical and electrochemical properties of complexes by 
controlling of the HOMO− LUMO gap and the number of triazole rings leads to control of the 
sensitivity of the complex to oxygen. Some of the possible applications of mixed metal 
complexes include: 
Mixed Ru/Re complexes for the photocatalysis of CO2 reduction. Rhenium chromophore was 
shown to be effective photocatalysts for CO2 reduction with a high level of catalytic stability.
248 
While the ruthenium chromophore will act as photosensitizer part.  
 
Chapter 6: General conclusions and outlook 
198 
 
 
Mixed Os/Ir complexes could be envisaged and have potential applications in water oxidation 
photocatalysis and CO2 reduction. This heteronuclear complex is expected to give dual 
emission resulting in near white light emission. Both chromophores showed good catalytic 
water oxidation activity.249, 250 Water soluble chloride salts of these complexes could be 
envisaged and subjected to preliminary cellular uptake and luminescence imaging microscopy 
studies. 
 
 
The photophysical and electrochemical properties of dinuclear transition metal complexes 
[Ru(bpy)2-L4-Ir(ppy)2](PF6)3 and related complexes can be improved and controlled by 
controlling the auxiliary ligands coordinated to the metal center which play a significant role 
in the photophysical properties of these complexes. For example: using (difppy = 2-(2,4-
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difluorophenyl)pyridine) as a chromophore ligand instead of ppy leads to an increase in the 
HOMO− LUMO gap, which make the Ir emitter more blue rather than a greenish emitter. This 
will take the line connecting the CIE coordinates of the complex closer to the white region, 
which may give the dinuclear transition metal complexes ability to emit white light and 
therefore maybe suitable for use in white light emiting LEC applications. As well we can also 
explore adapting the nature of the bridging ligand 
 
We can also control the photophysical and electrochemical properties of complexes by using 
CuAAC reactions for ligand design and as supramolecular linkers to modify the design. For 
example, we might prepare a shorter linker ligand to improve the electron communication in 
the complex. The spacer of the linker ligand effects the photophysical and properties of the 
complex. Removing the saturated ethyl group makes the metal centres closer to each other and 
thus increases the electron communication. 
 
 
We can also control the regiochemistry of the substituents of the central benzene ring of the 
ligand to vary the rate of energy transfer through varying the distance between the metal cente, 
which give ability to prepare complexes even with more than two metal centres 
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This provides a new opportunity for the synthesis and application of novel luminescent iridium 
complexes, for example, in electrochemiluminescent devices (LECs) with highly improved 
efficiency. The water soluble chloride form of these complexes could be subjected to 
luminescent imaging microscopy studies.  
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7.1 General methods  
 
Ammonium hexachloroosmate(IV) was purchased from Alfa Aesar whilst all other reagents 
and solvents were purchased from Sigma-Aldrich or Acros Organics and used as supplied. 
[Re(bpy)(CO)3Cl],
185 [Re(bpy)(CO)3(Py)][PF6],
185 [Ru(bpy)2Cl2]
251 and [Ir(ppy)2Cl]2
252
  were 
all prepared according to literature procedures. NMR spectra were recorded on a Bruker 
Ascend 400 MHz spectrometer, with all chemical shifts being quoted in ppm referenced 
relative to the residual solvent signal (MeCN, δ = 1.94, CDCl3 δ = 7.26, DMSO δ = 2.5). High 
resolution mass spectrometry was performed on an Agilent 6210 TOF instrument with a dual 
ESI source. UV-visible absorption spectra were recorded on an Agilent Cary 60 
spectrophotometer whilst emission spectra were recorded on a Fluoromax-4 spectrophotometer 
(aerated and degassed in acetonitrile and data at 77 K in ethanol: methanol 4:1). Lifetime 
measurements were recorded by time-correlated single-photon counting using an Edinburgh 
instruments Mini-Tau spectrometer.  
7.2 Electrochemistry: 
 
The autolab PGSTAT100N potentiostat alongside NOVA electrochemical program was used 
to record the cyclic voltammograms. Dry acetonitrile saturated with nitrogen was used to 
prepare analyte solutions. All measurements were made at room temperature under a stream of 
dry nitrogen at scan rates between 20 and 500 mVs-1. NBu4PF6 acted as a supporting 
electrolyte, with a solution concentration of 0.2 mol dm-3. A platinum disc was the working 
electrode, while the counter electrode was a platinum wire. The reference electrode was 
Ag/AgCl. Finally, Ferrocene was used as an internal reference, with all potentials reported 
against the Fc+/Fc couple. 
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7.3 Ligand Synthesis: 
7.3.1 Synthesis of benzyl azide 
Benzyl azide may cause an explosion, as many other azides, so it is advisable to use extreme 
caution during purification and handling. Pure compound can be stored in dark and cold, and 
even then, shelf-life is only weeks. 
 
 
 
Benzyl bromide (12.0 ml, 101 mmol, 1.0 eq.) was dissolved in water and acetone (1:4 v/v) (120 
ml). Sodium azide (10 g, 154 mmol, 1.5 eq.) was added and the reaction was stirred overnight 
at 50 oC. After evaporating acetone, water (75 ml) was added slowly before extracting the 
product into diethyl ether (3 × 150 ml). The combined diethyl ether layers were washed with 
brine (1 × 150 ml), dried over magnesium sulphate and the solvent removed to leave colourless 
oil. Yield = 10.5 g, 74 mmol, 75%. 1H NMR (400 MHz, CDCl3): δ: 7.42-7.32 (m, 5H), 4.35 (s, 
2H). 13C NMR (101 MHz, CDCl3) δ: 135.4, 128.9, 128.3, 128.2, 54.82.  IR solution (cm-1) C-
N=N=N: 2090 s.   
7.3.2 Synthesis of 1-benzyl-4-(2-pyridyl)-1,2,3-triazole (Bn-pytz):96  
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Benzyl azide (2.32 g, 17 mmol) and 2-ethynylpyridine (1.676 g, 17 mmol) were dissolved in a 
mixture of THF and water (1:1 v/v) (120 ml). To the solution was added 1 M sodium ascorbate 
(aq) (3.2 ml) and 7.5 wt% CuSO4 (aq) (5.2 ml). The mixture was stirred at 50 
OC overnight. 
After the mixture had cooled down. THF was evaporated under reduced pressure. The resulting 
precipitate of the Cu complex was decomposed by addition of small portions of aqueous 
ammonia. The aqueous phase was extracted with CHCl3, washed with water, saturated 
NaHCO3 (aq) and brine. After drying over Na2SO4, the solvent was removed under reduced 
pressure. The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% 
DCM) to give a white solid (2.95 g). Yield 82%.1H NMR (400 MHz, CD3CN): δ:  8.55 (d, J = 
4.5 Hz, 1H), 8.26 (s, 1H), 8.11 (dt, J =1.0 , 8.0 Hz, 1H), 7.76 (tt, J = 1.1, 7.5 Hz, 1H), 7.41–
7.30 (m, 5H), 7.28-7.24 (m, 1H), 5.60 (s, 2H). 13C NMR (101 MHz, CD3CN): δ: 150.1, 149.3, 
147.9, 135.6, 135.5, 128.6, 128.0, 127.6, 122.3, 119.2, 117.0, and 53.3. ESI HRMS: m/z 
calculated for (C14H13N4) m/z = 237.1135 (M+H)
+, found m/z = 237.1129 [M+H]+. ESI HRMS: 
m/z calculated for (C14H12N4Na) m/z = 259.0954 [M+Na]
+ found m/z = 259.0950 [M+Na] +. 
7.3.3 Synthesis of 4'-(p-tolyl)-2,2':6',2''-terpyridine = tol-terpy229 
 
 
The ligand 4'-(p-tolyl)-2,2':6',2''-terpyridine = tol-terpy was synthesized as follows:229 2-
Acetylpyridine (4.84 g, 40 mmol) and 4-methylbenzaldehyde (2.40 g, 20 mmol) were added 
into EtOH (100 mL). KOH pellets (3.08 g, 85%, 46 mmol) and NH3 (60 mL, 30%) were then 
added to the solution. The solution was stirred at 34 °C for 24 hrs. The mixture was cooled to 
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room temperature and then the off-white solid was collected by filtration and washed with ice-
cold EtOH (10 mL). Recrystallization from EtOH. Yield = 4.2 g, 13.0 mmol, 65%. 1H NMR 
(400 MHz, CDCl3) δ: 8.74-8.72 (m, 4H); 8.67 (d, J = 7.9 Hz, 2H); 7.87 (td, J = 1.8, 7.7 Hz, 
2H); 7.83 (d, J = 8.1 Hz, 2H); 7.36-7.31 (m, 4H); 2.42 (s, 3H); 13C NMR (101 MHz, CDCl3) 
δ: 156.4, 155.9, 150.2, 149.1, 139.1, 136.85, 135.5, 129.7, 127.2, 123.8, 121.4, 118.6, 21.3. 
ESI HRMS calculated for (C22H17N3) m/z = 323.1422, found m/z = 323.1430 [M]
+. 
7.3.4 Synthesis of 2,6-bis(trimethylsilylethynyl)pyridine 
 
2,6-Dibromopyridine (2.4 g, 10 mmol), dichlorobis(triphenylphosphine)palladium(II) (561 
mg, 0.8 mmol), copper(I) iodide (285 mg,  1.5 mmol), triphenylphosphine (210 mg, 0.8 mmol) 
and triethylamine (5 ml) were dissolved in a mixture of dry THF (20 ml) and 
trimethylsilylacetylene (2.8 ml, 20 mmol) and heated at reflux under nitrogen overnight. The 
solvent was removed under reduced pressure, then the crude product was purified by column 
chromatography (SiO2, (2:1) Hexane: DCM) to give a white solid. Yield = 2.25 g, 90%. 
1H 
NMR (400 MHz, CDCl3) δ: 7.70 (t, J = 7.8 Hz, 1H); 7.41 (d, J = 7.8 Hz, 2H); 0.25 (s, 18H); 
13C NMR (101 MHz, CDCl3) δ: 142.89, 137.2, 126.7, 103.21, 94.4, and 0.96). ESI HRMS 
calculated for (C15H21NSi2) m/z = 272.1285, found m/z =272.1287 [M]
+. 
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7.3.5 Synthesis of 2,6-bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, btzpy:88  
 
 
In a 500 ml round-bottomed flask equipped with a magnetic stirrer, acetonitrile (100 ml) and 
aniline (1.82 g, 20 mmol) were added. The mixture was stirred in an ice bath then tert butyl 
nitrite (1.5 g, 20 mmol) and trimethylsilylazide (2.3 g, 20 mmol) were added. The mixture was 
warmed up to room temperature and stirred for 2 hrs. To the solution were added 1 M sodium 
ascorbate (aq) (10 ml) and 7.5 wt% CuSO4 (aq) (10 ml), 1 M potassium carbonate (10 ml) (aq), 
100 ml of H2O, pyridine (10 ml), tert-butanol (10 ml) and 2,6-bis(trimethylsilyl)pyridine (2 g, 
7.4 mmol). The mixture was stirred overnight at room tempreture. Acetonitrile was removed 
under reduced pressure. The resulting precipitate of the Cu complex was decomposed by 
addition of small portions of aqueous ammonia. The product was extracted into CHCl3, washed 
with aqueous ammonia, water and brine. After drying over Na2SO4, the solvent was removed 
under reduced pressure. The crude product was purified by column chromatography (SiO2, 5% 
Ethyl acetate, 95% DCM) to give the btzpy ligand (3.15 g, 8.2 mmol). Yield 91%. 1H NMR 
(400 MHz, CD3CN) δ: 8.97 (s, 2H); 8.13 (d, J = 7.7 Hz, 2H); 7.99 (t, J = 8.2 Hz, 1H); 7.93 (d, 
J = 7.8 Hz, 4H); 7.63 (t, J = 7.6 Hz, 4H); 7.53 (t, J = 7.5 Hz, 2H); 13C NMR (101 MHz, CD3CN) 
δ: 149.99, 138.28,137.3, 129.91, 128.97, 121.27, 120.50, 118.88, 117.33.  ESI HRMS 
calculated for (C21H15N7Na) m/z = 388.1281, found m/z = 388.1285 [M+Na]
+. 
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7.3.6 Synthesis of 1, 4-bis-({4-(pyrid-2-yl)-1, 2, 3-triazol-1-yl}methyl) benzene 
=L 
 
1,4-Dibromomethylbenzene (2 g, 7.6 mmol) and sodium azide (1.00 g, 15.35 mmol) were 
combined in dimethyl sulfoxide (20 mL). The mixture was stirred at room temperature for two 
hours. Then to the reaction mixture was added water (15 ml), 2-ethynylpyridine (3.4 g, 31 
mmol), CuSO4 (1M aqueous solution 5 ml), sodium ascorbate (1M aqueous solution 5 ml)  and 
2,6-lutidine (2.4 mL, 31 mmol). The mixture was stirred at room temperature overnight. The 
resulting precipitate of the Cu complex was decomposed by addition of small portions of 
aqueous ammonia. The remaining solids were filtered and washed with water (50 mL) and 
dilute ammonia (50 mL) and the product was recrystallised from dichloromethane and hexane 
to yield a white solid. (Yield = 3.6 g, 88 %) 1H NMR (400 MHz, (CD3)2SO) δ: 8.66 (s,  2H); 
8.57 (d, J = 4.3 Hz, 2H); 8.01 (d, J = 7.9 Hz, 2H); 7.87 (td, J =1.6, 7.6 Hz, 2H); 7.39 (s, 4H); 
7.34-7.31 (m, 2H); 5.66 (s, 4H); 13C NMR (101 MHz, (CD3)2SO) δ: 150.33, 150.07, 147.95, 
137.66, 136.42, 128.93, 123.91, 123.47, 119.87, 53.09. 1H NMR (400 MHz, CDCl3) δ: 8.52 (s, 
2H); 8.16 (d, J = 7.6 Hz, 2H); 8.04 (s,  2H); 7.76 (t, J = 7.4 Hz, 2H); 7.34 (s,  4H); 7.20 (s,  
2H); 5.58 (s, 4H); 13C NMR (101 MHz, CDCl3) δ: 150.2, 149.4, 148.9, 136.9, 135.3, 129.03, 
122.9, 121.94, 120.3, 53.9. ESI HRMS calculated for (C22H18N8) m/z = 394.16544, found m/z 
= 394.16550 [M]+. 
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7.4 Synthesis of rhenium complexes 
7.4.1 Preparation of the rhenium complexes [Re(N^N)(CO)3Cl] 
 
The rhenium complexes were prepared from pentacarbonylchlororhenium (I) [Re(CO)5Cl] by 
the following general procedure: [Re(CO)5Cl] one equivalent and the diimine ( L) one 
equivalent (L= 2,2′-Bipyridyl,  1,10-Phenanthroline and 1-Benzyl-4-(2-pyridyl)-1,2,3-triazole 
in toluene were heated at 100 OC for 3 hr. After the solution cooled to room tempreture, the 
precipitate was collected, washed with diethyl ether and dried in vacuo. Yields were typicaly 
80-90%. Thin-layer chromatography on silica gel plates and NMR were used to test for purity. 
7.4.1.1 Synthesis of [Re(CO)3(btzpy)Cl] 
 
The rhenium complex was prepared from pentacarbonylchlororhenium(I) [Re(CO)5Cl] by the 
general procedure,191 a typical experiment: [Re(CO)5Cl] (200 mg, 0.55 mmol)  and 2,6-bis(1-
phenyl-1H-1,2,3-triazol-4-yl)pyridine, (btzpy) (205 mg, 0.55 mmol)  in toluene (20 mL) were 
heated overnight under reflux. The resulting mixture was allowed to cool to room temperature, 
and then the precipitate was collected by filtration, washed with diethyl ether and dried in 
vacuo. The crude product was purified by column chromatography (SiO2, THF) to give a light 
yellow powder. Yield = 175 mg, 87 %.1H NMR (400 MHz, (CD3)2SO) δ : 10.0 (s, 1H); 9.32 
(s, 1H); 8.52-8.44 (m, 2H); 8.06 (d, J = 7.04 Hz, 2H); 7.97 (d, J = 6.8 Hz, 3H); 7.76-7.69 (m, 
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5H); 7.59 (d, J = 6.4 Hz, 1H); 13C NMR (101 MHz, (CD3)2SO) δ: 153.2, 150.4, 150.2, 148.1, 
141.4, 136.9, 135.9, 131.0, 130.8, 130.6, 129.7, 128.0, 125.4, 124.9, 123.1, 121.4, 121.0. ESI 
HRMS calculated for (C24H15N7ClRe) m/z = 694.0347, found m/z = 694.0364 [M+Na]
+. 
7.4.2 Synthesis of [Re(N^N)(CO)3(X)](PF6) 
[Re(L)(CO)3(bpy)]
+ can be synthesized using different techniques. The first technique (method 
A) involves the treatment of [Re(L)(CO)3Cl)] with AgPF6. AgPF6 and [Re(L)(CO)3Cl)] are 
dissolved in dichloromethane and stirred in the dark for 12 hours at room temperature. One 
equivalent of Py (X) is then added to the solution and stirred for 48 hours in darkness. This 
solution is then filtered through celite and the filtrate thereafter dried through evaporation under 
reduced pressure98 The obtained residue is then re-crystallized from DCM and diethyl ether to 
generate the product required. Another method (method B) involves producing 
[Re(N^N)(CO)3(CH3CN)](PF6) through modifying the method reported
185 whereby 
[Re(N^N)(CO)3Cl] as well as one equivalent of silver hexafluorophosphate AgPF6 are 
dissolved into acetonitrile under an atmosphere of nitrogen which is heated to 85°C in darkness 
for twelve hours. After cooling, the solution is filtered through celite and then the filtrate is 
dried through evaporation under reduced pressure. The obtained residue is re-crystallized from 
acetonitrile and diethyl ether hence [Re(bpy)(CO)3(CH3CN](PF6) is obtained. Afterwards, 
rhenium complex [Re(N^N)(CO)3(CH3CN)](PF6), (one equivalent) is reacted with (X) (X = 
pyridine, 4-tert-butylpyridine, 4-methlypyridine, 3-methylpyridine, 4-dimethylaminopyridine, 
3,5-dimethylpyridine) (six equivalents) in tetrahydrofuran (THF) under a nitrogen atmosphere 
at 65°C overnight. After cooling, hexane is added gradually to precipitate the product. 
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7.4.3 [Re(bipy)(CO)3(py)](PF6) 
 
According to (method A): 2,2′-Bipyridyl (bpy) (216 mg, 1.383 mmol) was used to prepare the 
rhenium complex [Re(bpy)(CO)3Cl]. In the second step 278 mg of [Re(bipy)(CO)3Cl]  was 
used to prepare [Re(bpy)(CO)3(py)][PF6]. The crude product was purified by column 
chromatography (SiO2, 2% MeOH, 98% DCM) to give a yellow powder Yield 74%. 
1H NMR 
(400 MHz, CD3CN): δ: 9.21 (d, J = 5.4 Hz, 2H), 8.36 (d, J = 8.0 Hz, 2H), 8.29- 8.22 (m, 4H), 
7.85 (t, J = 7.5 Hz, 1H), 7.78 (t, J = 6.4 Hz, 2H), 7.29 (t, J = 6.7 Hz, 2H). 13C NMR (101 MHz, 
CD3CN) δ: 155.4, 153.5, 151.6, 140.8, 139.6, 128.5, 126.4, 124.4. ESI HRMS calculated for 
(C18H13N3O3Re) m/z = 504.0481, found m/z = 504.0468 [M]
+. 
7.4.4  [Re(1,10-phenanthroline)(CO)3(py)](PF6) 
 
According to method A. In the first step 1,10-phenanthroline (249 mg, 1.383 mmol) was used 
to prepare the rhenium complex [Re(1,10-phenanthroline)(CO)3Cl], then (318 mg) of 
[Re(1,10-phenanthroline)(CO)3Cl] complex was used in the second step of this reaction to 
prepare [Re(1,10-phenanthroline)(CO)3(py)](PF6). The crude product was purified by column 
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chromatography (SiO2, 2% MeOH, 98% DCM) to give a yellow powder Yield 72%. 
1H NMR 
(400 MHz, CD3CN): δ : 9.60 (dd, J = 1.0, 5.3 Hz, 2H), 8.84 (dd, J = 1.1 , 8.3 Hz, 2H), 8.27 (d, 
J = 5.0 Hz, 2H), 8.16 (s, 2H), 8.13-8.09 (m, 2H), 7.74 (t, J = 7.8 Hz, 1H)7.19 (t, J = 6.6 Hz, 
2H), 13C NMR (101 MHz, CD3CN) δ : 154.2, 151.5, 146.2, 140.0, 139.5, 130.9, 127.8, 126.8, 
126.2.   ESI HRMS calculated for (C20H13N3O3Re) m/z = 528.0481, found m/z = 528.0469 
[M]+. 
7.4.5 Preparation of [Re(btz)(CO)3Cl]  
 
The Rhenium complex were prepared from pentacarbonylchlororhenium(I) [Re(CO)5Cl] by 
the general procedure191 a typical experiment: [Re(CO)5Cl] (200 mg, 0.55 mmol)  and 2,6-
bis(1-phenyl-1H-1,2,3-triazol-4-yl)pyridine, (ph-tripy) L3 (205 mg, 0.55 mmol)  in toluene (20 
mL) were heated overnight under reflux. The resulting mixture was allowed to cool to room 
temperature, and then the precipitate was collected, by filtration, washed with diethyl ether and 
dried in vacuo. The crude product was purified by column chromatography (SiO2, THF) to 
give a light yellow powder Yields = 175mg, 87%.1H NMR (400 MHz, (CD3)2SO) δ: 10.0 (s, 
1H); 9.32 (s, 1H); 8.52-8.44 (m, 2H); 8.01 (dd, J = 7.04 , 36.2Hz, 5H); 7.76-7.69 (m, 5H); 7.59 
(d, J = 6.4 Hz, 1H); 13C NMR (101 MHz, (CD3)2SO) δ: 153.2, 150.4, 150.2, 148.1, 141.4, 
136.9, 135.9, 131.1, 130.8, 130.6, 129.7, 128.0, 125.4, 124.9, 123.1, 121.4, 12,. ESI HRMS 
calculated for (C24H15N7O3ClRe) m/z = 694.0347, found m/z = 694.0364 [M+Na]
+. 
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7.4.6 Preparation of [Re(Bn-pytz)(CO)3Cl] 
 
The rhenium complexes were prepared from pentacarbonylchlororhenium(I) [Re(CO)5Cl] by 
the general procedure:191 [Re(CO)5Cl] (2.78 g, 0.516 mmol) and the substituted pytz (1-benzyl-
4-(2-pyridyl)-1,2,3-triazole) compound (2.04 g, 0.516 mmol) in toluene (60 ml) were heated 
overnight at 100 oC. After the cooling to room temperature, the resulting precipitate was 
collected, washed with diethyl ether and dried in vacuo. Yields were typical 80% - 90%. Thin-
layer chromatography on silica gel plates and NMR were used to test for purity. 1H NMR (400 
MHz, CD3CN): δ:  8.95 (d, J = 5.6 Hz, 1H), 8.57 (s, 1H), 8.11 (td, J = 1.6 , 7.8 Hz, 1H), 8 (d, 
J = 8.1 Hz, 1H), 7.53-7.49 (m, 1H), 7.48-7.42 (m, 5H), 5.74 (s, 2H). 13C NMR (101 MHz, 
CD3CN): δ: 153.9, 150.0, 149.8, 141.2, 134.6, 130.2, 130.2, 129.7, 127.1, 125.9, 123.5, and 
56.4. ESI HRMS calculated for (C17H12Cl N4O3Re) m/z = 505.0434, found m/z = 505.0427 
[M]+. 
7.4.7 Preparation of [Re(Bn-pytz)(CO)3(CH3CN)](PF6) 
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[Re(Bn-pytz)(CO)3(CH3CN)](PF6) was prepared by a modification of the method reported:
185 
560 mg (1.03 mmol, 1 equiv) of [Re(Bn-pytz)(CO)3Cl] and silver hexafluorophosphate 
(AgPF6) (270 mg, 1.06 mmol, 1.03 equiv) were dissolved in 150 ml of acetonitrile under a 
nitrogen atmosphere and heated at 85 OC  in the dark for 12 h. After the solution had cooled to 
room temperature, the solution was then filtered through celite and the filtrate was then dried 
by evaporation under reduced pressure. The resulting residue was re-crystallised from DCM 
and hexane [Re(Bn-pyta)(CO)3(CH3CN)](PF6) was obtained as bright yellow-green powder. 
The crude product was purified by column chromatography (SiO2, 2% MeOH , 98% DCM).
1H 
NMR (400 MHz, CDC3N): δ : 8.96 (d, J = 5.4 Hz, 1H), 8.65 (s, 1H), 8.21 (t, J = 7.6 Hz, 1H), 
8.07 (d, J = 7.3 Hz, 1H), 7.60 (t, J = 6.3 Hz, 1H), 7.47 (s, 5H), 5.76 (s,  2H).13C NMR (101 
MHz, CD3CN) δ: 153.8, 149.4, 149.1, 141.0, 133.0, 129.0, 128.9, 128.50, 126.5, 125.3, 122.7, 
122.2, 55.4. ESI HRMS calculated for [C19H15N5O3Re]
+ m/z = 546.0694, found m/z = 
546.0704[M]+. 
 
7.4.8 Synthesis of [Re(Bn-pytz)(CO)3(py)](PF6) 
 
According to method B. Pyridine (py) (280 µl, 3.47 mmol) used in this reaction. The crude 
product was purified by column chromatography (SiO2, 2% MeOH, 98% DCM) to give a 
yellow powder Yield 74%. 1H NMR (400 MHz, CD3CN): δ :  9.17 (d, J  = 5.4 Hz, 1H), 8.53 
(s, 1H), 8.26 (d, J = 5.2 Hz, 2H), 8.17 (t, J  = 7.7 Hz, 1H), 7.92 (d, J  =  8.2 Hz, 1H), 7.85 (t, J  
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= 7.4 Hz, 1H), 7.66 (t, J  = 6.5 Hz, 1H), 7.46 (s, 5H), 7.29 (t, J  = 6.5 Hz, 2H), 5.78 (d, J  = 3.7 
Hz, 2H). 13C NMR (101 MHz, CD3CN) δ: 153.6, 151.8, 149.2, 148.8, 141.1, 139.5, 133.2, 
129.0, 128.9, 128.4, 127.1, 126.3, 125.6, 123.0, 55.6.  ESI HRMS calculated for 
[C22H17N5O3Re]
+  m/z = 584.0861, found m/z = 584.0855 [M]+. 
7.4.9 Synthesis of [Re(Bn-pytz)(CO)3(tbutpy)](PF6) 
 
 
According to method B. 4-tert-butylpyridine (tbutpy) (508 µl, 3.47 mmol) used in this reaction. 
The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% DCM) to 
give a yellow powder Yield 72%. 1H NMR (400 MHz, CD3CN): δ : 9.17 (d,  J = 5.7 Hz, 1H), 
8.55 (s, 1H), 8.18 (td,  J  = 1.3,  7.9 Hz, 1H), 8.11 (dd, J  = 1.3 , 4.94 Hz, 2H), 7.94 (d, J  = 7.9 
Hz, 1H), 7.68-7.64 (m, 1H), 7.46 (s, 5H), 7.25 (dd, J  = 1.6 , 5.2 Hz, 2H), 5.78 (d, J  = 6.6 Hz, 
2H), 1.19 (s, 9H).13C NMR (101 MHz, CD3CN) δ : 164.2, 153.6, 151.2, 149.3, 148.8, 141.1, 
133.2, 129.0, 128.9, 128.4, 127.1, 125.6, 123.3, 122.9, 55.6, 34.6, 28.8. ESI HRMS calculated 
for [C26H28N5O3Re]
+  m/z = 640.1481, found m/z = 640.1472 [M]+. 
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7.4.10 Synthesis of [Re(Bn-pytz)(CO)3(4-Picoline)](PF6) 
 
 
According to method B. 4-methylpyridine (4-picoline) (377 µl, 3.47 mmol) used in this 
reaction. The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% 
DCM) to give a yellow powder Yield 75%. 1HNMR (400 MHz, CD3CN): δ :  9.15 (d, J  = 5.3 
Hz, 1H), 8.53 (s, 1H), 8.17 (td, J  = 1.3, 7.87 Hz, 1H), 8.07 (d, J = 6.4 Hz, 2H), 7.92 (d, J = 8.1 
Hz, 1H), 7.65 (t, J = 6.6 Hz, 1H), 7.45 (d, J = 4.3 Hz, 5H), 7.10 (d, J = 6.1Hz, 2H), 5.78 (d, J 
= 3.8 Hz, 2H), 2.28 (s, 3H). 13C NMR (101 MHz, CD3CN) δ: 153.6, 152.3, 151.0, 149.2, 148.8, 
141.1, 133.2, 129.0, 128.9, 128.4, 127.1, 126.9, 125.6, 122.9, 118.0, 55.6, 19.8. ESI HRMS 
calculated for [C23H19N5O3Re]
+  m/z = 598.1012, found m/z = 598.1011[M]+. 
7.4.11 Synthesis of [Re(Bn-pytz)(CO)3(3-Picoline)](PF6) 
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According to method B. 3-methylpyridine (3-picoline) (377 µl, 3.47 mmol) used in this 
reaction. The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% 
DCM) to give a yellow powder Yield 75%. 1H NMR (400 MHz, CD3CN): δ : 9.18 (d, J  = 5.2 
Hz, 1H), 8.55 (s, 1H), 8.17 (t, J = 7.6 Hz, 1H), 8.06 (s, 2H), 7.93 (d, J = 8.1 Hz, 1H), 7.65 (s, 
2H), 7.46 (s, 5H), 7.16 (t, J = 6.7 Hz, 1H), 5.78 (d, J = 5.9 Hz, 2H), 2.12 (s, 3H). 13C NMR 
(101 MHz, CD3CN) δ: 153.9, 151.9, 149.2, 141.5, 140.3, 129.3, 129.3, 128.7, 127.4, 125.9, 
123.2, 55.9, 17.3.  ESI HRMS calculated for [C23H19N5O3Re]
+ m/z = 598.1012, found m/z = 
598.1011[M]+. 
7.4.12 Synthesis of [Re(Bn-pytz)(CO)3(3,5-Lutidine)](PF6) 
 
 
According to method B. 3,5-dimethylpyridine (3,5-Lutidine) (350 µl, 3.47 mmol) used in this 
reaction. The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% 
DCM) to give a yellow powder Yield 75%. 1H NMR (400 MHz, CD3CN): δ :  9.19 (d, J = 5.4 
Hz, 1H), 8.58 (s, 1H), 8.17 (t, J = 7.7 Hz, 1H), 7.93 (d, J = 8.1 Hz, 1H), 7.87 (s, 2H) 7.65 (t, J 
= 6.6 Hz, 1H), 7.46 (s, 6H), 5.78 (d, J  = 10.5 Hz, 2H), 2.07 (s, 6H). 13C NMR (101 MHz, 
CD3CN) δ : 153.68, 149.2, 148.8, 141.1, 136.2, 133.3, 129.0, 129.0, 128.4, 127.1, 125.6, 122.8, 
55.6, 16.7.  ESI HRMS calculated for [C23H19N5O3Re]
+ m/z = 612.1168, found m/z = 612.1162 
[M]+. 
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7.4.13 Synthesis of [Re(Bn-pytz)(CO)3(DMAP)](PF6) 
 
 
 
According to method B. 4-dimethylaminopyridine (DMAP) (424 mg, 3.47 mmol) used in this 
reaction. The crude product was purified by column chromatography (SiO2, 2% MeOH, 98% 
DCM) to give a yellow powder Yield 75%. 1H NMR (400 MHz, CD3CN): δ :  9.12 (d, J = 5.6 
Hz, 1H), 8.54 (s, 1H), 8.15 (td, J = 1.2 , 8.9 Hz, 1H), 7.92 (d, J = 8.0 Hz, 1H), 7.63 (d, J = 6.4 
Hz, 1H), 7.59 (d, J = 7.3 Hz, 2H), 7.45 (s, 6H), 6.27 (d, J = 7.30 Hz, 2H), 5.77 (d, J = 11.0 Hz, 
2H), 2.89 (s, 6H). 13C NMR (101 MHz, CD3CN) δ: 153.7, 151.9, 149.9, 148.3, 129.3, 129.2, 
128.9, 128.4, 125.9, 107.6, 55.9, 38.2. ESI HRMS calculated for [C24H22N6O3Re]
+  m/z = 
627.1277, found m/z = 627.1285 [M]+. 
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7.5 Synthesis of osmium complexes  
7.5.1 Synthesis of osmium complexes with bidentate ligands  
7.5.1.1 Synthesis of [Os(bpy)3](PF6)2 
 
 
Ammonium hexachloroosmate [(NH4)2OsCl6] (150 mg, 0.341 mmol) and (bpy) (218 mg, 1.4 
mmol) were dissolved in ethylene glycol (20 ml) and refluxed under nitrogen for 2hrs. The 
resulting solution was allowed to cool to room temperature, then NH4PF6 (230 mg, 1.4 mmol) 
was added to the solution and stirred for 45 min. The dark green precipitate was separated by 
vacuum filtration and washed with cold water and diethyl ether. The product was dissolved in 
acetonitrile and filtered through a celite pad then the filtrate recrystallized from acetone and 
diethyl ether to give a dark green powder. Yield = 270 mg, 80%.  1H NMR (400 MHz, CD3CN) 
δ: 8.48 (d, J = 8.04 Hz, 6H); 7.86 (t, J = 7.68 Hz, 6H); 7.64 (d, J = 5.36 Hz, 6H); 7.30 (t, J = 
6.44 Hz, 6H); 13C NMR (101 MHz, CD3CN) δ: 158.6, 150.5, 136.8, 127.7, and 124.1. ESI 
HRMS calculated for (C30H24N6Os) m/z = 330.0833, found m/z = 330.0843 [M]
2+. 
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7.5.1.2 Synthesis of [Os(bpy)2(Bn-pytz)](PF6)2253 
 
The complex [Os(bpy)2(pytz)](PF6)2 was prepared through a two-step procedure. Firstly,
254 
ammonium hexachloroosmate [(NH4)2OsCl6] (150 mg, 0.341 mmol) and bpy (108 mg, 0.69 
mmol) were dissolved in ethylene glycol (20 ml) and refluxed under nitrogen for 2hr. The 
resulting solution was allowed to cool to room temperature, then a 1M aqueous solution of 
Na2S2O3 was added slowly (over 20 min). The solution was cooled in an ice bath for 1hr. The 
darkish precipitate [Os(bpy)2Cl2]  was separated by vacuum filtration and washed with cold 
water and diethyl ether and used in further reactions without purification. [Os(bpy)2Cl2] (125 
mg, 0.218 mmol) and (pytz) (52 mg. 0.218 mmol) were dissolved in ethylene glycol (50 ml) 
and refluxed under nitrogen for 4hr. The resulting solution was allowed to cool to room 
temperature, then NH4PF6 (123 mg, 0.75 mmol) was added to the solution and stirred for 45 
min. The dark green precipitate was separated by vacuum filtration and washed with cold water 
and diethyl ether. The product was dissolved in MeCN and filtered through a celite pad, then 
the filtrate recrystallized from DCM and hexane to give a dark green powder. Yield = 100 mg, 
61%. 1H NMR (400 MHz, CD3CN) δ: 8.59 (s, 1H); 8.49 (d, J = 8.2 Hz, 2H); 8.45-8.39 (m, 
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2H); 8.08 (d, J = 8.0 Hz, 1H); 7.88-7.82 (m, 4H); 7.8-7.76 (m, 3H); 7.72 (d, J = 5.6 Hz, 1H); 
7.67 (d, J = 5.7 Hz, 1H); 7.52 (d, J = 5.7 Hz, 1H); 7.39-7.29 (m, 6H); 7.26-7.13 (m, 4H); 5.49 
(d, J = 4.5 Hz, 2H); 13C NMR (101 MHz, CD3CN) δ: 159.0, 151.1, 151.0 150.9, 150.6, 150.6, 
148.9, 137.3, 136.7, 136.6, 136.6, 133.3, 128.8, 128.7, 127.9, 127.7, 127.6, 127.5, 126.9, 126.0, 
125.8, 124.1, 124.1, 123.7, 123.3, 122.2, 62.8, 55.1. ESI HRMS calculated for (C34H28N8Os) 
m/z = 370.1020, found m/z = 370.1027 [M]2+. 
7.5.1.3 Synthesis of [Os(bpy)(Bn-pytz)2](PF6)2 
 
 
The complex [Os(bpy)(pytz)2](PF6)2 was prepared in a three-step procedure.
255 Firstly, osmium 
(III) chloride hydrate OsCl3·3H2O (150 mg, 0.429 mmol) and 1,3-cyclohexadiene (690 mg, 
8.58 mmol) were dissolved in degassed ethanol (50 ml) and refluxed under nitrogen for 48 hrs. 
The resulting solution was allowed to cool to room temperature and cooled in the fridge for 
2hrs, then the green  precipitate was separated by vacuum filtration and washed with ethanol 
and diethyl ether (<10 ml). The resulting dimer (230 mg, 0.338 mmol) and bpy (106 mg, 0.676 
mmol) were dissolved in methanol (50 ml) and heated at 45 oC under nitrogen for 24 hrs. The 
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resulting solution was allowed to cool to room temperature and filtered through a celite pad, 
then NH4PF6 (275 mg, 1.69 mmol) was added to the filtrate and stirred for 45 min. The yellow 
precipitate was separated by vacuum filtration and washed with cold water and diethyl ether. 
The resulting [Os(ƞ6-C6H6)(bpy)Cl](PF6) (400 mg, 0.66 mmol) was dissolved in ethanol: water 
(3:1 v/v) (40 ml) with (pytz) (410 mg, 1.73 mmol) and refluxed under nitrogen for 48 hr. The 
resulting solution was allowed to cool to room temperature, then NH4PF6 (230 mg, 1.4 mmol) 
was added to the solution and stirred for 45 min and filtered. The solvent was removed and the 
solid recrystallized from DCM and hexane. The crude product was purified by column 
chromatography (SiO2, 2% MeOH, 98% DCM) to give a dark green powder. Yield = 246 mg, 
30%. 1H NMR (400 MHz, CD3CN) δ: 8.63-8.59 (m, 2H); 8.45-8.37 (m, 2H); 8.10-8.05 (m, 
2H); 7.89-7.76 (m, 6H); 7.65-7.61 (m, 2H); 7.41-7.32 (m, 6H); 7.30-7.10 (m, 8H); 5.55-5.46 
(m, 4H); 13C NMR (101 MHz, CD3CN) δ: 159.6, 152.2, 151.2, 150.9, 150.7, 149.3, 137.1, 
136.5, 133.2, 128.8, 128.7, 128.0, 127.9, 127.5, 126.7, 126.0, 125.8, 123.0, 122.2, 55.2. ESI 
HRMS calculated for (C38H32N10Os) m/z = 410.1208, found m/z = 410.1209 [M]
2+. 
7.5.1.4 Synthesis of mer- and fac-[Os(Bn-pytz)3](PF6)2256 
 
Ammonium hexachloroosmate [(NH4)2OsCl6] (150 mg, 0.341 mmol) and pytz (330 mg, 1.4 
mmol) were dissolved in ethylene glycol (20 ml) and refluxed under nitrogen for 2hrs. The 
resulting solution was allowed to cool to room temperature, then NH4PF6 (230 mg, 1.4 mmol) 
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was added and stirred for 45 min. The dark orange precipitate was separated by vacuum 
filtration and washed with cold water and diethyl ether. The product was dissolved in acetone 
and filtered through a celite pad then the filtrate recrystallized through adding of diethyl ether 
to give a dark orange powder. Yield = 185 mg, 61% (the product is a mixture of two isomers 
of [Os(pytz)3](PF6)2, meridional and facial isomers in an approximate 1: 0.8 ratio as estimated 
by 1H NMR. 1H NMR (400 MHz, CD3CN) δ: 8.62 (t, J = 5.9  Hz, 3H); 8.08 (d, J = 7.8  Hz, 
2H); 8.02 (t, J = 8.2  Hz, 1H); 7.83 (t, J = 7.2  Hz, 2H); 7.79-7.76 (m, 1H); 7.73 (d, J = 5.7  Hz, 
2H); 7.68 (t, J = 4.5 Hz, 1H); 7.4-7.32 (m, 9H); 7.25-7.14 (m, 9H); 5.54 (s, 2H); 5.53 (s, 4H); 
13C NMR (101 MHz, CD3CN) δ: 152.8, 152.6, 151.7, 151.3, 151.2, 151.1, 149.7, 149.4, 149.2, 
137.1, 136.9, 136.9, 133.7, 133.3, 128.8, 128.7, 128.6, 128.0, 128.0, 127.5, 125.9, 125.8, 125.7, 
125.5, 125.2, 125.1, 124.9, 122.1, 121.8, 121.4, 121.3, 55.2, 55.2, 55.01, 53.3. ESI HRMS 
calculated for (C42H36N12Os) m/z = 450.1395, found m/z = 450.1406 [M]
2+. 
7.5.2 Separation of meridional and facial - [Os(Bn-pytz)3](PF6)2 
Separation of the two meridional and facial isomers of [Os(pytz)3](PF6)2 proved extremely 
difficult with both co-eluting in column chromatography with a wide range of solvent systems. 
Successful separation was possible on a small scale by preparative thin-layer chromatography 
(Gradient: DCM then 20:80 acetone/ DCM) which resulted in the separation of the mer and fac 
isomers. This procedure yielded are only very small quantities of each isomer, enough to allow 
spectroscopic characterisation. 
 
 
 
7.5.2.1 Meridional -[Os(Bn-pytz)3](PF6)2 
 
Chapter 7: EXPERIMENTAL 
223 
 
 
1H NMR (400 MHz, CD3CN) δ: 8.61 (t, J = 6.6 Hz, 3H); 8.09 (d, J = 7.8 Hz, 1H); 8.02 (t, J = 
7.9 Hz, 2H); 7.83-7.74 (m, 3H); 7.73 (d, J = 5.7 Hz, 1H); 7.67 (t, J = 4.5 Hz, 2H); 7.41-7.34 
(m, 9H); 7.25-7.22 (m, 5H); 7.17-7.13 (m, 4H); 5.54-5.53 (m, 4H); 5.51 (s, 2H);  13C NMR 
(101 MHz, CD3CN) δ: 153.0, 152.9, 152.6, 151.7, 151.3, 151.2, 149.7, 149.3, 136.9, 136.9, 
133.7, 133.3, 133.3, 128.8, 128.8, 128.7, 128.6, 128.0, 128.0, 127.5, 125.9, 125.8, 125.5, 125.1, 
124.9, 122.1, 121.4, 121.3, 55.2, 55.2, 55.0. ESI HRMS calculated for (C42H36N12Os) m/z = 
450.1395, found m/z = 450.1368 [M]2+. 
7.5.2.2 Facial -[Os(Bn-pytz)3](PF6)2 
 
 
1H NMR (400 MHz, CD3CN) δ: 8.61 (s, 1H); 8.07 (d, J = 7.9 Hz, 1H); 7.82 (td, J =1.2, 7.8 Hz, 
1H); 7.72 (d, J = 5.6 Hz, 1H); 7.37-7.32 (m, 3H); 7.19 (t, J = 6.9 Hz, 1H); 7.13 (dd, J = 1.3, 
7.6 Hz, 2H); 5.50 (s, 2H); 13C NMR (101 MHz, CD3CN) δ:152.8, 151.1, 149.4, 137.1, 136.9, 
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133.7, 128.8, 128.6, 127.6, 125.7, 125.2, 121.9, 117.0, 55.0. ESI HRMS calculated for 
(C42H36N12Os) m/z = 450.1395, found m/z = 450.1381 [M]
2+. 
7.5.3 Metathesis of PF6 counter ions to chloride salts  
The relevant Os complex as its hexafluorophosphate salt (100 mg) together with 2.5 weight 
equivalents of Amberlite IRA-400 chloride-form ion exchange resin (250 mg) were stirred in 
MeOH (25 ml) at room temperature in the dark for 24 hr. The resin was removed by filtration 
and the filtrate evaporated to dryness. The residue was re-dissolved in the minimum volume of 
H2O (< 10 ml) with subsequent freeze drying afforded the relevant chloride salts as powders. 
Successful counter-ion metathesis was confirmed by the complete absence of resonances in 31P 
and 19F NMR spectra. 
7.5.3.1 Synthesis of [Os(bpy)3]Cl2 
  
1H NMR (400 MHz, CD3CN) δ: 8.61 (d, J = 8.2 Hz, 6H); 7.86 (t, J = 7.4 Hz, 6H); 7.63 (d, J = 
5.6 Hz, 6H); 7.30 (t, J = 6.7 Hz, 6H); 13C NMR (101 MHz, CD3CN) δ: 158.7, 150.5, 136.8, 
127.7, 124.4,   
7.5.3.2 Synthesis of [Os(bpy)2(Bn-pytz)]Cl2  
1H NMR (400 MHz, CD3CN) δ: 8.96 (s, 1H); 8.53 (d, J = 7.9 Hz, 2H); 8.47-8.42 (m, 2H); 8.19 
(d, J = 7.4 Hz, 1H); 7.88-7.76 (m, 7H); 7.72 (d, J = 5.6 Hz, 1H); 7.66 (d, J = 5.6 Hz, 1H); 7.51 
(d, J = 5.7 Hz, 1H); 7.37-7.29 (m, 6H); 7.25-7.15 (m, 4H); 5.52 (d, J = 11.5 Hz, 2H);  
7.5.3.3 Synthesis of [Os(bpy)(Bn-pytz)2]Cl2 
1H NMR (400 MHz, CD3CN) δ: 9.09-8.95 (m, 2H); 8.49-8.39 (m, 2H); 8.25-8.18 (m, 2H); 
7.88-7.75 (m, 6H); 7.65-7.60 (m, 2H); 7.37-7.29 (m, 6H); 7.27-7.12 (m, 8H); 5.59-5.49 (m, 
4H);  
7.5.3.4 Synthesis of [Os(Bn-pytz)3]Cl2 
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From the NMR spectra the ratio between two isomers mer: fac is 1:0.8  
1H NMR (400 MHz, CD3CN) δ: 9.26 (s, 1H); 9.18 (s, 1H); 9.15 (s, 3H); 9.06 (s, 1H); 8.3 (d, J 
= 7.9 Hz, 1H); 8.26 (d, J = 7.8 Hz, 1H); 8.21 (d, J = 7.9 Hz, 3H); 8.15 (d, J = 7.9 Hz, 1H); 
7.84-7.78 (m, 4H); 7.76-7.71 (m, 6H); 7.66 (t, J = 6.3 Hz, 2H); 7.38-7.3 (m, 18H); 7.27-7.25 
(m, 4H); 7.22-7.11 (m, 14H); 5.64-5.55 (m, 4H); 5.54 (s, 8H); 13C NMR (101 MHz, CD3CN) 
δ: 151.5, 151.0, 150.9, 136.9, 136.7, 136.6, 128.6, 128.6, 128.5, 128.4, 127.9, 127.8, 127.4, 
125.7, 125.5, 124.8, 122.2, 121.9, 121.4, 121.3, 54.8,  
7.5.4 Synthesis of Osmium tridentate Ligand complexes 
7.5.4.1 Synthesis of Os(tol-terpy)2(PF6)2257 
 
Ammonium hexachloroosmate [(NH4)2OsCl6] (150 mg, 0.341 mmol) and 2.5 eq of 4'-(p-tolyl)-
2,2':6',2''-terpyridine (toltpy) (310 mg, 0.85 mmol) in ethylene glycol (25 ml) were heated at 
reflux overnight under N2 . The resulting mixture was allowed to cool to room temperature, 
then 2.5 eq of NH4PF6 (10 ml) was added. The resulting dark brown precipitate was collected 
by filtration and washed with cold water and diethyl ether then redissolved in acetonitrile. The 
acetonitrile solution was cooled in the fridge overnight and filtered through celite. Then the 
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filtrate was recrystallized by the addition of diethylether to give a dark brown powder. Yield = 
185 mg, 58% 1H NMR (400 MHz, CD3CN) δ: 9.13 (s, 2H); 8.36 (d, J = 8.0 Hz, 2H); 8.01 (t, J 
= 8.0 Hz, 1H); 7.59-7.55 (m, 4H); 7.54-7.51 (m, 6H); 13C NMR (101 MHz, CD3CN) δ: 152.0, 
150.5, 137.0, 135.7, 129.9, 129.8, 123.7, 120.4, 118.9. ESI HRMS calculated for 
[C44H34N6Os]
2+ m/z = 419.1224, found m/z = 419.1238 [M]2+ . 
7.5.4.2 Synthesis of Os(btzpy)2(PF6)2 
 
 
Ammonium Hexachloroosmate [(NH4)2OsCl6] (150 mg, 0.341 mmol) and 2.5 eq of 2,6-bis(1-
phenyl-1H-1,2,3-triazol-4-yl)pyridine, (btzpy) (310 mg, 0.85 mmol) in ethylene glycol (25 ml) 
was heated at reflux overnight under N2 . The resulting mixture was allowed to cool to room 
temperature, then 2.5 eq of NH4PF6 (10 ml) was added. The resulting dark brown precipitate 
was collected by filtration and washed with cold water and diethyl ether then redissolved in 
acetonitrile. The acetonitrile solution was cooled in the fridge overnight and filtered. Then the 
filtrate recrystallized by the addition of diethylether to give a dark brown powder. Yield = 185 
mg, 58%. 1H NMR (400 MHz, CD3CN) δ: 9.13 (s, 2H); 8.36 (d, J = 8.0 Hz, 2H); 8.01 (t, J = 
8.0 Hz, 1H); 7.59-7.55 (m, 4H); 7.54-7.51 (m, 6H); 13C NMR (101 MHz, CD3CN) δ: 152.01, 
150.48, 137.01, 135.69, 129.86, 129.82, 123.73, 120.39, and 118.93. ESI HRMS calculated for 
[C42H30N14Os]
2+ m/z = 461.1191, found m/z = 461.1195 (M2+). 
7.5.4.3 Synthesis of [Os(btzpy)2]Cl2  
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A suspension of  (100 mg, 0.083 mmol) from [Os(btzpy)2][PF6]2 in methanol (25 ml ) was 
stirred with 2.5 weight equivalents of Amberlite IRA-400 chloride-form ion exchange resin 
(200 mg) at room temperature in the dark for 24 hrs. The resin was removed by filtration and 
the solvent then removed by evaporation. The residue was re-dissolved in the minimum volume 
of H2O (< 10 ml) with subsequent freeze drying affording the chloride salt of the  complex 
[Os(btzpy)2]Cl2 as a powder.
1H NMR (400 MHz, d6-DMSO): δ 10.15 (s, 4H); 8.58 (d, J = 8.0 
Hz, 4H); 8.21 (t, J = 8.0 Hz, 2H); 7.66 - 7.72 (m, 8H); 7.47 – 7.57 (m, 12H). 13C NMR (101 
MHz, d6-DMSO): δ 152.01, 150.32, 137.57, 135.58, 130.08, 130.00, 125.27, 120.46, 119.31. 
ESI HRMS: calculated for [C42H30N14Os]
2+ m/z = 461.1191; found m/z = 461.1192 [M]2+. 
7.6 Synthesis of osmium complexes using triazole-based bridging ligand 
7.6.1 Synthesis of [Os(bpy)2]2L](PF6)4 
 
Os(bpy)2Cl (573 mg, 1 mmol), ligand L (197 mg, 0.5 mmol) and AgPF6 (250 mg, 1 mmol) 
were dissolved in ethylene glycol (20 ml) and refluxed under nitrogen for 24 hrs in the dark. 
The resulting solution was allowed to cool to room temperature and the precipitate was 
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separated by vacuum filtration and washed with cold water and diethyl ether .The soleds were 
redissolved in acetonitrile and stored in the fridge for 24 hr and filtered through a celite pad to 
remove AgCl. Recrystallization from DCM and hexane give the pure product. (Yield = 720 
mg, 70%).   1H NMR (400 MHz, CD3CN) δ: 8.62 (d, J = 3.0 Hz, 2H); 8.51 (d, J = 8.1 Hz, 4H); 
8.40-8.33 (m, 4H); 8.13 (d, J = 7.9 Hz, 2H); 7.89-7.72 (m, 16H); 7.67 (d, J = 5.8 Hz, 2H); 7.54 
(d, J = 5.6 Hz, 2H); 7.36-7.28 (m, 6H); 7.25-7.2 (m, 4H); 7.12 (d, J = 1.8 Hz, 4H); 5.5 (d, J = 
4.4 Hz, 4H); 13C NMR (101 MHz, CD3CN) δ: 128.4, 128.4, 128.2, 127.2, 127.0, 126.1, 125.5, 
123.4, 122.9, 122.4, 121.4, 54.2, ESI HRMS calculated for [C62H50N16Os2]
4+ m/z = 350.0905, 
found m/z = 350.0903 [M]4+.  
7.6.2 Synthesis of [Os(Bn-pytz)2]2L](PF6)4 
 
Os(Bn-pytz)2Cl2 (733mg, 1 mmol), ligand L4 (197 mg, 0.5 mmol) and AgPF6 (250 mg, 1 
mmol) were dissolved in ethylene glycol (20 ml) and refluxed under nitrogen for 24hrs in the 
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dark. The resulting solution was allowed to cool to room temperature and the precipitate was 
separated by vacuum filtration and washed with cold water and diethyl ether. The product was 
dissolved in acetone and filtered through a celite pad. The filtrate was recrystallized by addition 
of diethyl ether. The soldes were then redissolved in acetonitrile and stored in fridge for 24 hrs 
and filtered. Recrystallization from DCM and hexane gave the pure product. (Yield = 760 mg, 
70%).  1H NMR (400 MHz, CD3CN) δ: 8.64-8.55 (m, 6H); 8.27 (s, 1H); 8.09-7.95 (m, 6H); 
7.84-7.62 (m, 12H); 7.40-7.30 (m, 14H); 7.24-7.09 (m, 15H); 5.61 (d, J = 8.8 Hz, 2H); 5.54-
5.47 (m, 10H); 13C NMR (101 MHz, CD3CN) δ: 153.4, 153.2, 152.9, 152.1, 151.6, 151.5, 
150.0, 149.8, 149.7, 137.4, 137.3, 134.4, 134.1, 133.7, 129.1, 129.1, 128.9, 128.7, 128.7, 128.4, 
128.3, 127.9, 126.2, 125.9, 125.6, 125.5, 125.4, 125.2, 122.9, 122.5, 122.2, 55.6, 55.4, 55.2, 
55.0, ESI HRMS calculated for [C78H66N24Os2]
4+ m/z = 430.6233, found m/z = 430.6277 [M-
4Cl]4+.  
7.7 Synthesis of Iridium Complexes 
 
7.7.1 Synthesis of [{Ir(ppy)2Cl}2]252 
 
Iridium trichloride hydrate (1.5 g, 0.426 mmol) was combined with 2-phenylpyridine (1.2 ml, 
0.84 mmol), dissolved in 60 ml of a mixture of 2-ethoxyethanol: water (3:1 v/v), and refluxed 
for 24 h. The solution was cooled to room temperature, and the yellow precipitate was collected 
by filtration. The precipitate was washed with ethanol (30 ml), water (30 ml), acetone (30 ml) 
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and diethyl ether. (Yield: 3.2 g; 70 %). 1H NMR (400 MHz, (CD3)2SO) δ: 9.82 (d, J = 5.6 Hz, 
2H); 9.54 (d, J = 5.5 Hz, 2H); 8.26 (d, J = 8.1 Hz, 2H); 8.17 (d, J = 8.0 Hz, 2H); 8.08 (t, J = 
7.5 Hz, 2H); 7.99 (t, J = 7.6 Hz, 2H); 7.79 (d, J = 7.68 Hz, 2H); 7.73 (d, J = 7.68 Hz, 2H); 7.56 
(t, J = 6.48 Hz, 2H); 7.44 (t, J = 6.52 Hz, 2H); 6.89 (t, J = 7.32 Hz, 2H); 6.83 (t, J = 7.36 Hz, 
2H); 6.76 (t, J = 7.4 Hz, 2H); 6.69 (t, J = 7.4 Hz, 2H); 6.26 (d, J = 7.56 Hz, 2H); 5.67 (d, J = 
7.56 Hz, 2H); 13C NMR (101 MHz, (CD3)2SO) δ: 167.8, 167.4, 152.6, 152.5, 151.1, 145.9, 
144.2, 143.7, 139.7, 138.6, 131.7, 130.4, 130.1, 129.4, 125.3, 124.3, 124.0, 123.3, 122.7, 122.5, 
120.5, 119.9. ESI HRMS calculated for (C45H35N4Cl2Ir2) m/z = 542.11905, found m/z = 
542.11912 [M]+. 
7.7.2 Synthesis of [Ir(ppy)2-L-Ir(ppy)2](PF6)2 
 
[{Ir(ppy)2Cl}2] (272 mg, 0.25 mmol), L4 (100 mg, 0.25 mmol) and Na4PF6 (250 mg, 1 mmol) 
were dissolved in 30 ml of a mixture of methanol: chloroform (1:1) and refluxed under nitrogen 
for 24hr. The resulting solution was allowed to cool to room temperature. Diethylether was 
added and the yellow precipitate was collected by filtration. The precipitate was washed with 
water (5ml) and diethyl ether. The crude product was redissolved in acetonitrile kept in fridge 
for 24 hr and filtered. Acetonitrile removed under vacum, then precipitate recrystallized from 
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(DCM and hexane) (Yield: 265mg; 70%). 1H NMR (400 MHz, CD3CN) δ: 8.66 (s, 1H); 8.65 
(s, 1H); 8.12-8.03 (m, 6H); 7.99-7.93 (m, 2H); 7.87-7.78 (m, 8H); 7.74 (d, J = 5.6 Hz, 2H); 
7.71-7.66 (m, 2H); 7.61 (d, J = 5.6 Hz, 2H); 7.36 (t, J = 6.4 Hz, 2H); 7.21 (d, J = 4.6 Hz, 4H); 
7.08-6.98 (m, 6H); 6.96-6.90 (m, 4H); 6.81 (t, J = 7.44 Hz, 2H); 6.25 (t, J = 6.92 Hz, 4H); 5.59 
(s, 4H); 13C NMR (101 MHz, CD3CN) δ: 167.3, 166.9, 150.1, 149.3, 149.0, 149.0, 148.9, 148.6, 
146.2, 144.0, 143.9, 139.4, 138.3, 138.1, 134.2, 131.6, 131.1, 130.0, 129.3, 128.6, 128.5, 126.6, 
126.1, 126.0, 124.5, 124.1, 123.2, 123.0, 122.6, 122.4, 121.9, 119.5, 119.3, 119.2, 54.5.  ESI 
HRMS calculated for (C66H50N12Ir2) m/z = 696.17411, found m/z = 698.17640 [M]
2+. 
7.7.3 Synthesis of [Ir(ppy)2-L](PF6) 
 
[{Ir(ppy)2Cl}2] (136 mg, 0.25 mmol), L (197 mg, 0.5 mmol) and NaPF6 (250 mg, 1 mmol) 
were dissolved in 25 ml of mixture of methanol: chloroform (1:1 v/v) and refluxed under 
nitrogen for 24hrs. The resulting solution was allowed to cool to room temperature. 
Diethylether was added and the yellow precipitate [Ir(ppy)2-L4](PF6) was collected by 
filtration and washed with water (5ml), and diethyl ether. The crude product was redissolved 
in acetonitrile kept in the fridge for 24 hrs and filtered. Acetonitrile was removed under reduced 
pressure, then the precipitate recrystallized from DCM and hexane. (Yield: 180 mg; 75%).  1H 
NMR (400 MHz, CD3CN) δ: 8.64 (s, 1H); 8.54 (s, 1H); 8.29 (d, J = 8.4 Hz, 1H); 8.11-7.92 (m, 
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5H); 7.86-7.76 (m, 5H); 7.71 (d, J = 5.5 Hz, 1H); 7.67 (d, J = 7.5 Hz, 1H); 7.57 (d, J = 5.6 Hz, 
1H); 7.35-7.27 (m, 4H); 7.18 (d, J = 7.1 Hz, 2H); 7.04-6.95 (m, 3H); 6.92-6.86 (m, 2H); 6.82-
6.77 (m, 1H); 6.26-6.20 (m, 2H); 5.61 (d, J = 5.1 Hz, 2H); 5.57 (d, J = 1.5 Hz, 2H); 13C NMR 
(101 MHz, CD3CN) δ: 168.1, 167.7, 150.9, 150.3, 149.8, 149.5, 147.0, 144.9, 144.8, 140.3, 
139.1, 139.0, 134.6, 132.4, 132.0, 130.9, 130.2, 129.4, 129.3, 129.2, 127.4, 126.9, 125.4, 124.9, 
124.1, 123.9, 123.5, 123.2, 122.8, 120.4, 120.1, 117.9, 55.5. ESI HRMS calculated for 
(C42H34N12Ir) m/z = 448.13311, found m/z = 448.63122 [M]
+. 
7.8 Synthesis of Ruthenium Complexes 
7.8.1 Synthesis of Ru(bpy)2Cl2251 
 
 
Ru(bpy)2Cl2 was prepared according to the method previously reported,
251 RuCl3·3H2O (3.20 
g; 12.15 mmol) and bipyridine (3.78 g; 24.30 mmol) were refluxed under N2 at 155 
OC in 60 
ml of DMF for 4 h with magnetic stirring in the dark.. After the reaction mixture had cooled to 
room temperature, 100 mL of reagent grade acetone was added. and was then cooled to 0°C 
overnight. The mixture was filtered, yielding a dark green –black product which was 
recrystallized in LiCl solution (30 g/ 50 ml H2O). The black solid was washed three times with 
10 ml portions of cold water followed by three 10 ml portions of diethyl ether, and was 
subsequently dried under vacuum (Yield: 2.5 g; 40 %).1H NMR (400 MHz, (CD3)2SO) δ: 9.93 
(d, J = 4.1 Hz, 2H); 8.63 (d, J = 8.0 Hz, 2H); 8.49 (d, J = 7.9 Hz, 2H); 8.07 (t, J = 7.6 Hz, 2H); 
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7.75 (t, J = 5.7 Hz, 2H); 7.65 (t, J = 7.48 Hz, 2H); 7.47 (d, J = 3.16 Hz, 2H);  7.11 (t, J = 5.92 
Hz, 2H).  
 
7.8.2 Synthesis of [Ru(bpy)2-L](PF6)2 
 
Ru(bpy)2Cl2 (120 mg, 0.25mmol), L (197 mg, 0.5 mmol) were dissolved in ethanol (30 ml) 
and refluxed in the dark under nitrogen for 24hrs. The resulting solution was allowed to cool 
to room temperature, then NH4PF6 (250 mg, 1 mmol) was added to the solution and stirred for 
45 min. The dark orange precipitate was separated by vacuum filtration and washed with cold 
water and diethyl ether. The crude product was redissolved in acetonitrile, kept in the fridge 
for 24 hrs and filtered. Acetonitrile was removed under reduced pressure, then the precipitate 
recrystallized from DCM and hexane (Yield: 170 mg; 70%) 1H NMR (400 MHz, CD3CN) δ: 
8.63 (s, 1H); 8.56 (d, J = 3.6 Hz, 1H); 8.49 (t, J = 7.8 Hz, 2H); 8.37 (d, J = 7.9 Hz, 2H); 8.31 
(s, 1H); 8.10-7.94 (m,  7H); 7.87-7.82 (m, 3H); 7.77 (d, J = 5.4 Hz, 1H); 7.71 (d, J = 5.4 Hz, 
1H); 7.57 (d, J = 5.5 Hz, 1H); 7.42-7.25 (m,  8H); 7.13 (d, J = 8.0 Hz, 2H); 5.62 (s, 2H); 5.51 
(d, J = 1.7 Hz, 2H); 13C NMR (101 MHz, CD3CN) δ: 156.9, 156.8, 156.6, 151.9, 151.8, 151.7, 
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151.4, 151.3, 150.4, 147.5, 137.9, 137.4, 137.3, 137.2, 137.0, 136.3, 133.8, 128.4, 128.4, 127.2, 
127.1, 127.0, 126.4, 125.7, 125.5, 123.9, 123.8, 123.4, 123.1, 122.8, 122.6, 122.5, 117.0, 54.7, 
52.9, ESI HRMS calculated for (C42H34N12Ru) m/z = 404.1031, found m/z = 404.10300 [M]
2+. 
7.8.3 Synthesis of [Ru(bpy)2-L-Ru(bpy)2](PF6)4 
 
Ru(bpy)2Cl2 (242 mg, 0.5mmol), L (197mg, 0.5 mmol) were dissolved in ethanol (30 ml) and 
refluxed in the dark under nitrogen for 24hrs. The resulting solution was allowed to cool to 
room temperature. Then NH4PF6 (250 mg, 1 mmol) was added to the solution and stirred for 
45 min. The dark orange precipitate was separated by vacuum filtration and washed with cold 
water and diethyl ether. The crude product was redissolved in acetonitrile and kept in fridge 
for 24 hrs and filtered. Acetonitrile was removed under reduced pressure and the precipitate 
recrystallized from DCM and hexane (yield: 230 mg; 70. %). 1H NMR (400 MHz, CD3CN) δ: 
8.69 (d, J = 2.88 Hz, 2H); 8.53 (d, J = 7.92 Hz, 4H); 8.42-8.36 (m, 4H); 8.10-8.05 (m, 6H); 
8.04-7.96 (m, 6H); 7.85 (t, J = 5.6 Hz, 4H); 7.81 (d, J = 5.4 Hz, 2H); 7.74 (d, J = 5.4 Hz, 2H); 
7.60 (d, J = 5.48 Hz, 2H); 7.45-7.37 (m,  6H); 7.34-7.29 (m, 4H); 7.13 (s, 4H); 5.53 (s, 4H); 
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13C NMR (101 MHz, CD3CN) δ: 157.3, 157.0, 156.9, 156.7, 151.8, 151.8, 151.7, 151.5, 151.4, 
150.4, 147.6, 138.0, 137.5, 137.4, 137.3, 134.1, 128.5, 128.5, 127.3, 127.2, 127.1, 126.5, 125.8, 
125.6, 125.5, 124.0, 123.9, 123.4, 123.2, 122.5, 117.1, 54.6, ESI HRMS calculated for 
(C62H50N16Ru2) m/z = 305.56173, found m/z = 305.56216 [M]
4+.  
7.9 - [Ru(bpy)2-L-Ir(ppy)2](PF6)3 
 
 
[{Ir(ppy)2Cl}2] (136 mg, 0.125 mmol), [Ru(bpy)2-L4](PF6)2 (100 mg, 0.125 mmol) and 
NH4PF6 (125 mg, 0.5 mmol) were dissolved in 30 ml of a mixture of methanol: chloroform(1:1 
v/v) and refluxed under nitrogen for 24hrs in the dark. The resulting solution was allowed to 
cool to room temperature, then diethyl ether was added and the orange precipitate was collected 
by filtration. The precipitate was washed with water (5 ml) and diethyl ether. The crude product 
was redissolved in acetonitrile kept in the fridge for 24 hrs and filtered. Acetonitrile was 
removed under reduced pressure, then the precipitate recrystallized from DCM and hexane 
(Yield: 114 mg; 70%). 1H NMR (400 MHz, CD3CN) δ: 8.69-8.62 (m, 2H); 8.52 (d, J = 5.2 Hz, 
2H); 8.36-8.28 (m, 2H); 8.11-7.92 (m, 10H); 7.86-7.59 (m, 12H); 7.42-7.29 (m, 6H); 7.21-6.91 
(m, 9H); 6.80 (s, 1H); 6.24 (d, J = 6.9 Hz, 2H); 5.61 (d, J = 5.0 Hz, 2H); 5.54 (d, J = 15.7 Hz, 
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2H); 13C NMR (100 MHz, CD3CN) δ: 152.2, 151.8, 151.7, 150.4, 149.3, 139.8, 137.8, 131.9, 
130.4, 129.7, 128.9, 127.6, 126.1, 124.9, 124.4, 124.3, 124.2, 122.9, 122.7, 122.2, 119.9, 54.8, 
HRMS calculated for (C64H50IrN14Ru) m/z = 436.4333, found m/z = 436.4335 [M]
3+.  
 
7.10 Published Papers 
The following list of publications has risen from this research activity:   
7.10.1 Refereed Journal Papers 
1- Omar, S. A., Scattergood, P. A., McKenzie, L. K., Bryant, H. E., Weinstein, J. A., & 
Elliott, P. I. (2016). Towards Water Soluble Mitochondria-Targeting Theranostic 
Osmium (II) Triazole-Based Complexes. Molecules, 21(10), 1382. 
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